Lighting Science (LSCG) 10-K 31 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 25, 2014	Jun. 30, 2013
Document And Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Registrant Name	'LIGHTING SCIENCE GROUP CORP	'	'
Entity Central Index Key	'0000866970	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	207,850,113	'
Entity Public Float	'	'	$12.10

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Riverwood Warrants [Member]

Riverwood Warrants [Member]

September 2012 Warrants [Member]

September 2012 Warrants [Member]

Pegasus Warrant [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Current assets:

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and cash equivalents

$11,195,412

$15,834,077

'

'

'

'

'

'

'

'

'

'

'

Restricted cash

5,000,000

5,000,000

'

'

'

'

'

'

'

'

'

'

'

Accounts receivable, net

7,771,623

13,130,387

'

'

'

'

'

'

'

'

'

'

'

Inventories, net

19,061,119

28,981,444

'

'

'

'

'

'

'

'

'

'

'

Prepaid expenses

1,900,025

2,457,033

'

'

'

'

'

'

'

'

'

'

'

Other current assets

358,740

683,842

'

'

'

'

'

'

'

'

'

'

'

Total current assets

45,286,919

66,086,783

'

'

'

'

'

'

'

'

'

'

'

Property and equipment, net

6,498,605

16,543,113

'

'

'

'

'

'

'

'

'

'

'

Intangible assets, net

1,850,411

864,410

'

'

'

'

'

'

'

'

'

'

'

Pegasus Commitment

1,407,335

1,360,000

'

'

'

'

'

'

'

'

'

'

'

Other long-term assets

253,856

739,480

'

'

'

'

'

'

'

'

'

'

'

Total assets

55,297,126

85,593,786

'

'

'

'

'

'

'

'

'

'

'

Current liabilities:

'

'

'

'

'

'

'

'

'

'

'

'

'

Lines of credit

40,211,429

1,501,724

'

'

'

'

'

'

'

'

'

'

'

Current portion of long-term debt

4,998

4,087

'

'

'

'

'

'

'

'

'

'

'

Accounts payable

15,980,466

14,791,213

'

'

'

'

'

'

'

'

'

'

'

Provision for losses on non-cancelable purchase commitments

1,629,806

5,678,992

'

'

'

'

'

'

'

'

'

'

'

Accrued expenses

7,180,108

6,754,946

'

'

'

'

'

'

'

'

'

'

'

Total current liabilities

65,006,807

28,730,962

'

'

'

'

'

'

'

'

'

'

'

Long-term debt, less current portion

8,460

14,321

'

'

'

'

'

'

'

'

'

'

'

Warrants liability

'

'

5,002,664

7,960,705

1,407,335

1,360,000

2,765,047

'

'

'

'

'

'

Total other liabilities

9,183,506

9,335,026

'

'

'

'

'

'

'

'

'

'

'

Total liabilities

74,190,313

38,065,988

'

'

'

'

'

'

'

'

'

'

'

Redeemable Convertible Preferred Stock

391,956,776

352,025,176

'

'

'

'

'

227,220,149

227,288,549

124,736,627

124,736,627

40,000,000

'

Commitments and contingencies

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' deficit:

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, $.001 par value, authorized 25,000,000 shares, 113,609 shares of Series H, 62,365 shares of Series I and 20,000 shares of Series J issued and outstanding as of December 31, 2013 and 113,643 shares of Series H, 62,365 shares of Series I and 0 of Series J issued and outstanding as of December 31, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, $.001 par value, authorized 475,000,000 shares, 210,349,168 and 208,063,486 shares issued as of December 31, 2013 and 2012, respectively

210,349

208,063

'

'

'

'

'

'

'

'

'

'

'

Additional paid-in capital

331,199,891

347,686,258

'

'

'

'

'

'

'

'

'

'

'

Accumulated deficit

-734,733,900

-644,916,568

'

'

'

'

'

'

'

'

'

'

'

Accumulated other comprehensive loss

-3,768,803

-3,717,631

'

'

'

'

'

'

'

'

'

'

'

Treasury stock, 2,505,000 shares as of December 31, 2013 and 2012, at cost

-3,757,500

-3,757,500

'

'

'

'

'

'

'

'

'

'

'

Total stockholders' deficit

-410,849,963

-304,497,378

'

'

'

'

'

'

'

'

'

'

'

Total liabilities and stockholders' deficit

$55,297,126

$85,593,786

'

'

'

'

'

'

'

'

'

'

'

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
			Series H Redeemable Convertible Preferred Stock [Member]	Series H Redeemable Convertible Preferred Stock [Member]	Series I Redeemable Convertible Preferred Stock [Member]	Series I Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]
Preferred stock, par value	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Preferred stock, shares authorized	25,000,000	25,000,000	135,000	135,000	90,000	90,000	50,000	50,000
Preferred stock, shares issued	113,609	113,643	113,609	113,609	62,365	62,365	20,000	0
Preferred stock, shares outstanding	113,609	113,643	113,643	113,643	62,365	62,365	20,000	0
Common stock, par value	$0.00	$0.00	'	'	'	'	'	'
Preferred stock, shares issued	113,609	113,643	113,609	113,609	62,365	62,365	20,000	0
Common stock, shares authorized	475,000,000	475,000,000	'	'	'	'	'	'
Preferred stock, shares outstanding	113,609	113,643	113,643	113,643	62,365	62,365	20,000	0
Common stock shares issued	210,349,168	208,063,486	'	'	'	'	'	'
Treasury stock, shares	2,505,000	2,505,000	'	'	'	'	'	'

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Comprehensive Loss (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue	$83,221,557	$127,111,351	$108,981,588
Cost of goods sold (exclusive of depreciation shown below)	98,043,280	146,902,807	129,187,145
Gross deficit	-14,821,723	-19,791,456	-20,205,557
Operating expenses:	'	'	'
Selling, distribution and administrative (includes related party expenses of $2.2 million, $1.8 million and $1.7 million for 2013, 2012 and 2011, respectively)	51,395,936	60,928,462	52,817,425
Research and development	10,338,799	10,071,839	10,670,455
Write-off of deferred offering costs	'	'	1,269,318
Restructuring expenses	4,657,497	6,212,936	598,037
Impairment of goodwill and other long-lived assets	'	379,537	4,121,349
Depreciation and amortization	8,722,030	8,411,187	4,895,742
Total operating expenses	75,114,262	86,003,961	74,372,326
Loss from operations	-89,935,985	-105,795,417	-94,577,883
Other income (expense):	'	'	'
Interest income	4,749	5,458	153,539
Interest expense	-4,026,560	-4,646,628	-2,016,388
Related party interest expense	'	-250,000	-43,200
Decrease in fair value of liabilities under derivative contracts	3,892,994	8,503,480	'
Dividends on preferred stock	'	-1,799,392	-237,824
Accretion of preferred stock	'	-7,523,459	-239,408
Other income, net	247,470	165,549	6,526,596
Total other (expense) income	118,653	-5,544,992	4,143,315
Loss before income tax expense	-89,817,332	-111,340,409	-90,434,568
Income tax expense	'	'	'
Net loss	-89,817,332	-111,340,409	-90,434,568
Foreign currency translation loss	-51,172	-69,734	-89,486
Comprehensive loss	-89,868,504	-111,410,143	-90,524,054
Basic and diluted net loss per weighted average common share	'	'	($0.48)
Basic and diluted weighted average number of common shares outstanding	'	'	189,671,299
Controlling Shareholders [Member]	'	'	'
Other income (expense):	'	'	'
Loss before income tax expense	-74,506,560	-93,066,715	'
Basic and diluted net loss per weighted average common share	($0.55)	($1.47)	'
Basic and diluted weighted average number of common shares outstanding	170,662,220	171,336,891	'
Noncontrolling Shareholders [Member]	'	'	'
Other income (expense):	'	'	'
Loss before income tax expense	($15,310,772)	($18,273,694)	'
Basic and diluted net loss per weighted average common share	($0.55)	($1.92)	'
Basic and diluted weighted average number of common shares outstanding	35,070,340	33,642,080	'

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Related party expense	$0	$313,000	$625,000
Selling, Distribution and Administrative Expenses [Member]	'	'	'
Related party expense	$2,200,000	$1,800,000	$1,700,000

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Series J Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]
					Series J Redeemable Convertible Preferred Stock [Member]
Balance at Dec. 31, 2010	$24,681,511	'	$125,595	$471,255,918	'	($443,141,591)	($3,558,411)	'
Balance, shares at Dec. 31, 2010	'	'	125,595,418	'	'	'	'	'
Issuance of common stock for directors' compensation	945,001	'	286	944,715	'	'	'	'
Issuance of common stock for directors' compensation, shares	'	'	286,365	'	'	'	'	'
Stock based compensation expense	3,675,353	'	'	3,675,353	'	'	'	'
Stock issued under equity compensation plans	1,364,628	'	2,381	1,362,247	'	'	'	'
Stock issued under equity compensation plans, shares	'	'	2,380,556	'	'	'	'	'
Issuance of common stock in connection with private placements	57,516,431	'	15,780	57,500,651	'	'	'	'
Issuance of common stock in connection with private placements, shares	'	'	15,779,527	'	'	'	'	'
Issuance of common stock for conversion of debt	6,543,200	'	1,636	6,541,564	'	'	'	'
Issuance of common stock for conversion of debt, shares	'	'	1,635,800	'	'	'	'	'
Issuance of common stock in exchange for outstanding warrants	'	'	56,306	-56,306	'	'	'	'
Issuance of common stock in exchange for outstanding warrants, shares	'	'	56,306,580	'	'	'	'	'
Issuance of common stock in connection with Series F and G Units	5,901,529	'	2,831	5,898,698	'	'	'	'
Issuance of common stock in connection with Series F and G Units, shares	'	'	2,830,964	'	'	'	'	'
Warrant issued to a customer	2,480,900	'	'	2,480,900	'	'	'	'
Net loss	-90,434,568	'	'	'	'	-90,434,568	'	'
Foreign currency translation adjustment	-89,486	'	'	'	'	'	-89,486	'
Balance at Dec. 31, 2011	12,584,499	'	204,815	549,603,740	'	-533,576,159	-3,647,897	'
Balance, shares at Dec. 31, 2011	'	'	204,815,210	'	'	'	'	'
Issuance of common stock for directors' compensation	1,563,519	'	659	1,562,860	'	'	'	'
Issuance of common stock for directors' compensation, shares	'	'	658,657	'	'	'	'	'
Stock based compensation expense	6,947,960	'	'	6,947,960	'	'	'	'
Stock issued under equity compensation plans	893,927	'	124	893,803	'	'	'	'
Stock issued under equity compensation plans, shares	'	'	125,280	'	'	'	'	'
Issuance of common stock in exchange for outstanding warrants	'	'	604	-604	'	'	'	'
Issuance of common stock in exchange for outstanding warrants, shares	'	'	603,589	'	'	'	'	'
Issuance of common stock in connection with Series F and G Units	1,904,684	'	1,515	1,903,169	'	'	'	'
Issuance of common stock in connection with Series F and G Units, shares	'	'	1,514,750	'	'	'	'	'
Warrant issued to a customer	458,162	'	'	458,162	'	'	'	'
Issuance of Repurchase Obligation	-12,100,000	'	'	-12,100,000	'	'	'	'
Change in fair value of Repurchase Obligation	-388,175	'	'	-388,175	'	'	'	'
Receipt of treasury stock	-3,757,500	'	'	'	'	'	'	-3,757,500
Deemed dividends on Series H, J and I Redeemable Convertible Preferred Stock (including a beneficial conversion feature of $34.6 million)	-203,610,872	'	'	-203,610,872	'	'	'	'
Pegasus Commitment	-1,600,000	'	'	-1,600,000	'	'	'	'
Issuance of common stock in exchange for outstanding Series H Preferred	816,561	'	346	816,215	'	'	'	'
Issuance of common stock in exchange for outstanding Series H Preferred, shares	'	'	346,000	'	'	'	'	'
Net loss	-111,340,409	'	'	'	'	-111,340,409	'	'
Foreign currency translation adjustment	-69,734	'	'	'	'	'	-69,734	'
Balance at Dec. 31, 2012	-304,497,378	'	208,063	347,686,258	'	-644,916,568	-3,717,631	-3,757,500
Balance, shares at Dec. 31, 2012	'	'	208,063,486	'	'	'	'	'
Issuance of common stock for directors' compensation	745,610	'	1,854	743,756	'	'	'	'
Issuance of common stock for directors' compensation, shares	'	'	1,854,507	'	'	'	'	'
Stock based compensation expense	7,021,503	'	'	7,021,503	'	'	'	'
Stock issued under equity compensation plans	38,998	'	396	38,602	'	'	'	'
Stock issued under equity compensation plans, shares	'	'	395,175	'	'	'	'	'
Deemed dividends on Series H, J and I Redeemable Convertible Preferred Stock (including a beneficial conversion feature of $34.6 million)	'	-24,358,592	'	'	-24,358,592	'	'	'
Issuance of common stock in exchange for outstanding Series H Preferred	68,400	'	36	68,364	'	'	'	'
Issuance of common stock in exchange for outstanding Series H Preferred, shares	'	'	36,000	'	'	'	'	'
Net loss	-89,817,332	'	'	'	'	-89,817,332	'	'
Foreign currency translation adjustment	-51,172	'	'	'	'	'	-51,172	'
Balance at Dec. 31, 2013	($410,849,963)	'	$210,349	$331,199,891	'	($734,733,900)	($3,768,803)	($3,757,500)
Balance, shares at Dec. 31, 2013	'	'	210,349,168	'	'	'	'	'

Consolidated_Statement_of_Stoc1

Consolidated Statement of Stockholders' Equity (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Issuance of common stock in connection with private placements, issuance costs	($7,620,413)	($1,783,497)
Beneficial conversion feature in preferred stock	34,600,000	'
Common Stock [Member]	'	'
Issuance of common stock in connection with private placements, issuance costs	'	1,800,000
Additional Paid-in Capital [Member]	'	'
Issuance of common stock in connection with private placements, issuance costs	'	1,800,000
Beneficial conversion feature in preferred stock	$34,600,000	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net loss	($89,817,332)	($111,340,409)	($90,434,568)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	8,722,030	8,411,187	4,895,742
Impairment of goodwill and other long-lived assets	'	379,537	4,121,349
Impairment of plant and equipment	2,420,132	1,698,356	'
Issuance of restricted stock and stock options for directors' compensation	745,610	1,563,519	945,001
Stock based compensation expense	7,021,503	6,947,959	3,675,353
Accretion of preferred stock redemption value	'	7,523,459	239,408
Non-cash sales incentive	'	458,162	2,480,900
Allowance for doubtful accounts receivable	245,151	577,090	2,001,614
Inventory valuation allowance	11,350,469	15,829,639	20,537,341
Provision for losses on non-cancelable purchase commitments	2,347,905	5,580,993	8,549,202
Write-off of deferred offering costs	'	'	1,269,318
Decrease in fair value of warrants	-3,892,994	-8,503,480	'
Dividends on preferred stock	'	1,799,392	237,824
(Gain) loss on disposal of assets	497,140	52,373	460,925
Changes in operating assets and liabilities:	'	'	'
Accounts receivable	5,065,780	15,264,498	-15,282,283
Inventories	-7,294,767	-5,654,120	-42,335,216
Prepaid expenses	555,549	6,701,545	-5,716,070
Other current and long-term assets	810,726	514,865	-825,702
Accounts payable	979,698	-14,559,603	-10,637,915
Accrued expenses and other liabilities	-189,675	2,861,426	-297,394
Unearned revenue	32,278	-40,999	-91,011
Net cash used in operating activities	-60,400,797	-63,934,611	-116,206,182
Cash flows from investing activities:	'	'	'
Purchases of property and equipment	-2,118,183	-5,895,070	-17,568,135
Capitalized patents	-1,026,325	-456,874	-217,621
Proceeds from sale of property and equipment	565,918	36,000	81,942
Net cash used in investing activities	-2,578,590	-6,315,944	-17,703,814
Cash flows from financing activities:	'	'	'
Net proceeds from draws on lines of credit and other short-term borrowings	38,709,705	-32,717,201	34,619,866
Proceeds from long-term borrowings	'	'	25,700
Payment of short and long-term debt	-4,950	-11,416	-97,860
Restricted cash related to line of credit	'	'	-5,000,000
Proceeds from issuance of common stock under equity compensation plans	38,998	893,927	1,364,628
Proceeds from private placement of common stock	'	'	59,299,928
Redemption of 6% Convertible Preferred Stock	'	-33,830	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	'	34,108,000
Payment in settlement of Repurchase Obligation	'	-10,245,675	'
Placement agent commissions on private placements	-658,592	-7,620,413	-1,783,497
Net cash provided by financing activities	58,085,161	83,078,986	122,536,765
Effect of exchange rate changes on cash	255,561	-66,027	-44,796
Net (decrease) increase in cash	-4,638,665	12,762,404	-11,418,027
Cash and cash equivalents balance at beginning of period	15,834,077	3,071,673	14,489,700
Cash and cash equivalents balance at end of period	11,195,412	15,834,077	3,071,673
Supplemental disclosures:	'	'	'
Interest paid during the period	3,963,304	5,038,919	1,878,635
Non-cash investing and financing activities:	'	'	'
Issuance of Repurchase Obligation	'	12,100,000	'
Change in fair value of Repurchase Obligation	'	388,175	'
Settlement of Repurchase Obligation with issuance of Series I Redeemable Convertible Preferred Stock	'	-6,000,000	'
Treasury stock received in settlement of Repurchase Obligation	'	3,757,500	'
Deemed dividends on Series H, I and J Redeemable Convertible Preferred Stock	-24,358,592	-202,105,466	'
Pegasus Commitment	'	-1,600,000	'
Conversion of Series H Preferred Stock to common stock	'	346	'
Conversion of debt to equity	'	'	6,543,200
Series G Preferred Units [Member]	'	'	'
Cash flows from financing activities:	'	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	18,250,000	34,108,000
Series H Redeemable Convertible Preferred Stock [Member]	'	'	'
Cash flows from financing activities:	'	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	108,199,594	'
Series I Redeemable Convertible Preferred Stock [Member]	'	'	'
Cash flows from financing activities:	'	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	6,364,000	'
Series J Redeemable Convertible Preferred Stock [Member]	'	'	'
Cash flows from financing activities:	'	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	$20,000,000	'	'

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Parenthetical)	12 Months Ended
	Dec. 31, 2013
Statement Of Cash Flows [Abstract]	'
Convertible Preferred stock dividend rate	6.00%

Description_of_Business_and_Ba

Description of Business and Basis of Presentation	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Description of Business and Basis of Presentation	'
	NOTE 1: DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
	Overview
	Lighting Science Group Corporation (the “Company”) was incorporated in Delaware in 1988 and designs, develops, manufactures and markets general illumination products that exclusively use light emitting diodes (“LEDs”) as their light source. The Company’s product portfolio includes LED-based retrofit lamps (replacement bulbs) that can be used in existing light fixtures and sockets as well as purpose built LED-based luminaires (light fixtures) for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. The Company assembles and manufactures its products both internally and through its contract manufacturers in Asia.
	Basis of Financial Statement Presentation
	The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and the rules of the Securities Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying consolidated financial statements.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Use of Estimates
	The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable, inventories, intangible assets and other long-lived assets, legal contingencies, and customer incentives, among others. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency and energy markets and declines in consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
	Foreign Currency Translation
	The functional currency for the foreign operations of the Company is the local currency of the respective foreign subsidiary. For the operations of Lighting Science Group B.V. (“LSGBV”), the Company’s Netherlands based subsidiary, the functional currency is the Euro, for the operations of Lighting Science Group Mexico SRL, (“LSG Mexico”), the Company’s Mexican subsidiary, the functional currency is the Mexican Peso and for the operations of Lighting Science India Private Limited (“LSIPL”), the Company’s Indian subsidiary, the functional currency is the Indian Rupee. The translation of foreign currencies into U.S. dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet dates and for revenue and expense accounts using the average exchange rate for each period during the year. Any gains or losses resulting from the translation are included in accumulated other comprehensive loss in the consolidated statements of stockholders’ (deficit) equity and are excluded from net loss.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. As of December 31, 2013 and 2012, the Company had $0 and $21,000, respectively, in cash equivalents. The Company regularly maintains cash balances in excess of federally insured limits. To date, the Company has not experienced any losses on its cash and cash equivalents. As of December 31, 2013, the Company had $16.0 million in cash and cash equivalents and restricted cash held in banks in the United States in excess of the federally insured limits.
	Restricted Cash
	As required by the Company’s asset-based revolving credit facility (as amended, the “Wells Fargo ABL”) with Wells Fargo Bank N.A. (“Wells Fargo”) the Company was required to maintain a minimum qualified cash balance of $5.0 million as a compensating balance against the Wells Fargo ABL. Changes in the restricted cash balance were reflected as a financing activity in the consolidated statement of cash flows.
	Accounts Receivable
	The Company records accounts receivable at the invoiced amount when its products are shipped to customers or upon the completion of specific milestone billing requirements. The Company’s receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, aging of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based upon age or customer circumstances that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of December 31, 2013 and 2012, the Company’s accounts receivable are reflected net of an allowance for doubtful accounts of $475,000 and $1.2 million, respectively.
	As of December 31, 2013 and 2012, there were $6.8 million and $11.4 million, respectively of eligible accounts receivable pledged as collateral for the Company’s line of credit with Wells Fargo.
	Inventories
	Inventories, which consist of raw materials and purchased components and subsystems, work-in-process and finished lighting products, are stated at the lower of cost or market. The Company uses a standard costing methodology to value its inventories. This costing methodology approximates actual cost on a weighted average basis. The Company reviews and sets its standard costs of raw materials, work-in-process and finished goods inventory on a periodic basis to ensure that its inventories approximate current actual costs. Any purchase price variances related to labor and overhead that would indicate a loss on disposition of inventory is recorded to cost of goods sold in the statement of operations at the end of each reporting period. Work in process and finished lighting products include raw materials, labor and allocated overhead. Slow product adoption, rapid technological changes and new product introductions and enhancements could result in excess or obsolete inventory. The Company evaluates inventory levels and expected usage on a periodic basis to specifically identify obsolete, slow-moving or non-salable inventory. The write-down of excess and obsolete inventory based on this evaluation creates a new cost basis and is included in cost of goods sold.
	On a quarterly basis, the Company considers the need to record a lower of cost or market adjustment once raw materials are used to produce specific finished goods. The market value of finished goods is determined based upon current sales transactions, less the cost of disposal of the respective finished goods. The write-down of inventory to the lower of cost or market creates a new cost basis that cannot be marked up even if there are subsequent changes in the underlying facts and circumstances.
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Equipment under capital leases is stated at the present value of future minimum lease payments. Depreciation is provided using the straight-line method over the estimated economic lives of the assets, as follows:
			Estimated
			Useful Lives
	Leasehold improvements		1-5 years
	Office, furniture and equipment		2-5 years
	Tooling, production and test equipment		2-4 years
	Leasehold improvements and equipment under capital leases are amortized on a straight-line basis over the shorter of the minimum lease term or the estimated useful life of the assets. Expenditures for repairs and maintenance are charged to expense as incurred. The costs for major renewals and improvements are capitalized and depreciated over their estimated useful lives. All costs incurred for building of production tooling and molds are capitalized and amortized over the estimated useful life of the tooling set or mold.
	Intangible Assets
	Intangible assets include patents and patents pending. Intangible assets with estimable useful lives are amortized over their respective useful lives on a straight-line basis. Finite–lived intangible assets are reviewed for impairment or obsolescence annually, or more frequently if events or changes in circumstance indicate that the carrying amount of an intangible asset may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash flows.
	Impairment of Long-lived Assets
	Long lived assets, such as property, plant and equipment, and purchased intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third party independent appraisals, as considered necessary.
	Derivative Instruments
	The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. All derivatives are recorded at fair value on the consolidated balance sheets and changes in the fair value of such derivatives are measured in each period and are reported in other income (expense).
	Fair Value of Financial Instruments
	The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
		•		Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
		•		Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
		•		Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.
	Revenue Recognition
	The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once these terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.
	Shipping and Handling Fees and Costs
	Shipping and handling fees billed to customers are included in revenue. Shipping and handling costs associated with in-bound freight are included in cost of goods sold. Other shipping and handling costs are included in selling, distribution and administrative expenses and totaled $3.4 million, $5.1 million and $3.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Research and Development
	The Company expenses all research and development costs, including amounts for design prototypes and modifications made to existing prototypes, as incurred, except for prototypes that have alternative future uses.
	Product Warranties
	The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products and such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The following table summarizes changes in the warranty provision during the years ended December 31, 2013 and 2012:
	Warranty provision as of December 31, 2011		$	526,906
	Additions to provision			2,966,313
	Less warranty costs			(1,385,207	)
	Warranty provision as of December 31, 2012			2,108,012
	Additions to provision			4,927,844
	Less warranty costs			(3,803,865	)
	Warranty provision as of December 31, 2013		$	3,231,991
	Share Based Compensation
	The Company recognizes all employee stock based compensation as a cost in the financial statements based on the fair value of the share based compensation award. Equity classified awards are measured at the grant date fair value of the award. The Company estimates grant date fair value using the Black Scholes Merton option pricing model.
	As of December 31, 2013 and 2012, the Company had two share based compensation plans. The fair value of share based compensation awards, which historically have included stock options and restricted stock awards, is recognized as compensation expense in the statement of operations. The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. Option valuation methods require the input of highly subjective assumptions, including the expected stock price volatility. Measured compensation expense related to such option grants is recognized ratably over the vesting period of the related grants. Restricted stock awards are valued on the date of grant.
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in the income tax provision.
	Advertising
	Advertising costs, included in sales and marketing expenses, are expensed when the advertising first takes place. The Company primarily promotes its product lines through print media and trade shows, including trade publications and promotional brochures. Advertising expenses were $1.3 million, $872,000 and $2.0 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Segment Reporting
	The Company operates as a single segment under Accounting Standard Codification (“ASC”) 280-10-50, “Disclosures about Segments of an Enterprise and Related Information”. The Company’s chief operating decision maker reviews financial information at the enterprise level and makes decisions accordingly.

Liquidity_and_Capital_Resource

Liquidity and Capital Resources	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Liquidity and Capital Resources	'
	NOTE 3: LIQUIDITY AND CAPITAL RESOURCES
	As shown in the consolidated financial statements, the Company has experienced significant net losses as well as negative cash flows from operations since its inception, resulting in an accumulated deficit of $734.7 million and stockholders’ deficit of $410.8 million as December 31, 2013. In addition, the Company has negative working capital of $19.7 million as of December 31, 2013. The Company’s cash expenditures primarily relate to procurement of inventory, payment of salaries, employee benefits and other operating costs and purchases of production equipment and other capital investments. The Company’s primary sources of liquidity have historically been borrowings from Wells Fargo and sales of common stock and preferred stock to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings, LLC (“LSGC Holdings”), LSGC Holdings II, LLC (“Holdings II”) and PCA LSG Holdings, LLC (“PCA Holdings”), which together with its affiliates, is the Company’s controlling stockholder. However, as detailed below, the Series H and I Preferred Offering (defined in Note 10 below) was provided primarily by parties other than Pegasus Capital and its affiliates.
	As of December 31, 2013, the Company had cash and cash equivalents of $11.2 million and an additional $5.0 million in cash subject to restriction pursuant to the Wells Fargo ABL. The Wells Fargo ABL provided the Company with a borrowing capacity of up to $50.0 million, which capacity was equal to the sum of (i) 85% of its eligible accounts receivable plus up to $7.5 million of eligible inventory, less certain allowances established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) unrestricted cash held in a Wells Fargo deposit account (“Qualified Cash”), plus (iii) the amount of the Second Lien Letter of Credit Facility with Ares Capital Corporation (“Ares Capital”), pledged in favor of Wells Fargo (the “Ares Letter of Credit Facility”) for the benefit of the Company (collectively, the “Borrowing Base”). The Company was required to maintain (i) a Borrowing Base that exceeds the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million in Qualified Cash. The Company would have been required to comply with certain specified EBITDA requirements in the event that it had less than $2.0 million available for borrowing under the Wells Fargo ABL. As of December 31, 2013, the Company had $40.2 million of outstanding borrowings under the Wells Fargo ABL and additional borrowing capacity of $4.8 million.
	On February 19, 2014, the Company entered into a five-year term loan (the “Medley Term Loan”) in the amount of $30.5 million and a two-year delayed draw term loan (the “Medley Delayed Draw Loan”) with Medley Capital Corporation (“Medley”). The Medley Delayed Draw Loan provides the Company with borrowing capacity of up to a maximum of $22.5 million, which capacity is limited by a borrowing base equal to the sum of (i) 85% of the Company’s eligible accounts receivable (ii) 60% of the Company’s eligible inventory, and (iii) qualified cash less any reserves imposed by Medley. The Company utilized proceeds from the Medley Term Loan to repay its outstanding obligations under the Wells Fargo ABL and the Ares Letter of Credit Facility.
	From September 11, 2013 through November 18, 2013 , the Company issued an aggregate of 20,000 shares of its Series J Preferred Stock, par value $0.001 per share (the “Series J Preferred Stock”), at a price of $1,000 per share (the “Stated Value”) for aggregate proceeds of $20.0 million (the “Initial Series J Preferred Offering”). The shares of Series J Preferred Stock were issued pursuant to a preferred stock subscription agreement (the “Series J Subscription Agreement”) entered into between the Company, RW LSG Holdings LLC, (“Riverwood Holdings”), an affiliate of Riverwood LSG Management Holdings LLC (“Riverwood Management”) and Riverwood Capital Partners L.P. (“Riverwood Capital,” and together with Riverwood Holdings, Riverwood Management and their affiliates, “Riverwood”), PCA Holdings and Holdings II.
	The Company believes it will have sufficient capital to fund its operations for at least the next 12 months based on its current business plan and assumptions of future results. The current business plan includes a focus on increasing revenue by updating and expanding our product offerings and capitalizing on the known product needs of our existing customers, improving gross margins by significantly leveraging contract manufacturers in Asia and reducing operating costs, primarily through the restructuring initiated in 2013. In future periods, if the Company does not adequately execute upon its business plan or its assumptions or forecasts do not prove to be accurate, the Company could exhaust its available capital resources, which could require the Company to seek to raise additional capital and/or further reduce its expenditures of cash. There can be no assurance that sources of liquidity will be available in an amount or on terms that are acceptable to the Company.
	Between January 3, 2014 and March 7, 2014, the Company issued an aggregate of 17,475 units of its securities (the “Series J Securities”), at a purchase price of $1,000 per Series J Security for aggregate proceeds of $17.5 million (the “Follow-On Series J Offering”). Each Series J Security consists of (i) one share of the Company’s Series J Preferred Stock and (ii) a warrant to purchase 2,650 shares of the Company’s common stock, at an exercise price of $0.001 per share (the “Series J Warrants”). The Series J Securities were issued pursuant to a preferred stock subscription agreement (the “Series J Securities Subscription Agreement”) entered into between the Company, PCA Holdings, Holdings II, Riverwood Holdings, Cleantech Europe II (A) LP (“ Cleantech A”), Cleantech Europe II (B) LP (“Cleantech B”, and together with Cleantech A, “Zouk”) and certain other accredited investors. In the Initial Series J Preferred Offering and the Following Offering, the Company issued an aggregate of 19,657 Series J Securities to Holdings II, 8,500 Series J Securities to PCA Holdings, 5,254 Series J Securities to Riverwood, 2,570 Series J Securities to Zouk and 1,494 Series J Securities to certain other accredited investors. Upon the consummation of the Follow-On Series J Offering, each of the shares of Series J Preferred Stock issued in the Initial Series J Preferred Offering were converted into Series J Securities pursuant to the terms of the Series J Subscription Agreement. In the Initial Series J Preferred Offering and the Follow-On Series J Offering, the Company issued an aggregate of 19,657 Series J Securities to Holdings II, 8,500 Series J Securities to PCA Holdings, 5,254 Series J Securities to Riverwood, 2,570 Series J Securities to Zouk and 1,494 Series J Securities to certain other accredited investors.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	NOTE 4: FAIR VALUE MEASUREMENTS
	Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and other current liabilities are carried at book value amounts, which approximate fair value due to the short-term maturity of these instruments.
	The Company reviewed the amortizable intangible assets acquired in the acquisition of LSGBV for impairment during the year ended December 31, 2012. An impairment charge was recorded primarily due to LSGBV’s ongoing negative cash flows from operations, and as a result these intangible assets were accounted for at fair value on a non-recurring basis, using Level 3 valuation inputs and were written down to their estimated fair values of $0.
	The Pegasus Warrant (as defined in Note 9 below) and the Riverwood Warrant, September 2012 Warrants and the Pegasus Commitment (each as defined in Note 10 below) were initially recorded at fair value and are marked to fair value each quarter.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013, according to the valuation techniques the Company used to determine their fair values:
		Fair Value Measurement as of December 31, 2013
		Quoted Price in			Significant Other		Significant
		Active Markets for			Observable Inputs		Unobservable Inputs
		Identical Assets
		Level 1			Level 2		Level 3
	Assets (Recurring):
	Pegasus Commitment	$	—		$	—	$	1,407,335
	Liabilities (Recurring):
	Riverwood Warrants	$	—		$	—	$	5,002,664
	September 2012 Warrants		—			—		1,407,335
	Pegasus Warrant		—			—		2,765,047
		$	—		$	—	$	9,175,046
	The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs as defined above for the year ended December 31, 2013:
		Total			Pegasus		Riverwood			September 2012			Pegasus
					Commitment		Warrants			Warrant			Warrant
	Beginning balance, December 31, 2012	$	(7,960,705	)	$	1,360,000	$	(7,960,705	)	$	(1,360,000	)	$	—
	Realized and unrealized gains (losses) included in net loss		3,892,994			47,335		2,958,041			(47,335	)		934,953
	Purchases, sales, issuances and settlements		(3,700,000	)		—		—			—			(3,700,000	)
	Transfers in or out of Level 3		—			—		—			—			—
	Ending balance, December 31, 2013	$	(7,767,711	)	$	1,407,335	$	(5,002,664	)	$	(1,407,335	)	$	(2,765,047	)
	The Company had financial assets and liabilities that were accounted for at fair value on a recurring basis during the year ended December 31, 2012 related to Series H and Series I Preferred Stock and Warrants (Note 10) using significant unobservable inputs (Level 3). All of these instruments were issued during the year ended December 31, 2012 and there were no transfers in or out of Level 3 during 2012. The unrealized loss on the Riverwood Warrants was $8.5 million for the year ended December 31, 2012. As of December 31, 2012, the Company had no financial assets or liabilities that were accounted for at fair value on a non-recurring basis.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Inventories	'
	NOTE 5: INVENTORIES
	Inventories are comprised of the following:
		December 31, 2013		December 31, 2012
	Raw materials and components	$	6,868,139	$	15,150,768
	Work-in-process		1,599,089		1,309,447
	Finished goods		10,593,891		12,521,229
	Total inventory, net	$	19,061,119	$	28,981,444
	Consigned inventory is held at third-party locations, including those of the Company’s contract manufacturers. The Company retains title to the inventory until such inventory is purchased by a third-party. Consigned inventory, consisting of raw materials, was $693,000 and $2.0 million as of December 31, 2013 and 2012, respectively.
	On a quarterly basis, the Company performs a review of its inventory for estimated obsolete or slow-moving inventory based upon assumptions about future demand and market conditions. As a result of these reviews, the Company recorded an inventory valuation allowance of $11.4 million, $15.8 million and $20.5 million for the years ended December 31, 2013, 2012 and 2011, respectively, with the expense included in cost of goods sold. As of December 31, 2013 and December 31, 2012, inventories are stated net of inventory valuation allowances (write-downs) of $24.1 million and $25.6 million, respectively. The Company considered a number of factors in estimating the required inventory allowances, including (i) the focus of the business on the next generation of the Company’s products, which utilize lower cost technologies, (ii) the strategic focus on core products to meet the demands of key customers and (iii) the expected demand for the Company’s current generation of products, which are approaching the end of their lifecycle upon the introduction of the next generation of products.
	During the years ended December 31, 2013, 2012 and 2011, the Company recorded $2.3 million, $5.6 million and $8.5 million, respectively, in provisions for losses on non-cancellable purchase commitments of which $1.6 million and $5.7 million were accrued as of December 31, 2013 and 2012, respectively, which were included in cost of goods sold in the Consolidated Statement of Operations.
	The Company has identified certain finished goods that have and continue to generate negative margins. These finished goods are manufactured using common raw materials that are implemented into a number of product SKUs, which are used in the manufacture of other finished goods inventory that also generate positive margins for the Company. On a quarterly basis, the Company considers the need to record a lower of cost or market adjustment for the raw materials and finished goods inventory. The market value of finished goods is determined based upon current sales transactions, less the cost of disposal of the respective finished goods.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2013
Property Plant And Equipment [Abstract]	'
Property and Equipment	'
	NOTE 6: PROPERTY AND EQUIPMENT
	Property and equipment consists of the following:
		December 31, 2013			December 31, 2012
	Leasehold improvements	$	1,486,628		$	1,627,933
	Office furniture and equipment		1,141,314			1,255,244
	Computer hardware and software		8,802,484			8,924,424
	Tooling, production and test equipment		16,141,358			19,194,959
	Construction-in-process		325,252			134,240
	Total property and equipment		27,897,036			31,136,800
	Accumulated depreciation		(21,398,431	)		(14,593,687	)
	Total property and equipment, net	$	6,498,605		$	16,543,113
	Depreciation related to property and equipment was $8.7 million, $8.2 million and $4.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Impairment of Property and Equipment
	Property and equipment are depreciated over their estimated economic lives. Long-lived assets, including property and equipment, are evaluated to determine whether, in management’s judgment, events or changes in circumstances have occurred that may warrant a revision of the estimated useful life or whether the remaining balance should be evaluated for possible impairment. Such impairment tests compare estimated undiscounted cash flows over the remaining life of the property and equipment in assessing whether an asset has been impaired. If an impairment is indicated, the asset is written down to its fair value based on an estimate of its discounted cash flows.
	In November and December 2013, the Company performed an impairment analysis of property and equipment related to its Satellite Beach, Florida headquarters, its facility in The Netherlands, LSGBV, and its facility in India, LSIPL, in connection with the transition of a majority of the Company’s manufacturing operations to its contract manufacturers in Asia and the winding down of business in the Netherlands and India. This impairment analysis included an assessment of the proposed future use of the property and equipment and their estimated useful lives. As a result of this assessment the Company recorded an impairment charge of $2.6 million for the year ended December 31, 2013, which is included in Restructuring Expense.
	In connection with the Company’s September 2012 transition of its manufacturing operations in Mexico to its contract manufacturer in Mexico, Jabil Circuit, Inc. (the “Mexico Closing”), the Company performed an impairment analysis of property and equipment related to its wholly-owned subsidiary, Lighting Science Group Mexico S. de R.L. de C.V. (“LSG Mexico”). This review included an assessment of the proposed future use of the property and equipment and their estimated useful lives. As a result of this assessment the Company recorded an impairment charge of $1.7 million for the year ended December 31, 2012, which is included in restructuring expense.

Intangible_Assets_and_Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'
Intangible Assets and Goodwill	'
	NOTE 7: INTANGIBLE ASSETS AND GOODWILL
	Intangible assets that have finite lives are amortized over their useful lives. The intangible assets, their original fair values, adjusted for impairment charges in the third quarter of 2012, and their net book values are detailed below as of the dates presented:
		Cost, Less		Accumulated			Net Book		Estimated
		Impairment		Amortization			Value		Remaining
		Charges							Useful Life
	December 31, 2013:
	Technology and intellectual property	$	2,011,654	$	(161,243	)	$	1,850,411		10.6 to 20.0 years
	December 31, 2012:
	Technology and intellectual property	$	988,629	$	(124,219	)	$	864,410		11.6 to 20.0 years
	Total intangible amortization expense was $40,000, $203,000 and $713,000 for the years ended December 31, 2013, 2012 and 2011, respectively.
	Impairment of Goodwill and Intangible Assets
	Goodwill and intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead are tested for impairment annually at the end of the Company’s third quarter, or more frequently if certain indicators arise. This review includes an assessment of industry factors, contract retentions, cash flow projections and other factors the Company believes are relevant. If an impairment is indicated, the asset is written down to its fair market value based on an estimate of its discounted cash flows and income.
	The fair value of the business related to the acquisition of LED Effects in 2007 and the associated goodwill was estimated using the income approach, which was based on the future, expected cash flows to be generated by LED Effects, discounted to their present values. During the restructuring of the Company’s California based operations, the Company closed its California location and moved the business to the Company’s Satellite Beach, Florida headquarters in October 2010. The portion of the business related to the acquisition of LED Effects incurred a significant reduction in revenue during 2011, which had an impact on the projected cash flows and estimated fair value of the reporting unit. In connection with the restructuring (see note 16) and the Company’s annual impairment test, that the Company recorded an impairment charge of $1.6 million for the year ended December 31, 2011, which resulted in a write-down of goodwill to $0.
	Intangible assets with estimable useful lives are amortized over their respective useful lives to their estimated residual values, and reviewed to determine if their estimable lives have decreased. Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever, in management’s judgment, conditions indicate a possible impairment. Such impairment tests compare estimated undiscounted cash flows to the carrying value of the asset. If an impairment is indicated, the asset is written down to its fair value based on an estimate of its discounted cash flows.
	The Company reviewed the amortizable intangible assets acquired in the acquisition of LSGBV for impairment as of September 30, 2012 primarily due to LSGBV’s ongoing negative cash flows from operations, among other factors. This review included an assessment of the current use of these intangible assets and their estimated useful lives. As a result of this review, the Company recorded an impairment charge of $380,000 for the year ended December 31, 2012.
	The following table summarizes the total impairment charges recorded by the Company in 2012:
	Patents acquired on the acquisition of LSGBV	$	15,984
	Trademarks acquired on the acquisition of LSGBV		19,541
	License agreements acquired on the acquisition of LSGBV		44,923
	Customer relationships acquired on the acquisition of LSGBV		299,089
	Total impairment charge	$	379,537
	In addition, the Company performed an impairment analysis of amortizable intangible assets related to the acquisition of LED Effects in the third quarter of 2011 due to the reduction in revenue noted above to determine whether the intangible assets were impaired. This review included an assessment of the current use of these intangible assets and their estimated useful lives. The Company also performed an impairment analysis of the intangible assets related to Lamina as of December 31, 2011 due to the continued decline in sales of products related to this acquisition to determine whether the intangible assets were impaired. This review also included an assessment of the current use of these intangible assets and their estimated useful lives. As a result of these assessments, the Company recorded an impairment charge of $4.1 million for the year ended December 31, 2011.
	The following table summarizes the total impairment charges recorded by the Company in 2011:
	Goodwill arising on the acquisition of LED Effects	$	1,626,482
	Technology and patents acquired on the acquisition of LED Effects		1,252,335
	Trademarks acquired on the acquisition of Lamina		590,782
	Customer relationships acquired on the acquisition of Lamina		651,750
	Total impairment charge	$	4,121,349
	The table below is the estimated amortization expense, adjusted for any impairment charges, for the Company’s intangible assets for each of the next five years and thereafter:
	2014	$	76,021
	2015		76,021
	2016		76,021
	2017		76,021
	2018		76,021
	Thereafter		1,470,306
		$	1,850,411

Lines_of_Credit

Lines of Credit	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Lines of Credit	'
	NOTE 8: LINES OF CREDIT
	Wells Fargo
	The Wells Fargo ABL provided the Company with borrowing capacity of up to $50.0 million, which capacity was equal to the sum of (i) 85% of its eligible accounts receivable plus $7.5 million of eligible inventory less certain allowances established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) Qualified Cash, plus (iii) the amount of the Ares Letter of Credit Facility. As of December 31, 2013 and 2012, the Company had $40.2 million and $1.5 million, respectively, outstanding under the Wells Fargo ABL and additional borrowing capacity of $4.8 million and $48.5 million, respectively.
	As of December 31, 2013, eligible collateral included $6.8 million of accounts receivable, $16.2 million of inventory and $11.2 million of Qualified Cash. Borrowings under the Wells Fargo ABL bore interest at one of the following two rates (at the Company’s election): (a) the sum of (1) the greater of: (x) the federal funds rate plus 0.50%, (y) the daily three month LIBOR rate plus 1.0% and (z) Wells Fargo’s prime rate; and (2) 0.75%, 1.25% or 1.75%, as applicable, depending on the amount available for borrowing under the facility and subject to any reserves established by Wells Fargo in accordance with the terms of the Wells Fargo ABL; or (b) the sum of (1) the daily three month LIBOR rate; plus 3.0%, 3.5% or 4.0%, as applicable, depending on the amount available for borrowing under the facility and subject to any reserves established by Wells Fargo in accordance with the terms of the Wells Fargo ABL. The interest rate on the Wells Fargo ABL was 3.3% and 3.1% as of December 31, 2013 and 2012, respectively.
	The Company was required to pay certain fees, including an unused line fee ranging from 0.375% to 1.0% of the unused portion of the facility. Outstanding loans could be prepaid without penalty or premium, except that the Company was required to pay a termination fee ranging from $250,000 to $500,000 (depending on the date of termination) if the facility was terminated by Wells Fargo during a default period.
	The Wells Fargo ABL contained customary financial covenants that limited the Company’s ability to incur additional indebtedness or guarantee indebtedness of others, create liens on the Company’s assets, enter into mergers or consolidations, dispose of assets, prepay indebtedness, make changes to the Company’s governing documents and certain agreements, pay dividends or make other distributions on the Company’s capital stock, redeem or repurchase capital stock, make investments, including acquisitions; and enter into transactions with affiliates. The Company was also required to maintain (i) a Borrowing Base that exceeded the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million of Qualified Cash. The Company would have been required to comply with certain specified EBITDA requirements in the event that it has less than $2.0 million available for borrowing on the Wells Fargo ABL. The Wells Fargo ABL also contained customary events of default and affirmative covenants, a subjective acceleration clause, a lockbox requirement and cross default provisions.
	On February 24, 2012, the Company entered into Amendment No. 5 (“Amendment No. 5”) to the Wells Fargo ABL, which increased the maximum amount of authorized advances or payments to or for the benefit of LSG Mexico in each month from $750,000 to (i) $860,000 for the month ended December 31, 2011, (ii) $1.4 million for the period from January 1, 2012 through March 31, 2012, (iii) $1.5 million for the period from April 1, 2012 through September 30, 2012, and (iv) $1.8 million for October 1, 2012 and for each month thereafter. Amendment No. 5 also provides the Company with borrowing base eligibility for additional accounts receivable. The Company paid Wells Fargo a fee of $5,000 in connection with this amendment.
	On March 31, 2013, the Company entered into Amendment No. 6 to the Wells Fargo ABL, which among other things, (i) extended the maturity date of the Wells Fargo ABL to April 2, 2014, and (ii) reduced the maximum credit available under the Wells Fargo ABL by $2.5 million (from $50.0 million to $47.5 million) on November 22, 2013 if (x) the Company’s consolidated earnings (loss) before interest, tax, depreciation and amortization for the nine month period ending on September 30, 2013 is greater than $(20.2 million) and (y) excess availability under the Wells Fargo ABL on November 22, 2013 is less than $10.0 million. As of November 22, 2013, there was no reduction in the maximum credit available under the Wells Fargo ABL.
	Pursuant to Amendment No. 6, Wells Fargo also waived certain events of default under the Wells Fargo ABL related to the Company’s creation of LSIPL. The Company also agreed to pledge 65% of the issued and outstanding capital stock of LSIPL as collateral supporting the Wells Fargo ABL. Further, Amendment No. 6 permits the Company to make additional advances to certain affiliates (including LSIPL) in an amount not to exceed $500,000 from the date of Amendment No. 6 through October 1, 2013, and in an amount not to exceed $250,000 thereafter.
	On June 4, 2013, the Company entered into Amendment No. 7 to the Wells Fargo ABL, which among other things, increased the limit on the aggregate amount of all letters of credit the Company may issue (the “Letter of Credit Limit”) to $7.0 million from $2.0 million.
	On February 19, 2014, the Company entered into the Medley Term Loan and the Medley Delayed Draw Loan and utilized proceeds from the Medley Term Loan to repay its outstanding obligations under the Wells Fargo ABL.
	Ares Capital
	On September 21, 2011, the Company entered into the Ares Letter of Credit Facility, a $25.0 million standby letter of credit issued by Ares Capital in favor of Wells Fargo for the benefit of the Company. As a condition to Ares Capital’s agreement to provide the Ares Letter of Credit Facility for the benefit of the Company, the Company entered into the Second Lien Letter of Credit, Loan and Security Agreement (the “Ares Loan Agreement”) with Ares Capital. In accordance with the Ares Loan Agreement, the Company agreed to reimburse Ares Capital for any amounts drawn on the Ares Letter of Credit Facility and to permanently reduce the face amount of the Ares Letter of Credit Facility by such amount. Further, the Company agreed that any such reimbursement obligation would automatically convert into a term loan (an “Ares Term Loan”) by Ares Capital to the Company secured by substantially all of the assets of the Company. The Ares Letter of Credit Facility may only be used to collateralize borrowings pursuant to the Wells Fargo ABL.
	Interest on any Ares Term Loan accrued at either (at the Company’s election): (a) 9.0% per annum plus the highest of (i) The Wall Street Journal prime rate, (ii) the sum of 0.50% per annum and the federal funds rate and (iii) the sum of 1.0% per annum and the higher of the daily one month LIBOR rate and 1.5% per annum; or (b) 10.0% per annum plus the highest of (i) 1.5% per annum and (ii) the daily one-month LIBOR rate. The Company was required to pay certain fees to Ares Capital under the Ares Loan Agreement including: (a) an annual administrative fee of $50,000, payable quarterly in advance; (b) a quarterly fronting fee equal to the product of the average daily undrawn face amount of the Ares LOC multiplied by 0.75% per annum; and (c) a quarterly letter of credit fee equal to the product of the average daily undrawn face amount of the Ares LOC multiplied by 10.0% per annum.
	On April 1, 2013, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Ares Letter of Credit Facility (the “Ares Amendment”), which extends the maturity date of the Ares Letter of Credit Facility to April 2, 2014. Pursuant to the Ares Amendment, Ares Capital also waived certain events of defaults under the Ares Letter of Credit Facility related to our creation of LSIPL. The Company also agreed to pledge 65% of the issued and outstanding capital stock of LSIPL as collateral supporting the Ares Letter of Credit Facility.
	On February 19, 2014, the Company entered into the Medley Term Loan and the Medley Delayed Draw Loan and utilized proceeds from the Medley Term Loan to repay its outstanding obligations under the Ares Letter of Credit Facility.

Series_J_Redeemable_Convertibl

Series J Redeemable Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Series J Redeemable Convertible Preferred Stock	'
	NOTE 9. SERIES J REDEEMABLE CONVERTIBLE PREFERRED STOCK
	Series J Preferred Stock
	On September 11, 2013, the Company entered into the Series J Subscription Agreement with Riverwood Holdings, PCA Holdings and Holdings II, pursuant to which the Company issued an aggregate of 17,394 shares of Series J Preferred Stock, at a price of $1,000 per share, for gross proceeds of $17.4 million. The Company issued 12,500, 2,500 and 2,394 shares of Series J Preferred Stock to Holdings II, PCA Holdings and Riverwood Holdings, respectively. As compensation for advisory services provided by Pegasus, on September 11, 2013 the Company issued a warrant to Holdings II, (the “Pegasus Warrant”) representing the right to purchase 10,000,000 shares of common stock at a variable exercise price that will be determined on the date of exercise.
	In connection with the Series J Preferred Offering, and pursuant to the certificates of designation governing the shares of the Company’s Series H Preferred Stock (the “Series H Certificate of Designation”) and Series I Preferred Stock (the “Series I Certificate of Designation”), the Company agreed to offer to all holders of shares of Series H Preferred Stock (defined in Note 9), and Series I Preferred Stock (defined in Note 9), the right to purchase shares of Series J Preferred Stock based upon such holder’s ownership of the Company’s outstanding shares of common stock on a fully diluted, as converted basis (the “Preemptive Rights Offering”). Pursuant to the Series J Subscription Agreement, Pegasus committed to purchase the number of shares of Series J Preferred Stock equal to 20,000 minus the aggregate number of shares of Series J Preferred Stock issued in the Series J Preferred Offering and the Preemptive Rights Offering at a price per share equal to the Stated Value (the “Pegasus Series J Commitment”). On October 16, 2013, the Company completed the Preemptive Rights Offering and issued an aggregate of 1,449 shares of Series J Preferred Stock at the Stated Value, for aggregate gross proceeds of $1.4 million. On November 21, 2013, Pegasus fulfilled its obligations pursuant to the Pegasus Series J Commitment and purchased 1,157 shares of Series J Preferred Stock for aggregate gross proceeds of $1.2 million.
	The Series J Preferred Stock is senior to the Series H Preferred Stock, the Series I Preferred Stock and the common stock and is entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each share of Series J Preferred Stock is convertible at any time, at the election of the holder thereof, into the number of shares of common stock (the “Optional Conversion Shares”) equal to the quotient obtained by dividing (a) the Stated Value of such shares of Series J Preferred Stock by (b) the $0.95 conversion price, subject to certain adjustments.
	The Company will redeem all outstanding shares of Series J Preferred Stock for an amount in cash equal to the Liquidation Amount (as defined below) upon the Company’s receipt of a notice from the holders of Series H Preferred Stock that would require the Company to redeem the shares of Series H Preferred Stock pursuant to the Series H Certificate of Designation. The redemption of any shares of Series J Preferred Stock would be senior and prior to any redemption of Series H Preferred Stock or Series I Preferred Stock and any holder of shares of Series J Preferred Stock may elect to have less than all or none of such holder’s shares of Series J Preferred Stock redeemed. At any time after the Company has redeemed any shares of Series H Preferred Stock, at any time thereafter each holder of shares of Series J Preferred Stock may elect to have all or a portion of such holder’s shares of Series J Preferred Stock redeemed by the Company for an amount in cash equal to the Liquidation Amount of such shares of Series J Preferred Stock.
	The “Liquidation Amount” of each share of Series J Preferred Stock is equal to the greater of (a) the fair market value of the Optional Conversion Shares and (b) if the applicable reference date occurs (i) on or prior to May 26, 2014, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 1.75; and (ii) subsequent to May 26, 2014, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 2.0.
	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the shares of Series J Preferred Stock are recorded as mezzanine equity because such shares contain terms that allow the holder to redeem the shares for cash, and for which redemption is not solely within the control of the Company. In accordance with ASC 480-10-S99, the Company will recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the shares of Series J Preferred Stock to equal the redemption value at the end of each reporting period. The Series J Preferred Stock was recorded at redemption value on each date of issuance, which included a deemed dividend due to the redemption feature. As of December 31, 2013, Series J Preferred Stock redemption value included an aggregate deemed dividend of $24.3 million with an offset in additional paid-in capital.
	Pegasus Warrant
	The Pegasus Warrant was issued to Holdings II on September 11, 2013 in consideration for advisory services provided by Pegasus. The Pegasus Warrant represents the right to purchase 10,000,000 shares of common stock at a variable exercise price that will be determined on the date of exercise. The exercise price will be equal to the difference obtained by subtracting (a) the fair market value for each share of common stock on the day immediately preceding the date of exercise from (b) the quotient obtained by dividing (i) approximately 2.764% of the amount by which the total equity value of the Company exceeds $523.9 million (as may be adjusted for subsequent capital raises) by (ii) the number of shares of common stock underlying the Pegasus Warrant; provided that for so long as the total equity value of the Company is less than or equal to $523.9 million (as may be adjusted for subsequent capital raises) the Pegasus Warrant will not be exercisable. The Pegasus Warrant provides for certain anti-dilution adjustments and if unexercised, expires on May 25, 2022.
	The Pegasus Warrant is considered a derivative financial instrument in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the variable nature of the warrant exercise price. The Pegasus Warrant was recorded as a liability at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. There was a change of $935,000 in fair value of the Pegasus Warrant for the period from September 11, 2013 (date of issuance) through December 31, 2013.

Series_H_and_Series_I_Redeemab

Series H and Series I Redeemable Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2013
Text Block [Abstract]	'
Series H and Series I Redeemable Convertible Preferred Stock	'
	NOTE 10: SERIES H AND SERIES I REDEEMABLE CONVERTIBLE PREFERRED STOCK
	Series H and I Preferred Stock
	On May 25, 2012, the Company entered into the Series H and I Subscription Agreement with Riverwood and certain other accredited investors. Pursuant to the Series H and I Subscription Agreement, the Company issued an aggregate of 60,705 shares of Series H Preferred Stock and 6,364 shares of Series I Preferred Stock at a price of $1,000 (the “Stated Value”) per Preferred Share. The Company raised gross proceeds of $67.1 million in the Series H and I Preferred Offering.
	The Preferred Shares are entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each Preferred Share is convertible at any time, at the election of the holder thereof, into the number of shares of common stock (the “Optional Conversion Shares”) equal to the quotient obtained by dividing (a) the Stated Value of such Preferred Share by (b) the $1.18 conversion price, subject to certain adjustments. The fair market value of the common stock was $1.50 per share on the date of the Series H and I Preferred Offering. Consequently, the Company recorded a beneficial conversion feature of $17.7 million and $16.9 million to the Series H Preferred Stock and Series I Preferred Stock, respectively, and an offset of $34.6 million to additional paid-in capital, each as of May 25, 2012. The beneficial conversion feature was calculated as the product of (a) $0.32 (the difference between the conversion price of $1.18 and the fair market value of the common stock of $1.50) multiplied by (b) the number of shares of common stock issuable upon conversion of such Preferred Shares.
	Upon the consummation of a qualified public offering (a “QPO”) where (i) the gross proceeds received by the Company and any selling stockholders in the offering are no less than $100 million and (ii) the market capitalization of the Company immediately after consummation of the offering is no less than $500 million, each outstanding Preferred Share will automatically convert into the number of shares of common stock equal to the greater of (a) the number of Optional Conversion Shares or (b) the quotient obtained by dividing (i) the Returned Value (as defined below) by (ii) the price per share of common stock paid by the public in the QPO.
	At any time on or after November 25, 2015, so long as the “Primary Investor” (as defined in the certificate of designation governing the Series H Preferred Stock (the “Series H Certificate of Designation”) and Series I Preferred Stock (the “Series I Certificate of Designation”), respectively) of the respective series of Preferred Shares beneficially owns any shares of such series of Preferred Shares, the respective Primary Investor will have the right to require the Company to redeem all or a portion of such Primary Investor’s Preferred Shares for an amount in cash equal to the Liquidation Amount (as defined below) of such Preferred Shares (the “Optional Redemption Right”). If the Primary Investor of a series of the Preferred Shares elects to exercise its Optional Redemption Right, all other holders of such series of Preferred Shares will have a contingent redemption right to have all or any portion of their Preferred Shares redeemed for an amount in cash equal to the Liquidation Amount of such Preferred Shares.
	After the Primary Investor of a series of Preferred Shares no longer beneficially owns any shares of such series of Preferred Shares, each holder of such series will have the right, at any time thereafter, to require the Company to redeem all or a portion of such holder’s Preferred Shares for an amount in cash equal to the Liquidation Amount of such Preferred Shares. Each holder of Preferred Shares may also require the Company to redeem all or a portion of such holder’s Preferred Shares for an amount in cash equal to the Liquidation Amount upon the occurrence of a Redemption Event or a Change of Control (each as defined in the Series H Certificate of Designation and Series I Certificate of Designation). The Company may not redeem, or be required to redeem, any Preferred Shares for so long as such redemption would result in an event of default under the Wells Fargo ABL or the Ares Loan Agreement.
	The “Liquidation Amount” of each Preferred Share is equal to the greater of (a) the fair market value of the Optional Conversion Shares and (b) if the applicable reference date occurs (i) on or prior to the one year anniversary of the original date of issuance, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 1.5; (ii) subsequent to the one year anniversary of the original date of issuance and on or prior to the two year anniversary of the original date of issuance, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 1.75; and (iii) subsequent to the two year anniversary of the original date of issuance, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 2.0 (collectively, the “Returned Value”).
	On September 11, 2013, in connection with the Series J Preferred Offering, Riverwood and Pegasus, as the “Primary Investors” of the Series H Preferred Stock and Series I Preferred Stock, respectively, approved the Amended and Restated Series H Certificate of Designation and the Amended and Restated Series I Certificate of Designation (collectively, the “ Amended Certificates of Designation”) and certain holders of shares of Series H Preferred Stock and Series I Preferred Stock agreed to make certain amendments to the agreements entered into in connection with the purchase of (i) the shares of Series H Preferred Stock and Series I Preferred Stock and (ii) the Company’s previously issued shares of Series F Preferred Stock and Series G Preferred Stock, which were subsequently converted into shares of Series H Preferred Stock and Series I Preferred Stock (collectively, the “Preferred Stock Subscription Agreements”).
	The Amended Certificates of Designation amend the terms of the Series H Certificate of Designation and Series I Certificate of Designation to, among other things, (i) reduce the price used to determine the number of shares of common stock each share of Series H Preferred Stock and Series I Preferred Stock can be converted into at the election of each holder from $1.18 to $0.95 (the “Conversion Price”); (ii) remove the covenant requiring the Company to comply with certain minimum thresholds related to the Company’s consolidated earnings before interest, taxes, depreciation and amortization for 2013 and 2014; (iii) increase, from $10 million to $50 million, the amount of indebtedness the Company can incur without the consent of Riverwood and Pegasus (in each case, in their capacity as “Primary Investor” of the Series H Preferred Stock and Series I Preferred Stock, respectively) and (iv) make certain other clarifying amendments to the Certificates of Designation. The reduction in the Conversion Price for the Series H Preferred Stock and the Series I Preferred Stock resulted in the Company recording a deemed dividend of $14.4 million, which is reflected in earnings per share allocated to controlling shareholders and noncontrolling shareholders.
	The Preferred Shares are entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each Preferred Share is convertible at any time, at the election of the holder thereof, into the Optional Conversion Shares equal to the quotient obtained by dividing (a) the $1,000 by (b) the $0.95 conversion price, subject to certain adjustments.
	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the Preferred Shares are recorded as mezzanine equity because the Preferred Shares contain terms that allow the holder to redeem the shares for cash, and for which redemption is not solely within the control of the Company. In accordance with ASC 480-10-S99, the Company will recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the Preferred Shares to equal the redemption value at the end of each reporting period. The Preferred Shares were recorded at redemption value as of May 25, 2012, which included a deemed dividend due to the redemption feature and resulted in the Company recording an increase of $66.2 million and $47.7 million to the Series H Preferred Stock and Series I Preferred Stock, respectively, and an offset of $113.9 million to additional paid-in capital. There was no change in the redemption value as of December 31, 2013.
	September 2012 Preferred Offering
	On September 25, 2012, the Company entered into the September 2012 Subscription Agreements with each of (i) Portman and (ii) Cleantech A and Cleantech B, pursuant to which the Company issued 49,000 shares of Series H Preferred Stock (the “September 2012 Preferred Shares”) for gross proceeds of $49.0 million. In the September 2012 Preferred Offering the Company issued (i) 24,500 shares of Series H Preferred Stock to Portman, and (ii) 20,862 and 3,638 shares of Series H Preferred Stock to Cleantech A and Cleantech B, respectively.
	The September 2012 Preferred Shares are entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each September 2012 Preferred Share is convertible at any time, at the election of the holder thereof, into the Optional Conversion Shares equal to the quotient obtained by dividing (a) the Stated Value of such September 2012 Preferred Share by (b) the $1.18 conversion price, subject to certain adjustments. The fair market value of common stock was $0.86 per share on the date of the September 2012 Preferred Offering. Consequently, since the conversion price was greater than the fair market value of the common stock there was no deemed dividend due to the beneficial conversion feature on the date of issuance.
	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the September 2012 Preferred Shares are recorded as mezzanine equity because the September 2012 Preferred Shares have certain conditions that allow the holder to redeem the shares for cash, and for which redemption is not solely within the control of the Company. In accordance with ASC 480-10-S99, the Company will recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the September 2012 Preferred Shares to equal the redemption value at the end of each reporting period. The September 2012 Preferred Shares were recorded at redemption value as of September 25, 2012, which included a deemed dividend due to the redemption feature and resulted in the Company recording an increase of $53.6 million to the Series H Preferred Stock and an offset of $53.6 million to additional paid-in capital. There was no change in the redemption value as of December 31, 2013.
	The Company initiated the September 2012 Preferred Offering pursuant to the preemptive rights granted to the holders of Preferred Shares (collectively, the “Holders”) in the Series H Certificate of Designation and the Series I Certificate of Designation. On September 25, 2012, the Company offered each Holder the right to purchase its Pro Rata Share (as defined in the Series H Certificate of Designation and the Series I Certificate of Designation) of 51,000 shares of Series H Preferred Stock (the “Offered Shares”) at a purchase price of $1,000 per share. In addition, any Holder, or such Holder’s permitted assignee, that elected to purchase at least 95% of its Pro Rata Share of the Offered Shares would be entitled to receive a Warrant (the “September 2012 Warrants”) to purchase up to 163.2653 shares (rounded to the nearest whole share) of the Company’s common stock with respect to each Offered Share purchased by such Holder or permitted assignee. As further discussed below, an affiliate of Pegasus Capital has agreed to sell shares of common stock equal to the number of shares, if any, issued upon exercise of any September 2012 Warrants, which shares would be sold on the same terms and at the same exercise price as the September 2012 Warrants and having the effect of reducing the dilutive effects of the September 2012 Warrants. Holders owning the right to purchase an aggregate of 49,102 Offered Shares and 8,016,653 September 2012 Warrants assigned their rights to participate in the September 2012 Preferred Offering to Portman and Zouk. In addition, due to the exercise by Portman and Zouk of at least 95% of the Pro Rata Share of Offered Shares assigned to them, each of Portman, Cleantech A and Cleantech B received September 2012 Warrants to purchase 4,000,000, 3,406,041 and 593,959 shares of common stock, respectively.
	In connection with the issuance of the September 2012 Warrants, on September 25, 2012, the Company entered into a Commitment Agreement (the “September 2012 Commitment Agreement”) with Pegasus IV, pursuant to which the Company is obligated to buy from Pegasus IV or its affiliates shares of common stock equal to the number of shares, if any, for which the September 2012 Warrants are exercised, up to an aggregate number of shares of common stock equal to the aggregate number of shares of common stock underlying all of the September 2012 Warrants (the “Pegasus Commitment”). The purchase price for any Pegasus Commitment will be equal to the consideration paid to the Company pursuant to the September 2012 Warrants. With respect to any September 2012 Warrants exercised on a cashless basis, the consideration to Pegasus IV in exchange for the number of shares of common stock issued to the exercising holder of September 2012 Warrants would be the reduction in the Pegasus Commitment equal to the reduction in the number of shares underlying the September 2012 Warrants.
	Subject to certain limitations, Pegasus IV has the right to cancel its obligations to the Company pursuant to the September 2012 Commitment Agreement with respect to all or a portion of the Pegasus Commitment then outstanding (a “Pegasus Call”). Upon the exercise of a Pegasus Call, the Company will have the obligation to purchase that number of September 2012 Warrants equal to the Pegasus Commitment subject to the Pegasus Call for an amount equal to the consideration paid by Pegasus IV pursuant to such Pegasus Call.
	In addition to the rights provided in the Series H Certificate of Designation, the September 2012 Subscription Agreements provide Portman and Zouk, collectively, with the right, within ten (10) business days following September 25, 2015, to require the Company to redeem all or a portion of the outstanding Offered Shares for an amount in cash equal to the product obtained by multiplying (i) the Stated Value, (ii) the number of Offered Shares to be redeemed and (iii) 1.5. In connection with the September 2012 Preferred Offering, the Company committed to submit to the stockholders of the Company an amendment and restatement to the Series H Certificate of Designation and Series I Certificate of Designation (the “Amended Certificates”) which would, among other things, protect Zouk’s right to elect one director to the Company’s board of directors and amend the date on which the Primary Investors (as defined in the Series H Certificate of Designation and Series I Certificate of Designation, as applicable) could require the Company to redeem the shares of Series H Preferred Stock and Series I Preferred Stock from November 25, 2015 to September 25, 2015.
	Rollover Offering
	As a result of the consummation of the Series H and I Preferred Offering and the issuance of the Preferred Shares in connection therewith, PCA Holdings, Holdings II, Leon Wagner, Continental and certain other holders of the Company’s Series G Preferred Stock were entitled to elect to convert (the “Conversion Right”) all or less than all of their shares of Series G Preferred Stock into the number of shares of Series H Preferred Stock or Series I Preferred Stock equal to the quotient obtained by dividing (i) the aggregate liquidation value of such holders outstanding shares of Series G Preferred Stock by (ii) the Stated Value (the “Rollover Offering”).
	Pursuant to the Conversion Right, (a) each of PCA Holdings and Holdings II converted all 17,650 and 14,958 of their shares of Series G Preferred Stock, respectively, into 18,314 and 15,575 shares of Series I Preferred Stock, respectively; (b) Mr. Wagner converted all 6,500 of his shares of Series G Preferred Stock into 6,649 shares of Series I Preferred Stock, (c) Continental converted all 5,000 of its shares of Series G Preferred Stock into 5,176 shares of Series I Preferred Stock and (d) the remaining holders of Series G Preferred Stock collectively converted all 8,250 of the remaining shares of Series G Preferred Stock into 4,346 shares of Series H Preferred Stock and 4,281 shares of Series I Preferred Stock. In total, the Company issued 4,346 shares of Series H Preferred Stock and 50,001 shares of Series I Preferred Stock pursuant to the Rollover Offering.
	Settlement of Repurchase Obligation
	Pursuant to that certain letter agreement, dated January 17, 2012 from the Company to LSGC Holdings (the “LSGC Letter Agreement”), the Company agreed to indemnify LSGC Holdings for, among other things, the cost of redeeming the LSGC Holdings Class C Interests (the “Repurchase Obligation”) in the event that the Company issued preferred equity securities in excess of $80.0 million. Additionally, under the terms of the LSGC Letter Agreement, in the event that the Company would be required to indemnify LSGC Holdings under the LSGC Letter Agreement, LSGC Holdings agreed to surrender 3,750,000 shares of common stock to the Company less any shares of common stock previously distributed by LSGC Holdings to Continental. Following the consummation of the Series H and I Preferred Offering, the amount of preferred equity issued by the Company exceeded $80.0 million, and, as a result, LSGC Holdings, a related party, was required to redeem 15,000,000 of its issued and outstanding senior preferred member interests held by Continental (the “LSGC Holdings Class C Interests”). See Note 10 for a discussion of the Repurchase Obligation.
	On May 25, 2012, in conjunction with the Series H and I Preferred Offering, the Company, LSGC Holdings and Continental entered into that certain Exchange and Redemption Agreement (the “Exchange Agreement”) to, among other things, facilitate LSGC Holdings’ redemption of the LSGC Holdings Class C Interests held by Continental, the Company’s indemnification payment to LSGC Holdings and LSGC Holdings’ surrender of shares of common stock to the Company in accordance with the LSGC Letter Agreement. Pursuant to the Exchange Agreement, the Company made a $16.2 million indemnification payment directly to Continental, which amount represented the cost to redeem the LSGC Holdings Class C Interests. The payment consisted of: (i) a cash payment of $10.2 million, and (ii) in lieu of an additional $6.0 million in cash, 6,000 shares of Series I Preferred Stock at the Stated Value. Continental also surrendered the LSGC Holdings Class C Interests to LSGC Holdings and LSGC Holdings surrendered a total of 2,505,000 shares of common stock with a fair value of $3.8 million to the Company.
	Riverwood Warrant
	The Riverwood Warrant was issued to Riverwood Management on May 25, 2012 in consideration for services provided in connection with the Series H and I Preferred Offering. The Riverwood Warrant represents the right to purchase 18,092,511 shares of common stock at an exercise price to be determined on the date of exercise. The exercise price will be equal to the difference obtained by subtracting (a) the fair market value for each share of common stock on the day immediately preceding the date of exercise from (b) the quotient obtained by dividing (i) 5% of the amount by which the total equity value of the Company exceeds $500 million by (ii) the number of shares of common stock underlying the Riverwood Warrant. The Riverwood Warrant provides for certain antidilution adjustments and if unexercised, expires on May 25, 2022.
	The Riverwood Warrant is considered a derivative financial instrument in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the variable nature of the warrant exercise price. The Riverwood Warrant was recorded as a liability at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The change in fair value of the Riverwood Warrant was $3.0 million and $8.5 million for the years ended December 31, 2013 and 2012, respectively, and was included in the decrease in fair value of liabilities under derivative contracts in the consolidated statement of operations and comprehensive loss.
	September 2012 Warrants and September 2012 Commitment Agreement
	The September 2012 Warrants are exercisable on or after the tenth business day following the third anniversary of the Issuance Date at an exercise price of $0.72 per share of common stock. If unexercised, the September 2012 Warrants expire upon the earlier of (i) a Change of Control of the Company (as defined in the Series H Certificate of Designation) prior to the three-year anniversary of the Issuance Date; (ii) the occurrence of any event that results in holders of shares of Series H Preferred Stock having a right to require the Company to redeem the shares of Series H Preferred Stock prior to the three-year anniversary of the Issuance Date; (iii) consummation of a QPO (as defined in the Series H Certificate of Designation) prior to the three-year anniversary of the Issuance Date or (iv) receipt by the Company of a Redemption Notice (as defined in the Subscription Agreements). The September 2012 Warrants also provide for certain anti-dilution adjustments.
	The September 2012 Warrants are considered derivative financial instruments in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the cash settlement feature in the instrument. The September 2012 Warrants were recorded as liabilities at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The change in fair value of the September 2012 Warrants was $47,000 and $240,000 for the year ended December 31, 2013 and the period from September 25, 2012 (date of issuance) through December 31, 2012, respectively, and was included in additional paid-in capital.
	The Pegasus Commitment is classified as a financial instrument under ASC 480, “Distinguishing Liabilities from Equity” due to the Company’s obligation to purchase its own shares in the event the September 2012 Warrants are exercised by the holders. The Pegasus Commitment was recorded as an asset at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The change in fair value of the Pegasus Commitment for the year ended December 31, 2013 and the period from September 25, 2012 (date of issuance) through December 31, 2012 was $47,000 and $240,000, respectively, and was included in additional paid-in capital. The change in fair value of the Pegasus Commitment generally offsets the change in fair value of the September 2012 Warrants for the same period.

Series_F_and_Series_G_Preferre

Series F and Series G Preferred Units and Repurchase Obligation	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Series F and Series G Preferred Units and Repurchase Obligation	'
	NOTE 11. SERIES F AND SERIES G PREFERRED UNITS AND REPURCHASE OBLIGATION
	Series F Preferred Units and Series G Preferred Units
	On November 17, 2011, the Company entered into a Subscription Agreement (the “Series F Subscription Agreement”) with PCA Holdings and Pegasus IV, (together with PCA Holdings and any permitted assignees under the Subscription Agreement, the “Purchasers”) pursuant to which the Company gave the Purchasers the option (the “Series F Option”), on or prior to December 31, 2011, to purchase up to 40,000 units (the “Series F Units”) of its securities at a price per Series F Unit of $1,000. Each Series F Unit consisted of: (i) one share of the Company’s newly designated Series F Preferred Stock (the “Series F Preferred Stock”) and (ii) 83 shares of the Company’s common stock, par value $0.001 per share.
	Pursuant to the Series F Subscription Agreement, if, at any time while shares of Series F Preferred Stock remained outstanding, the Company issued securities (other than pursuant to the Company’s equity-based compensation plans) that resulted in gross proceeds to the Company of at least $50.0 million (a “Subsequent Issuance”), the Company was required to notify all holders of Series F Preferred Stock of the terms and conditions of such Subsequent Issuance. Simultaneous with, and subject to the closing of, such Subsequent Issuance, each holder of Series F Preferred Stock had the right to: (i) require the Company to use the proceeds of such Subsequent Issuance to redeem all of such holder’s Series F Preferred Stock or (ii) convert all or a portion of such holder’s Series F Preferred Stock into the securities issued in the Subsequent Issuance on substantially the same terms and conditions governing the Subsequent Issuance. If a holder elected to convert its shares of Series F Preferred Stock, such holder would retain all of the shares of Common Stock issued in conjunction with each converted share of Series F Preferred Stock. All outstanding Series F Preferred Stock were to be redeemed on the later of February 21, 2014 or up to 91 days after a Subsequent Issuance.
	In accordance with ASC 480, Distinguishing Liabilities from Equity, the Series F Preferred Stock was recorded initially at fair value as a liability and subsequently recorded at the present value of the amount to be paid at settlement, accruing interest cost using the rate implicit at inception. The common stock was recorded to equity at fair value and is not subsequently revalued. The difference between the amount recorded at issuance and the original issuance price is being accreted using the effective interest method over the term of the Series F Preferred Stock.
	In connection with the execution of the Series F Subscription Agreement, PCA Holdings purchased 10,000 Series F Units, for an aggregate purchase price of $10.0 million. On November 17, 2011, Leon Wagner, one of the Company’s directors, also purchased 1,500 Series F Units for an aggregate purchase price of $1.5 million.
	On December 1, 2011, the Company entered into a Series G Preferred Unit Subscription Agreement (the “Series G Subscription Agreement”) with PCA Holdings, Pegasus IV, Holdings II, Leon Wagner, a member of the Company’s board of directors and certain accredited investors (together with Pegasus IV, PCA Holdings, Holdings II and any additional investors that may become party to the Series G Subscription Agreement, the “Series G Purchasers”). Pursuant to the Series G Subscription Agreement, and subsequent subscription agreements on terms substantially similar to the Series G Subscription Agreement entered into between December 2011 and May 2012, the Company issued an aggregate of 52,358 Series G Preferred Units at a price per Series G Preferred Unit of $1,000 for total consideration of $52.4 million. Each Series G Preferred Unit consists of: (i) one share of the Series G Preferred Stock and (ii) 83 shares of the Company’s common stock. Holdings II purchased an aggregate of 14,958 Series G Preferred Units; PCA Holdings purchased an aggregate of 17,650 Series G Preferred Units; Leon Wagner purchased an aggregate of 6,500 Series G Preferred Units; and the additional accredited investors purchased an aggregate of 13,250 Series G Preferred Units.
	In accordance with ASC 480, Distinguishing Liabilities from Equity, the Series G Preferred Stock was recorded initially at fair value as a liability as the Series G Preferred Stock may require settlement in a variable number of shares of common stock. Subsequent to initial recognition, the Series G Preferred Stock was recorded at the present value of the amount to be paid at settlement, accruing interest cost using the rate implicit at inception. The common stock was recorded to equity at fair value and is not subsequently revalued. The difference between the amount recorded at issuance and the original issuance price was being accreted using the effective interest method over the term of the Series G Preferred Stock. Accretion of Series G Preferred Stock was $0, $7.5 million and $239,000 for the years ended December 31, 2013, 2012 and 2011, respectively. In conjunction with the Series H and I Preferred Offering, the Company recognized $6.3 million as a loss on the conversion of the Series G Preferred Stock, which is included in the accretion of preferred stock for the year ended December 31, 2012. The Series F Subscription Agreement provided that if the Company issued securities (other than issuances pursuant to the Company’s equity-based compensation plans) which PCA Holdings, in its sole discretion, determined were more favorable than the Series F Units, PCA Holdings would have the right (the “Conversion Right”), at any time prior to November 17, 2013, to require all Series F Unit Purchasers to exchange their Series F Units for such newly issued securities. Upon such occurrence, any outstanding right to purchase Series F Units under the Series F Option would also convert into the right to purchase the newly issued securities on substantially the same terms and conditions as those offered to the purchasers of the newly issued securities.
	In connection with the issuance of Series G Preferred Units by the Company, and pursuant to the Conversion Right, PCA Holdings elected to exchange all of its outstanding Series F Units and outstanding Series F Preferred Stock for Series G Preferred Units and Series G Preferred Stock, which required Mr. Wagner to also exchange his Series F Preferred Stock for Series G Preferred Stock. In connection with the exercise of the Conversion Right, (i) the Company exchanged each Series F Preferred Stock for one Series G Preferred Stock and agreed that the Series G Preferred Stock issued to the Series F Preferred Stock purchasers would be deemed to have begun earning and accruing the Dividend (as defined below) as of November 17, 2011 and (ii) the Series F Option was replaced by a right to purchase Series G Preferred Units pursuant to the terms and conditions of the Series G Subscription Agreement (the “Series G Option”). The Company issued 10,000 shares of Series G Preferred Stock to PCA Holdings and 1,500 shares of Series G Preferred Stock to Mr. Wagner pursuant to the Conversion Right. PCA Holdings, Pegasus IV and Holdings II may assign all or any portion of their right to purchase Series G Preferred Units pursuant to the Series G Option to assignees of their choosing. Upon the conversion of the Series F Preferred Stock to Series G Preferred Stock, the Company treated this as an exchange with no remeasurement of the fair value of the Series F Preferred Stock at that time given both the Series F Preferred Shares and Series G Preferred Shares have similar terms. The converted Series F Preferred Stock to Series G Preferred Stock would subsequently be valued consistently with the other outstanding Series G Preferred Stock which is at the present value of the amount to be paid at settlement, accruing interest cost using the rate implicit at inception. All outstanding shares of Series G Preferred Stock are to be redeemed on the later of February 21, 2014 or up to 91 days after a Subsequent Issuance.
	As of December 31, 2011, the Company had issued 34,108 Series G Preferred Units and raised an aggregate of $34.1 million pursuant to the Series G Subscription Agreement and the Series F Subscription Agreement. From January 1, 2012 through May 18, 2012, the Company issued an additional 18,250 Series G Preferred Units for total proceeds of $18.3 million.
	Pursuant to the Series G Subscription Agreement, if, at any time while shares of Series G Preferred Stock remained outstanding, the Company issued securities (other than pursuant to the Company’s equity-based compensation plans) that resulted in gross proceeds to the Company of at least $50.0 million (a “Series G Subsequent Transaction”), the Company was required to notify all holders of Series G Preferred Stock of the terms and conditions of such Series G Subsequent Transaction. Upon the consummation of the Series H and I Preferred Offering, the Company completed the required notification and, as described above, and pursuant to the Rollover Offering, all holders of Series G Preferred Stock converted their shares of Series G Preferred Stock into a number of shares of Series H Preferred Stock or Series I Preferred Stock (at the holder’s election) equal to the quotient obtained by dividing the aggregate liquidation value of the outstanding shares of Series G Preferred Stock held by each holder by the Stated Value. Each holder retained all of the shares of common stock issued as part of the Series G Preferred Units. Upon this conversion of the Series G Preferred Stock, each share of Series G Preferred Stock was valued at its accrued value, which included the initial fair value plus any dividends accrued through the date of conversion.
	The following table sets forth the allocation of the proceeds on the Series F and Series G Preferred Units between the fair market value of the common stock and the redeemable preferred shares:
		Total		Fair Market		Redeemable
		Proceeds		Value of		Preferred
				Common Stock		Stock
	2011:00:00
	Series F Preferred Units issued	$	11,500,000	$	2,204,895	$	9,295,105
	Series G Preferred Units issued		22,608,000		4,949,768		17,658,232
	Total Series F and G Preferred Units	$	34,108,000	$	7,154,663	$	26,953,337
	2012:00:00
	Series G Preferred Units issued	$	18,250,000	$	1,904,684	$	16,345,316
	Series G Preferred Stock Annual Cumulative Dividend
	Each share of Series G Preferred Stock was entitled to an annual cumulative dividend of, (i) initially, 10.0%, (ii) commencing on November 17, 2012, 15.0% and (iii) commencing on February 21, 2014, 18.0%, on the accrued value of such share. The dividend accrues daily and compounds on (i) November 17, 2012 and, (ii) from and after November 17, 2012, December 31 and June 30 of each year.
	The dividend was scheduled to accrue over the term of the Series G Preferred Stock on a weighted average rate based upon the applicable dividend rate over the term. On each dividend payment date subsequent to November 17, 2012, such dividend was required to be paid to each holder in cash semi-annually in arrears. The Company was only required to pay such dividend in cash to the extent that such payment would not result in an event of default under the Company’s (i) Wells Fargo ABL or (ii) Ares Capital Loan. Any dividend that was scheduled to accrue on or after November 17, 2012, and was required to be paid in cash but was not actually paid in cash, was to continue to accrue and compound and be added to the accrued value of the Series G Preferred Stock.
	During the years ended December 31, 2012 and 2011, the Company recorded $1.8 million and $238,000, respectively, of dividends expense on the Series G Preferred Stock.
	Repurchase Obligation
	In May 2011, the Company entered into an agreement with LSGC Holdings pursuant to which LSGC Holdings agreed to purchase 3,750,000 shares of the Company’s common stock at a purchase price of $4.00 per share (the “Holdings Placement”). This purchase was completed on May 26, 2011 and generated net proceeds, after deducting placement agent commissions of $14.4 million. To facilitate the Holdings Placement, in May 2011, LSGC Holdings issued 15,000,000 LSGC Holdings Class C Interests and distributed 562,500 shares of common stock of the Company to Continental for $15.0 million.
	On January 17, 2012, in connection with Continental’s purchase of 5,000 Series G Preferred Units from the Company for $5.0 million, LSGC Holdings agreed to certain amendments to the terms of the LSGC Holdings Class C Interests held by Continental, including to increase the interest rate on the LSGC Holdings Class C Interests and to distribute 682,500 additional shares of common stock of the Company to Continental (the “Class C Amendments”). In addition, pursuant to the terms of the agreement governing the Holdings Placement, LSGC Holdings was obligated to redeem the LSGC Holdings Class C Interests if the Company (i) incurred aggregate indebtedness that exceeded (a) the indebtedness permitted under the Wells Fargo ABL, not to exceed $75.0 million in total credit thereunder and (b) such additional unsecured indebtedness that when aggregated with such working capital facility, if any, exceeded 300% of its earnings before interest, taxes, depreciation and amortization for the preceding 12 months or (ii) issued outstanding preferred equity securities having an original principal amount of more than $80.0 million in the aggregate.
	On January 17, 2012, in connection with the Class C Amendments, the Company entered into the LSGC Letter Agreement with LSGC Holdings pursuant to which it agreed to the Repurchase Obligation arising out of or relating to the Company’s incurrence of indebtedness in excess of the applicable cap or issuance of preferred equity securities in excess of the applicable cap in the Class C Amendments. In exchange, LSGC Holdings agreed to return to the Company 3,750,000 shares of common stock less any shares of common stock that had been previously distributed to Continental (or 2,505,000 shares common stock) in the event the Company was required to settle the Repurchase Obligation. Pursuant to the LSGC Letter Agreement, the Company also agreed to pay Pegasus IV a fee of $250,000 for expenses incurred by Pegasus IV and its affiliates related to these transactions. This fee was recognized as interest expense over the life of the Series G Preferred Units. For the year ended December 31, 2012, the Company recognized related party interest expense of $250,000.
	The Repurchase Obligation was determined to be a financial instrument that may require the repurchase of common stock based on the contingent events described above. The Repurchase Obligation was recorded initially at fair value as a liability with an offset to additional paid-in capital. Subsequent changes in fair value of the Repurchase Obligation were also measured and recorded at the end of each period in the Company’s consolidated financial statements. The terms of the Repurchase Obligation required the Company to repurchase its common stock held by LSGC Holdings, an entity that is controlled by Pegasus Capital, for an amount that exceeded the fair value of the underlying common stock. The fair value of the Repurchase Obligation was considered a deemed dividend to the Company’s controlling stockholder. The deemed dividend was applicable only to the shares held by Pegasus Capital and its affiliates. The terms of the LSGC Letter Agreement and the related Repurchase Obligation resulted in the establishment of two classes of common stock, for financial reporting purposes only, with common stock attributable to controlling stockholders representing all common stock beneficially owned by Pegasus Capital and its affiliates and common stock attributable to noncontrolling stockholders representing the minority interest stockholders.
	As of May 25, 2012, pursuant to the Exchange Agreement, the Company made the required indemnification payments and completed the repurchase of its common stock, fulfilling the Repurchase Obligation. On May 25, 2012, the fair value of the Repurchase Obligation was $12.5 million and was recorded as a deemed dividend with a corresponding offset to additional paid in capital. Prior to fulfillment of the Repurchase Obligation, the fair value of the Repurchase Obligation was based on the probability of required settlement of the contractual terms of the LSGC Holdings Class C Interest of LSGC Holdings less the fair value of the common stock of the Company that it would receive upon settlement. As of May 25, 2012, the fair value of the Repurchase Obligation was based on the actual settlement terms, less the fair value of the common stock received.

Stockholders_Equity_and_Recapi

Stockholders' Equity and Recapitalization Agreement	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Stockholders' Equity and Recapitalization Agreement	'
	NOTE 12: STOCKHOLDERS’ EQUITY AND RECAPITALIZATION AGREEMENT
	Common Stock Issuances
	On January 2, 2013, Jeremy S. M. Cage was appointed Chief Executive Officer and the Company issued 500,000 shares of restricted stock to Mr. Cage as part of his compensation package. On November 8, 2013, upon the resignation of Mr. Cage, 385,417 unvested shares of restricted stock were cancelled and returned to the Company. On March 22, 2013, the Company issued 192,308 shares of restricted stock to Brad Knight as part of his compensation package. For the year ended December 31, 2013, the Company recorded expense of $173,000 related to the restricted stock awards issued to Messrs. Cage and Knight.
	On August 14, 2013, the Company issued 1,813,411 shares of restricted stock in settlement of director fees for the year ended December 31, 2013. On November 11, 2013 and December 4, 2013, the Company issued 26,301 and 14,795 shares, respectively, of restricted stock in settlement of the pro rata portion of director fees for the period served by directors appointed to the board of directors on the respective dates of issuance. The 2013 compensation package consists of: (i) 200,000 shares of restricted stock for each member of the Board of Directors who is not an employee of the Company; (ii) an additional 25,000 shares of restricted stock for each member of the Board of Directors serving on one or more committee of the Board of Directors and (iii) an additional 15,000 shares of restricted stock for chairman of one or more committee of the Board of Directors. The restricted shares vest for directors in office at such time on January 1, 2014. For any director serving less than the full year, a pro-rata portion of the restricted shares were issued on the later of August 14, 2013 or the date of appointment to the Board of Directors, with such pro rata shares vesting on the earlier of the date of resignation or January 14, 2014.
	On March 14, 2012, in settlement of director fees of $875,000 for the year ended December 31, 2012, the board of directors issued each of its non-employee directors an option to receive either: (i) stock options to purchase 100,000 shares of the Company’s common stock at an exercise price of $1.19 per share, the closing price of the Company’s common stock on March 13, 2012, or (ii) an amount of restricted shares of the Company’s common stock equal to $100,000 as of March 13, 2012. Additionally, each member of the Company’s Audit Committee and Committee of Independent Directors were issued an option to receive either: (i) stock options to purchase 25,000 shares of the Company’s common stock at an exercise price of $1.19 per share, or (ii) an amount of restricted shares of the Company’s common stock having a value equal to $25,000 as of March 13, 2012. The stock options and restricted shares of common stock vest, for directors in office at such time, on the first day of each calendar quarter, commencing January 1, 2012, at the rate of 25% for each quarter. Any stock options issued to a director would expire, if unexercised, on March 13, 2022. Pursuant to the respective elections made by each director, on March 28, 2012, the Company issued a total of 630,254 shares of restricted common stock and stock options to purchase 125,000 shares of the Company’s common stock to its non-employee directors.
	On May 25, 2012, in connection with the Series H and I Preferred Offering, six members of the board of directors resigned and five new directors were appointed. Upon the resignation of the board members, 220,594 unvested restricted shares were cancelled and returned to the Company. In settlement of the director fees of the newly appointed directors, which totaled $347,000 for the period from May 25, 2012 through December 31, 2012, and pursuant to the respective elections made by each new director, the Company issued a total of 218,096 shares of restricted common stock and stock options to purchase 15,068 shares of common stock to these non-employee directors.
	On September 25, 2012, in connection with the September 2012 Preferred Offering, one new director was appointed to the Board of Directors. In settlement of the director fees of the newly appointed director, which totaled $27,000 for the period from September 25, 2012 through December 31, 2012, and pursuant to the election made by the new director, the Company issued a total of 30,901 shares of restricted common stock to this non-employee director.
	For the years ended December 31, 2013, 2012 and 2011, the Company recorded expenses of $746,000, $846,000 and $945,000, respectively, related to the restricted stock awards and $20,000, $718,000 and $178,000, respectively, related to the stock options issued to the directors.
	On April 28, 2011, James Haworth was appointed Chief Executive Officer and the Company issued 1,000,000 shares of restricted stock to Mr. Haworth as part of his compensation package. On May 18, 2012, upon the resignation of Mr. Haworth, 736,111 unvested shares of restricted stock were cancelled and returned to the Company. For the years ended December 31, 2012 and 2011, the Company recorded expense of $332,000 and $592,000, respectively, related to the restricted stock awards issued to Mr. Haworth.
	Warrants for the Purchase of Common Stock
	On January 13, 2011, the Company issued a warrant (the “THD Warrant”) to The Home Depot, Inc. (“The Home Depot”) pursuant to which The Home Depot may purchase up to 5.0 million shares of the Company’s common stock at an exercise price of $2.00 per share, subject to certain vesting conditions. The THD Warrant was issued in connection with the Company’s Strategic Purchasing Agreement with The Home Depot, which it entered into on July 23, 2010 and pursuant to which it supplies The Home Depot with LED retrofit lamps and fixtures. The THD Warrant provided that 1.0 million shares of common stock would be eligible for vesting following each year ending December 31, 2011 through December 31, 2015, subject to The Home Depot having gross product orders from the Company, in dollar terms, that are at least 20% more than the gross product orders in the immediately preceding year. For the shares underlying the THD Warrant to be eligible for vesting following the years ending December 31, 2014 and 2015, The Home Depot would be required to extend the Strategic Purchasing Agreement for additional one-year periods beyond its initial term of three years. On August 12, 2013, the Company and The Home Depot entered into Amendment No. 1 to the Strategic Purchasing Agreement which, among other things, extended the term of the Agreement for an additional three years. As of May 25, 2012, as a result of the Series H and I Preferred Offering, the exercise price of the THD Warrants adjusted, pursuant to the terms of such warrants, from $2.00 to $1.95 per share of common stock. The number of shares of common stock into which the THD Warrants were exercisable also adjusted, pursuant to the terms of the warrant, from 5,000,000 to 5,123,715 shares. Each vested portion of the THD Warrant will expire on the third anniversary following the vesting of such portion.
	As of May 25, 2012, as a result of the Series H and I Preferred Offering, the exercise price of the warrants to purchase shares of common stock issued pursuant to that certain Securities Purchase Agreement, dated March 9, 2007 (the “2007 Private Placement Warrants”) adjusted pursuant to the terms of such warrants from $1.60 to $1.18 per share of common stock. The number of shares of common stock into which the 2007 Private Placement Warrants were exercisable also adjusted, pursuant to the terms of such warrants, from 1,273,112 to 1,726,249 shares. The remainder of the 2007 Private Placement Warrants expired in November 2012. In addition, as of May 25, 2012, as a result of the Series H and I Preferred Offering, the exercise price of the warrants issued in conjunction with the Company’s Series D Non-Convertible Preferred Stock (the “Series D Warrants”) adjusted pursuant to the terms of such warrants from a range of $5.90 to $5.92 per share of common stock to a range of $5.57 to $5.59 per share of common stock. The number of shares of common stock into which the Series D Warrants were exercisable also adjusted pursuant to the terms of such warrants from 1,171,044 to 1,240,798 shares.
	As of December 31, 2013, the Company had the following warrants outstanding for the purchase of common stock:
	Warrant Holder	Reason for Issuance	Number of		Exercise		Expiration Date
			Common		Price
			Shares
	Investors in rights offering	Series D Warrants		567,912	$	5.57 to	March 3, 2022 through April 19,
					$	5.59	2022
	The Home Depot	Purchasing agreement		5,123,715	$	1.95	2014 through 2018
	RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760		Variable	25-May-22
	Certain other investors	Riverwood Warrants		5,427,751		Variable	25-May-22
	Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$	0.72	25-Sep-22
	Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$	0.72	25-Sep-22
	Portman Limited	September 2012 Warrants		4,000,000	$	0.72	25-Sep-22
	Aquillian Investments LLC	Private Placement Series H		830,508	$	1.18	25-Sep-17
	Pegasus	Pegasus Warrant		10,000,000		Variable	25-May-22
				42,614,646
	As of December 31, 2013, all warrants shown in the table above are fully vested and exercisable, except a portion of the THD Warrant, the Riverwood Warrants, the September 2012 Warrants and the Pegasus Warrant. The September 2012 Warrants will become exercisable on October 9, 2015. Per the vesting terms discussed above, no shares issuable pursuant to the THD Warrant vested for the year ended December 31, 2013 and 1,024,743 shares issuable pursuant to the THD Warrant vested during both the years ended December 31, 2012 and 2011, for total warrants vested of 2,049,486, when the product purchases for these periods satisfied the prescribed vesting conditions, and 2,049,486 shares remain subject to vesting in accordance with similar product purchasing terms. Pursuant to the terms of the Riverwood Warrants and the Pegasus Warrant, these were not exercisable as of December 31, 2013 because the aggregate fair market value of the Company’s outstanding shares of common stock (as determined in accordance with the terms of the Riverwood Warrants and the Pegasus Warrant) was less than $523.9 million (subject to adjustment in accordance with the terms of the Riverwood Warrants and the Pegasus Warrant).
	The fair value of the THD Warrant is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until they have been earned for each year and these adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot. For the years ended December 31, 2013, 2012 and 2011, the Company recorded $0, $458,000 and $2.5 million as a reduction in revenue, respectively.

Earnings_Loss_Per_Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings (Loss) Per Share	'
	NOTE 13: EARNINGS (LOSS) PER SHARE
	Upon issuance of the LSGC Letter Agreement on January 17, 2012, the Company determined that two classes of common stock had been established for financial reporting purposes only, with common stock attributable to controlling stockholders representing shares beneficially owned and controlled by Pegasus Capital and its affiliates and the common stock attributable to noncontrolling stockholders representing the minority interest stockholders. For the years ended December 31, 2013 and 2012, the Company computed net loss per share of noncontrolling stockholders and controlling stockholders common stock using the two-class method. For the year ended December 31, 2011, the Company had a single class of common shares outstanding for financial reporting purposes only. Net loss from operations is initially allocated based on the underlying common shares held by controlling and noncontrolling stockholders. The allocation of the net losses attributable to the common stock attributable to controlling stockholders is then reduced by the amount of the deemed dividends.
	The following table sets forth the computation of basic and diluted net loss per share of common stock:
		For the Years Ended December 31,
		2013						2012						2011
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss from operations	$	(74,506,560	)	$	(15,310,772	)	$	(93,066,715	)	$	(18,273,694	)	$	(90,434,568	)
	Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders		—			—			12,488,175			(12,488,175	)		—
	Deemed dividends due to issuance of Commitment Shares attributable to all shareholders		—			—			(1,337,401	)		(262,599	)		—
	Deemed dividends related to the Series H, I and J Preferred Stock attributable to all shareholders		(20,206,288	)		(4,152,304	)		(170,193,331	)		(33,417,541	)		—
	Undistributed net loss	$	(94,712,848	)	$	(19,463,076	)	$	(252,109,272	)	$	(64,442,009	)	$	(90,434,568	)
	Basic and diluted weighted average number of common shares outstanding		170,662,220			35,070,340			171,336,891			33,642,080			189,671,299
	Basic and diluted net loss per common share:	$	(0.55	)	$	(0.55	)	$	(1.47	)	$	(1.92	)	$	(0.48	)
	Basic earnings per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share is computed in the same manner as basic earnings per share except the number of shares is increased to assume exercise of potentially dilutive stock options, unvested restricted stock and contingently issuable shares using the treasury stock method and convertible preferred shares using the if-converted method, unless the effect of such increases would be anti-dilutive. The Company had 88.1 million, 77.7 million and 9.2 million common stock equivalents for the years ended December 31, 2013, 2012 and 2011, respectively, which were not included in the diluted net loss per common share as the common stock equivalents were anti-dilutive, as a result of being in a net loss position.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 14: RELATED PARTY TRANSACTIONS
	Effective June 23, 2010, the Company entered into a support services agreement with Pegasus Capital (the “Original Support Services Agreement”), pursuant to which the Company agreed to pay Pegasus Capital $187,500 for each of the four calendar quarters following the effective date of the Original Support Services Agreement and $125,000 for each of the four calendar quarters thereafter in exchange for certain support services during such periods. The Original Support Services Agreement expired on June 30, 2012. On May 25, 2012, the Company entered into a new Support Services Agreement (“2012 Support Services Agreement”) with Pegasus Capital, pursuant to which the Company agreed to pay Pegasus Capital $125,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The 2012 Support Services Agreement expires upon the earlier of: (i) June 30, 2017; (ii) a Change of Control or (iii) a QPO. During the first 30 days of any calendar quarter, the Company has the right to terminate the 2012 Support Services Agreement, effective immediately upon written notice to Pegasus Capital. Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Company’s largest stockholders and beneficially owned approximately 83.1% of the Company’s common stock as of December 31, 2013.
	On January 17, 2012, the Company entered into the LSGC Letter Agreement with LSGC Holdings pursuant to which it agreed to the Repurchase Obligation. In accordance with the LSGC Letter Agreement, the Company agreed to pay Pegasus IV a fee of $250,000 for expenses incurred by Pegasus IV and its affiliates related to the these transactions. This fee was recognized as interest expense over the life of the Series G Preferred Units. For the year ended December 31, 2012, the Company recognized interest expense of $250,000 due to the conversion of the Series G Preferred Stock into Series H and I Preferred Stock. For the year ended December 31, 2011, the Company recognized interest expense of $43,000 related to the advance from Holdings II on the key-man life insurance policy for the Company’s former Chief Executive Officer and Chairman of the Board, Zachary Gibler. In addition, during the years ended December 31, 2013, 2012 and 2011, the Company recorded $0, $313,000 and $625,000, respectively, of management fees pursuant to the Original Support Services Agreement and the 2012 Support Services Agreement, included in selling, distribution and administrative expenses.
	On May 25, 2012, the Company entered into the Riverwood Support Services Agreement with Riverwood Holdings, pursuant to which the Company agreed to pay Riverwood Holdings $20,000 for the period from May 25, 2012 through June 30, 2012 and thereafter $50,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The Riverwood Support Services Agreement expires upon the earlier of: (i) May 25, 2022, (ii) such date that Riverwood Management and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the Preferred Offering, on an as-converted basis (together with any shares of common stock issued upon conversion thereof); (iii) such date that the Company and Riverwood may mutually agree in writing (iv) a Change of Control or (v) a QPO. In addition, the Company has brought in several employees of Riverwood to provide consulting services, including Brad Knight, who served as the Company’s Chief Executive Officer from October 19, 2012 through January 1, 2013 and is currently the Company’s Chief Operations Officer. During the year ended December 31, 2012, the Company recorded $70,000 of management fees pursuant to the Riverwood Support Services Agreement, included in selling, distribution and administrative expenses. During the years ended December 31, 2013 and 2012, the Company incurred $2.2 million and $1.0 million of consulting fees, respectively, for services provided by Riverwood, which were included in selling, distribution and administrative expenses. In addition, $48,000 was paid to Riverwood for the year ended December 31, 2013, for legal fees and out of pocket expenses related to the Series J Preferred Stock issuance to Riverwood Holdings, which was offset against the funds received for the Series J Preferred Stock.
	In connection with the September 2012 Preferred Offering, the Company entered into a Support Services Agreement (the “Zouk Support Services Agreement”) with Zouk, pursuant to which the Company agreed to pay Zouk $100,000 each calendar quarter beginning with the quarter ended September 30, 2012, in exchange for certain support services during such periods. The Zouk Support Services Agreement expires upon the earlier of: (i) September 25, 2022; (ii) such date that Zouk and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the September 2012 Preferred Offering, on an as-converted basis; (iii) such date that the Company and Zouk may mutually agree in writing; (iv) a Change of Control and (v) a QPO.
	On September 25, 2012 and in connection with the September 2012 Preferred Offering each of Pegasus Capital, Riverwood Holdings, Portman and Zouk entered into a Fee Waiver Letter Agreement, pursuant to which the parties agreed to suspend payment of the fees payable in connection with their respective Support Services or other agreements between the Company and such parties until revoked by their unanimous written consent.
	During the years ended December 31, 2013, 2012 and 2011, the Company incurred consulting fees of $0, $118,000 and $369,000, respectively, for services provided by GYRO LLC, a marketing company affiliated with Pegasus Capital, which were included in selling, distribution and administrative expense.
	During the years ended December 31, 2013, 2012 and 2011, the Company incurred consulting fees of $14,000 $40,000 and $122,000, respectively, for services provided by T&M Protection Resources, primarily for the facility in Monterrey, Mexico, which were included in selling, distribution and administrative expense. T&M Protection Resources is a security company affiliated with Pegasus Capital.
	During the years ended December 31, 2013, 2012 and 2011, the Company incurred consulting fees of $0, $174,000 and $549,000, respectively, for public relations and corporate communications services provided by MWW Group, a marketing company owned by Michael Kempner, a former director of the Company, which were included in selling, distribution and administrative expenses.
	On February 24, 2012, April 12, 2012 and May 2, 2012, respectively, the Company issued 2,000, 1,000 and 2,000 Series G Preferred Units to Leon Wagner, a member of the board of directors, for total proceeds of $5.0 million.
	On each of March 20, March 28, 2012 and May 18, 2012 the Company issued 2,000 Series G Preferred Units, respectively, to PCA Holdings for total proceeds of $6.0 million. On April 13, 2012, the Company issued 2,000 Series G Preferred Units to Holdings II for total proceeds of $2.0 million.

Equity_Based_Compensation_Plan

Equity Based Compensation Plans	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Equity Based Compensation Plans	'
	NOTE 15: EQUITY BASED COMPENSATION PLANS
	The Company currently has one equity-based compensation plan, the 2012 Amended and Restated Equity-Based Compensation Plan, (the “Equity Plan”). Awards granted under the Equity Plan may include incentive stock options, which are qualified under Section 422 of the Internal Revenue Code (the “Code”), stock options other than incentive stock options, which are not qualified under Section 422 of the Code, stock appreciation rights, restricted stock, phantom stock, bonus stock and awards in lieu of obligations, dividend equivalents and other stock-based awards. As of December 31, 2013, there were 55.0 million shares authorized for issuance under the plan and 22.1 million shares remaining for future grants. Awards may be granted to employees, members of the Board of Directors, and consultants. The Equity Plan is generally administered by the Compensation Committee of the Board of Directors. Vesting periods and terms for awards are determined by the plan administrator. The exercise price of each stock option or stock appreciation right is equal to or greater than the market price of the Company’s stock on the date of grant and no stock option or stock appreciation right granted may have a term in excess of ten years.
	The Board of Directors may also issue stock-based awards to the Company’s nonemployee directors who wish their awards to be issued to an entity other than an individual under the Directors Stock Plan (the “Directors Plan”). As of December 31, 2013, the Company has reserved an aggregate of 1,000,000 shares of common stock for issuance under the Directors Plan.
	Stock Option Awards
	The following table summarizes stock option activity for all of the Company’s stock-based plans as of December 31, 2013 and changes during the year then ended:
		Number of			Weighted		Weighted		Aggregate
		Shares			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term
	Outstanding as of December 31, 2012		31,877,527		$	1.42
	Granted		11,336,229			0.57
	Exercised		—			—
	Forfeited or expired		(14,817,607	)		1.21
	Outstanding as of December 31, 2013		28,396,149		$	1.19		5.71	$	—
	Vested or expected to vest as of December 31, 2013		26,598,213		$	1.21		5.59	$	—
	Exercisable as of December 31, 2013		13,898,301		$	1.31		4.1	$	—
	The total intrinsic value in the table above represents the total pretax intrinsic value, which is the total difference between the closing price of the Company’s common stock on December 31, 2013 and the exercise price for each in-the-money option that would have been received by the holders if all instruments had been exercised on December 31, 2013. This value fluctuates with the changes in the price of the Company’s common stock. As of December 31, 2013, there was $14.5 million of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 2.66 years.
	The following table summarizes information about stock options outstanding and exercisable as of December 31, 2013:
		Options Outstanding							Options Exercisable
	Range of Exercise Price	Number			Weighted		Weighted		Number		Weighted
					Average		Average				Average
					Remaining		Exercise				Exercise
					Contractual		Price				Price
					Term
	$0.44 - $ 0.44		36,750			9.29	$	0.44		1,750	$	0.44
	$0.50 - $ 0.50		5,352,000			7.67		0.5		18,000		0.5
	$0.60 - $ 0.92		2,018,000			3.89		0.7		1,331,500		0.67
	$1.00 - $ 1.00		5,382,375			5.49		1		5,271,375		1
	$1.01 - $ 1.09		160,750			7.44		1.07		56,125		1.07
	$1.34 - $ 1.34		13,597,989			5.12		1.34		6,153,516		1.34
	$1.35 - $ 10.80		1,848,285			6.7		3.25		1,066,035		3.54
	Total		28,396,149			5.71	$	1.19		13,898,301	$	1.31
	Other information pertaining to stock options is as follows:
		For the Years Ended December 31,
		2013			2012		2011
	Weighted average grant date fair value per share of options	$	0.39		$	1.02	$	3.66
	Total intrinsic value of options exercised	$	—		$	339,649	$	3,044,903
	Restricted Stock Awards
	A summary of nonvested shares of restricted stock awards (“RSAs”) outstanding under all of the Company’s stock-based plans as of December 31, 2013 and changes during the year then ended is as follows:
		Number of			Weighted
		Shares			Average
					Grant Date
					Fair Value
	Nonvested as of December 31, 2012		—		$	—
	Granted		2,546,815			0.47
	Vested		(384,699	)		0.54
	Forfeited		(385,417	)		0.64
	Nonvested as of December 31, 2013		1,776,699		$	0.42
	As of December 31, 2013, there was $47,000 of unrecognized compensation cost related to restricted stock granted under the Equity Plan and the Directors Plan, which is expected to be recognized over a weighted average period of 0.62 years. For the years ended December 31, 2013, 2012 and 2011, the Company recorded compensation expense related to RSAs of $891,000, $1.2 million and $484,000, respectively.
	Stock–Based Compensation Valuation and Expense
	The Company accounts for its stock-based compensation plan using the fair value method. The fair value method requires the Company to estimate the grant date fair value of its stock based awards and amortize this fair value to compensation expense over the requisite service period or vesting term. To estimate the fair value of the Company’s stock-based awards the Company currently uses the Black-Scholes pricing model. The determination of the fair value of stock-based awards on the date of grant using an option- pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include the expected stock price volatility over the term of the awards, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends. Due to the inherent limitations of option-valuation models available today, including future events that are unpredictable and the estimation process utilized in determining the valuation of the stock-based awards, the ultimate value realized by award holders may vary significantly from the amounts expensed in the Company’s financial statements. For restricted stock awards, grant date fair value is based upon the market price of the Company’s common stock on the date of the grant. This fair value is then amortized to compensation expense over the requisite service period or vesting term.
	Stock-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those stock-based awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates.
	The Company recorded stock option expense of $6.9 million, $7.3 million and $3.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	The weighted average assumptions used to value stock option grants were as follows:
		For the Years Ended December 31,
	Variable Ranges	2013		2012	2011
	Exercise price	$0.44 - $0.70		$0.74 - $1.59	$2.50 - $5.05
	Fair market value of the underlying stock on date of grant	$0.38 - $0.64		$0.74 - $1.59	$2.50 - $5.05
	Stock Option Grants:
	Risk-free interest rate	1.03% - 2.00%		0.60% - 1.24%	0.92% - 2.37%
	Expected life, in years	6.00 - 6.25		2.00 - 6.25	4.00 - 6.25
	Expected volatility	99.51% - 101.82%		97.25% - 103.17%	71.10% - 100.05%
Expected dividend yield	0.00%		0.00%	0.00%
Expected forfeiture rate	7.49%		8.78%	8.78%
Fair value per share	$0.08 - $0.52		$0.59 - $1.24	$1.91 - $3.29
The following describes each of these assumptions and the Company’s methodology for determining each assumption:
Risk-Free Interest Rate
The Company estimates the risk-free interest rate using the U.S. Treasury bill rate with a remaining term equal to the expected life of the award.
Expected Life
The expected life represents the period that the stock option awards are expected to be outstanding derived using the “simplified” method as allowed under the provisions of the SEC’s Staff Accounting Bulletin No. 107 as the Company does not believe it has sufficient historical data to support a more detailed assessment of the estimate.
Expected Volatility
The Company estimates expected volatility based on the historical volatility of the Company’s common stock and its peers.
Expected Dividend Yield
The Company estimates the expected dividend yield by giving consideration to its current dividend policies as well as those anticipated in the future considering the Company’s current plans and projections.
2011 Employee Stock Purchase Plan
The Company also has an Employee Stock Purchase Plan (the “2011 ESPP”) that provides employees with the opportunity to purchase common stock at a discount. All employees of the Company and any designated subsidiary are eligible to participate in the 2011 ESPP, subject to certain exceptions. As of December 31, 2013, there were 2.0 million shares authorized for issuance under the ESPP, with 1.8 million shares remaining for future issuance. The 2011 ESPP is a qualified employee stock purchase plan under Section 423 of the Code and was approved by the Company’s stockholders at its annual meeting on August 10, 2011.
The purpose of the 2011 ESPP is to provide employees of the Company and designated subsidiaries with an opportunity to acquire a proprietary interest in the Company. Accordingly, the 2011 ESPP offers eligible employees the opportunity to purchase shares of common stock of the Company at a discount to the market value through voluntary systematic payroll deductions. For the 2013 offering under the 2011 ESPP, a participant may elect to use up to 30% of his or her compensation to purchase whole shares of common stock of the Company, but may not purchase more than 2,000 shares per year. The purchase price for each purchase period will be 85% of the fair market value of a share of common stock of the Company on the purchase date, rounded up to the nearest whole cent. Unless sooner terminated by the board of directors, the 2011 ESPP will remain in effect until December 31, 2020. During the years ended December 31, 2013, 2012 and 2011, the Company issued 88,284, 89,707 shares and 13,705 shares of its common stock to certain employees under the 2011 ESPP at prices ranging from $0.29 to $2.32 per share.

Restructuring_Expenses

Restructuring Expenses	12 Months Ended
	Dec. 31, 2013
Restructuring And Related Activities [Abstract]	'
Restructuring Expenses	'
	NOTE 16: RESTRUCTURING EXPENSES
	The following table summarizes our restructuring expenses and related charges for the following years ended December 31:
			For the Years Ended December 31,
			2013			2012			2011
	Broad based reduction of facilities and personnel (1)		$	4,479,076		$	—		$	—
	Mexico Closing (2)			102,688			3,908,562			—
	Organization Optimization Initiative (3)			77,061			2,304,374			598,037
	Total		$	4,658,825		$	6,212,936		$	598,037
	-1	These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company’s manufacturing to its contract manufacturers in Asia, related workforce reduction in Satellite Beach, Florida of approximately 43 positions, including the termination of several members of the Company’s senior management and a $2.4 million write-down of property and equipment, cost reductions in our foreign subsidiaries and refocusing the Company’s efforts within North America, which resulted in the elimination of all but one employee at LSGBV and a commitment to close LSIPL. In addition to the charges noted above, the Company expects to incur approximately $100,000 additional expense throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred in the first half of 2014.
	-2	On September 24, 2012, the Company’s Board of Directors committed to the closing of our manufacturing facility in Mexico, which was substantially complete as of December 31, 2013. The Mexico Closing resulted in the termination of approximately 520 employees and $1.7 million in a non-cash asset impairment.
	-3	In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. This restructuring plan included a reduction in full time headcount in the United States, which was completed in October 2011. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount in Mexico resulting from the Company’s continued shift of its manufacturing and production processes to the Company’s contract manufacturer in Mexico, the replacement of ten members of management in the United States, following the completion of the Series H and I Preferred Offering in May 2012 and the closing of the Companies offices in the United Kingdom and Australia. As of December 31, 2013, this plan was substantially complete.
	As of December 31, 2013 and 2012, the accrued liability associated with the restructuring and other related charges consisted of the following:
			Workforce			Excess			Other			Total
			Reduction			Facilities			Exit Costs
	Accrued liability as of December 31, 2011		$	368,168		$	174,839		$	—		$	543,007
	Charges			4,158,032			—			—			4,158,032
	Payments			(2,905,244	)		(174,839	)		—			(3,080,083	)
	Accrued liability as of December 31, 2012		$	1,620,956		$	—		$	—		$	1,620,956
	Charges			1,449,584			134,373			509,541		$	2,093,498
	Payments			(2,370,708	)		(134,373	)		(232,585	)		(2,737,666	)
	Accrued liability as of December 31, 2013		$	699,832		$	—		$	276,956		$	976,788
	The remaining accrual as of December 31, 2013, of $977,000 is expected to be paid during the year ending December 31, 2014.
	The restructuring and other related charges are included in the line item restructuring expenses in the consolidated statement of operations.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	NOTE 17: INCOME TAXES
	The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes” (“ASC 740”). Deferred income tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
	The components of the consolidated income tax provision (benefit) from continuing operations are as follows:
		For the Years Ended December 31,
		2013			2012			2011
	Loss before taxes
	Domestic	$	(86,599,121	)	$	(108,719,057	)	$	(88,529,365	)
	Foreign		(3,218,211	)		(2,621,352	)		(1,905,203	)
	Total	$	(89,817,332	)	$	(111,340,409	)	$	(90,434,568	)
	The reconciliation of the provision for income taxes from continuing operations at the United States Federal statutory tax rate of 34% is as follows:
		For the Years Ended December 31,
		2013			2012			2011
	Loss before taxes	$	(89,817,332	)	$	(111,340,409	)	$	(90,434,568	)
	Income tax benefit applying United States federal statutory rate of 34%	$	(30,537,893	)	$	(37,855,739	)	$	(30,747,753	)
	State taxes, net of federal benefit		(1,674,412	)		(2,472,538	)		(2,101,978	)
	Permanent differences
	Accretion of preferred stock		—			2,869,489			81,399
	Preferred stock dividends		—			128,850			80,860
	Derivative fair value adjustment		(1,323,618	)		(2,891,183	)		—
	Goodwill impairment		—			—			978,797
	Life insurance proceeds		—			—			(2,380,000	)
	Other		40,669			87,336			110,030
	Increase in valuation allowance		31,336,114			37,172,107			31,771,303
	Change in effective tax rate—United States		1,597,640			—			2,333,139
	Change in effective tax rate—foreign					—			266,728
	Expiration/true up of NOL’s		110,950			2,594,689			—
	Rate difference between United States federal statutory rate and Netherlands statutory rate		450,550			366,989			—
	Other		—			—			(392,525	)
	Income tax expense (benefit)	$	—		$	—		$	—
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred income taxes are as follows:
		As of December 31,
		2013			2012
	Deferred income tax assets
	Net operating loss carryforwards	$	147,867,489		$	118,000,686
	Charitable contribution carryforward		41,080			35,681
	Stock based compensation		7,699,202			5,032,075
	Inventories		8,536,445			9,017,002
	Reserve for losses on non-cancelable purchase commitments		439,438			2,439,522
	Accounts receivable		150,639			366,973
	Warranty liability		1,158,759			725,723
	Accrued vacation					—
	Goodwill impairment on asset acquisition		857,283			943,552
	Accrued compensation		425,923			321,906
	Accrued legal fees		186,934			107,277
	Fixed Asset Impairment		919,185			—
	India Start up Costs		32,122			—
	Depreciation		28,236			18,303
	Accrued Florida use tax		286			223
	Total deferred income tax assets		168,343,021			137,008,923
	Less: valuation allowance		(168,176,326	)		(136,840,211	)
	Net deferred tax assets	$	166,695		$	168,712
	Deferred income tax liabilities
	Stock losses	$	(166,695	)	$	(168,712	)
	Total deferred income tax liabilities		(166,695	)		(168,712	)
	Net deferred tax liabilities	$	—		$	—
	ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all evidence, both positive and negative, management has determined that a $168.2 million valuation allowance as of December 31, 2013 is necessary to reduce the deferred tax assets to the amount that will more likely than not be realized. The change in the valuation allowance for the current year is $31.3 million.
	As of December 31, 2013, the Company had tax loss carryforwards available to offset future income taxes, subject to expiration as follows:
	Year of Expiration	United States			The Netherlands
		Net Operating			Net Operating
		Tax Loss			Tax Loss
		Carryforwards			Carryforwards
	2016	$	—		$	3,869,995
	2017		—			4,265,206
2018		13,760,592			4,692,440
2019		2,293,432			908,706
2020		1,473,066			1,200,654
2021		2,769,043			1,967,494
2022		1,840,300			—
2023		2,031,270			—
2024		3,353,481			—
2025		2,293,432			—
2026		2,293,432			—
2027		9,937,230			—
2028		33,456,349			—
2029		33,916,312			—
2030		50,887,617
2031		67,057,312
2032		90,683,320
2033		85,216,468
Total	$	403,262,656		$	16,904,495
At the time of the reverse merger transaction and resulting change in control, the Company had accumulated approximately $75.0 million in loss carryforwards. As a result of the change in control, the Company is limited by Section 382 of the Internal Revenue Code in the amount of loss carryforwards that it may apply to its taxable income in any tax year. These loss carryforwards expire from 2016 through 2033. To the extent the Company is able to utilize available loss carryforwards that arose from operations in tax years prior to September 26, 2003, any benefit realized will be credited to income tax expense.
The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of December 31, 2013 and 2012, the Company had no unrecognized tax benefits. The Company’s policy is to recognize interest and penalties related to income taxes in its income tax provision. The Company has not accrued or paid interest or penalties which were material to its results of operations for the years ended December 31, 2013, 2012 and 2011.
The Company files income tax returns in its U.S. federal jurisdictions and various state jurisdictions. As of December 31, 2013, the Company’s income tax returns prior to 2010 and 2009 are closed to examination for federal and state purposes, respectively. Additionally, income tax returns filed in the Netherlands for the 2011 and 2012 tax years have received a final assessment from the taxing authorities. The Company does not anticipate any material change in the next 12 months for uncertain tax positions.

Concentrations_of_Credit_Risk

Concentrations of Credit Risk	12 Months Ended
	Dec. 31, 2013
Risks And Uncertainties [Abstract]	'
Concentrations of Credit Risk	'
	NOTE 18: CONCENTRATIONS OF CREDIT RISK
	For the year ended December 31, 2013, the Company had one customer whose revenue represented 55% of total revenue. For the years ended December 31, 2012 and 2011, the Company had two customers whose revenue collectively represented 70% and 73% of total revenue, respectively.
	As of December 31, 2013, the Company had one customer whose accounts receivable balance represented 55% of accounts receivables, net of allowances. As of December 31, 2012, the Company had two customers whose accounts receivable balance collectively represented 77% of accounts receivables, net of allowances.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	NOTE 19: COMMITMENTS AND CONTINGENCIES
	Purchase Commitments
	As of December 31, 2013, the Company had $19.0 million in purchase commitments, which are generally non-cancellable.
	Lease Commitments
	As of December 31, 2013, the Company had the following commitments under operating leases for property and equipment for each of the next five years:
	Year	Amount
	2014	$	955,436
	2015		891,829
	2016		842,856
	2017		724,476
	2018		120,746
	Thereafter		—
		$	3,535,343
	During the years ended December 31, 2013, 2012 and 2011, the Company incurred rent expense of $2.1 million, $2.3 million and $2.6 million, respectively.
	Agreements with Contract Manufacturers
	The Company currently depends on a small number of contract manufacturers to manufacture its products. If any of these contract manufacturers were to terminate their agreements with the Company or fail to provide the required capacity and quality on a timely basis, the Company may be unable to manufacture and ship products until replacement contract manufacturing services could be obtained.
	Other Contingencies
	The Company is subject to the possibility of loss contingencies arising in its business and such contingencies are accounted for in accordance with ASC Topic 450, “Contingencies.” In determining loss contingencies, the Company considers the possibility of a loss as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recorded when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. In the ordinary course of business, the Company is routinely a defendant in or party to various pending and threatened legal claims and proceedings. The Company believes that any liability resulting from these various claims will not have a material adverse effect on its results of operations or financial condition; however, it is possible that extraordinary or unexpected legal fees could adversely impact our financial results during a particular period. During its ordinary course of business, the Company enters into obligations to defend, indemnify and/or hold harmless various customers, officers, directors, employees, and other third parties. These contractual obligations could give rise to additional litigation costs and involvement in court proceedings.
	On June 22, 2012, Geveran Investments Limited (“Geveran”), a stockholder of the Company, filed a lawsuit against the Company and several others in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida. On October 30, 2012, the court entered an order transferring the lawsuit to the Ninth Judicial Circuit in and for Orange County, Florida. The action, styled Geveran Investments Limited v. Lighting Science Group Corp., et al., Case No. 12-17738 (07), names as defendants the Company; Pegasus Capital Advisors, L.P. (“Pegasus”) and nine other entities affiliated with Pegasus; Richard Weinberg, a former Director and former interim CEO of the Company and a former partner of Pegasus; Gregory Kaiser, a former CFO of the Company; J.P. Morgan Securities, LLC (“J.P. Morgan”); and two employees of J.P. Morgan. Geveran seeks rescission of its $25.0 million investment in the Company, as well as recovery of attorneys’ fees and court costs, jointly and severally against the Company, Pegasus, Mr. Weinberg, Mr. Kaiser, J.P. Morgan and the two J.P. Morgan employees, for alleged violation of Florida securities laws. Geveran alternatively seeks unspecified money damages, as well as recovery of court costs, for alleged common law negligent misrepresentation against these same defendants. In February 2014, Geveran filed a motion to amend their first amended complaint, seeking to assert a claim for punitive damages against the defendants; that motion is currently pending before the court. The case is currently in the discovery stage.
	The Company has retained counsel, denies liability in connection with this matter and intends to vigorously defend against the claims asserted by Geveran. While the case is in its early stages and the outcome of any litigation is inherently difficult to predict, the Company currently believes that it has strong defenses against Geveran’s claims. Nonetheless, the amount of possible loss, if any, cannot be reasonably estimated at this time. The outcome, if unfavorable, could have a material adverse effect on the Company.
	The Company believes that, subject to the terms and conditions of the relevant policies (including retention and policy limits), Directors and Officers insurance coverage will be available to cover the Company’s legal fees and costs in this matter. However, given the unspecified nature of Geveran’s maximum damage claims, insurance coverage may not be available for, or such coverage may not be sufficient to fully pay, a judgment or settlement in favor of Geveran. The Company has also been paying, and expects to continue to pay, the reasonable legal expenses incurred by J.P. Morgan and its affiliates in this lawsuit in connection with the engagement of J.P. Morgan as placement agent for the Company’s private placement with Geveran. Such payments are not covered by the Company’s insurance coverage. The engagement letter executed with J.P. Morgan provides that the Company will indemnify J.P. Morgan and its affiliates from liabilities relating to J.P. Morgan’s activities as placement agent, unless such activities are finally judicially determined to have resulted from J.P. Morgan’s bad faith, gross negligence or willful misconduct. While the case is in its early stages and the outcome of any litigation is inherently difficult to predict, the Company currently believes that it has strong defenses against Geveran’s claim for rescission that a grant of the remedy of rescission is unlikely and the amount of possible loss, if any, cannot be reasonably estimated.
	During October 2011, the Company was notified of a contract dispute between LSGBV and one of its distributors in which the distributor is seeking monetary damages of approximately $1.2 million. Following arbitration before the International Chamber of Commerce, in The Hague, in January 2013, the parties settled this matter for the sum of € 310,000 (or $460,000) in February 2014, which is included in accrued expenses on the Consolidated Balance Sheet.

Defined_Contribution_Plan

Defined Contribution Plan	12 Months Ended
	Dec. 31, 2013
Postemployment Benefits [Abstract]	'
Defined Contribution Plan	'
	NOTE 20: DEFINED CONTRIBUTION PLAN
	The Company has a qualified 401(k) plan (the “401(k) Plan”) covering substantially all employees in the United States. The 401(k) Plan was established under Internal Revenue Code Section 401(k). As of January 1, 2011, the Company began matching 50% of the first 6% of employee contributions and for the years ended December 31, 2013, 2012 and 2011, the Company contributed $303,000, $332,000 and $194,000, respectively, to the 401(k) Plan.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Data (Unaudited)	'
	NOTE 21: QUARTERLY FINANCIAL DATA (UNAUDITED)
	The following is a summary of the Company’s consolidated quarterly results of operations for each of the years ended December 31, 2013 and 2012:
		2013
		1st Quarter			2nd Quarter			3rd Quarter			4th Quarter
	Revenue	$	19,981,607		$	19,992,942		$	21,951,094		$	21,295,914
	Gross deficit		1,868,492			393,545			(5,309,971	)		(11,773,789	)
	Net loss		(16,478,204	)		(15,737,704	)		(25,503,127	)		(32,098,297	)
	Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.01	)	$	(0.98	)	$	(0.37	)	$	(0.16	)
	Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.51	)	$	(0.94	)	$	(0.37	)	$	(0.16	)
		2012
		1st Quarter			2nd Quarter			3rd Quarter			4th Quarter
	Revenue	$	38,938,981		$	30,073,451		$	32,056,779		$	26,042,140
	Gross deficit		3,920,992			(20,266,275	)		(475,431	)		(2,970,742	)
	Net loss		(18,524,116	)		(50,429,655	)		(23,995,506	)		(18,391,132	)
	Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.01	)	$	(0.98	)	$	(0.37	)	$	(0.09	)
	Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.51	)	$	(0.94	)	$	(0.37	)	$	(0.09	)

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation And Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	NOTE 22: VALUATION AND QUALIFYING ACCOUNTS
	Valuation and qualifying accounts deducted	Balance as of		Currency			Additions		Additions			Deductions from			Balance as of
	from the assets to which they apply	Beginning of		Translation			Charged to Costs		Charged			Allowances			End of Period
		Period		Adjustments			and Expenses		(Credited) to
									Other Accounts
	Allowance for doubtful accounts
	2013	$	1,188,366		7,381			245,151		—			(965,943	)	$	474,955
	2012	$	1,513,611		2,720			577,090		—			(905,055	)	$	1,188,366
	2011	$	851,191		(9,133	)		2,001,614		—			(1,330,061	)	$	1,513,611
	Provision for purchase commitments
	2013	$	5,678,992		—			844,233		(4,562,550	)		(770,080	)	$	1,190,595
	2012	$	5,806,032		—			5,580,993		(5,708,033	)		—		$	5,678,992
	2011	$	—		—			8,549,202		(2,743,170	)		—		$	5,806,032

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 23: SUBSEQUENT EVENTS
	2014 Series J Issuance
	Between January 3, 2014 and March 7, 2014, the Company issued an aggregate of 17,475 Series J Securities in the Series J Follow-On Offering. The Series J Securities were issued pursuant to separate Series J Securities Subscription Agreements (the “Follow-On Subscription Agreements”) between the Company, PCA Holdings, Holdings II, Riverwood Holdings, Zouk and certain other accredited investors. We issued 6,000, 6,000, 2,860, 2,570 and 45 shares of Series J Preferred Stock to Holdings II, PCA Holdings, Riverwood Holdings, Zouk and other accredited investors, respectively.
	The Follow-On Offering was deemed to be a “Qualified Follow-On”, as such term is used and defined in the Series J Certificate of Designation and the Preferred Stock Subscription Agreements (the “Existing Subscription Agreements”) by and between the Company and the existing holders of Series J Preferred Stock (the “Initial Series J Investors”). As a result, and in accordance with the Existing Subscription Agreements, the Initial Series J Investors exchanged their Series J Preferred Stock for Series J Securities (the “Series J Exchange”).
	Accordingly, on January 3, 2014, each of LSGC Holdings II, PCA LSG and Riverwood Holdings received Series J Warrants to purchase 36,191,050, 6,625,000 and 6,344,100 shares of Common Stock, respectively. Pursuant to the terms of the Series J Certificate of Designation and the Existing Subscription Agreement, because Holdings II, PCA Holdings and Riverwood Holdings collectively held at least a majority of the issued and outstanding shares of Series J Preferred Stock and elected to participate in the Series J Exchange with respect to all of their previously purchased shares of Series J Preferred Stock, all of the Initial Series J Investors were required to participate in the Series J Exchange. As of March 7, 2014, the Company had issued an aggregate of 37,475 Series J Preferred Stock and Series J Warrants to purchase 99,308,750 shares of Common Stock.
	Medley Loan
	On February 19, 2014, the Company, entered into the Medley Term Loan and the Delayed Draw Term Loan. The Closing Date Term Loan bears interest at a floating rate equal to three-month LIBOR plus 12% per annum, as follows: (i) up to 2% (at the Company’s election) of interest may be paid as “payment in kind” by adding such accrued interest to the unpaid principal balance of the term loan and (ii) the remaining accrued interest amount is payable in cash monthly in arrears. Additionally, $3.0 million of the Closing Date Term Loan were funded directly into a deposit account in which Medley has exclusive access, to further secure the loan. The outstanding principal balance and all accrued and unpaid interest on the Closing Date Term Loan are due and payable on February 19, 2019.
	The Delayed Draw Term Loan may be borrowed and re-borrowed on a revolving basis by the Company, from the closing date through June 2014 (the “Revolving Loan Termination Date”). Following the Revolving Loan Termination Date, the remaining maximum amount of the Delayed Draw Term Loan may be drawn by the Company from time to time, provided that such loan may not be re-borrowed once repaid, subject to certain exceptions. Borrowings under the Delayed Draw Term Loan is limited by a borrowing base equal to the sum of (i) 85% of eligible accounts, (ii) 60% of inventory, and (iii) qualified cash, less any reserves imposed by Medley. Each draw on the Delayed Draw Term Loan made by the Company is subject to a $2.0 million liquidity requirement and the payment of a funding fee based upon the amount of the applicable draw being funded. From February 19, 2014 through the Revolving Loan Termination Date, the Delayed Draw Term Loan bears interest at a floating rate equal to three month LIBOR plus 10.5% per annum, payable in cash monthly in arrears. Following the Revolving Loan Termination Date, the Delayed Draw Term Loan bears interest equal to three month LIBOR plus 12% per annum, as follows: (i) up to 2% (at the Company’s election) of interest may be paid as “payment in kind” by adding such accrued interest to the unpaid principal balance of the Closing Date Term Loan and (ii) the remainder is payable in cash monthly in arrears. The outstanding principal balance and all accrued and unpaid interest on the Delayed Draw Term Loan is due and payable on February 19, 2016.
	The Company utilized proceeds from the Closing Date Term Loan to repay its outstanding obligations under the Wells Fargo ABL and the Ares Loan Agreement. On February 19, 2014, the Company terminated the Wells Fargo ABL and the Ares Loan Agreement.
	Medley Warrants
	On February 19, 2014 and in connection with the consummation of the transactions contemplated by the Medley Loan Agreement, the Company issued a warrant to purchase 5,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) to each of Medley and Medley Opportunity Fund II LP (the “Medley Warrants”). The Medley Warrants have an exercise price equal to $0.95 and, if unexercised, expire on February 19, 2024.
	The Medley Warrants are not exercisable until the Company amends its Certificate of Incorporation to increase the number of authorized shares of Common Stock to a number sufficient to permit the Company to reserve shares of Common Stock for issuance upon the exercise or conversion in full of all of the Company’s outstanding securities that are convertible into or exercisable or exchangeable for shares of Common Stock (the “Charter Amendment”).
	On February 19, 2014, the Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Medley and Medley Opportunity Fund II LP pursuant to which the Company granted piggyback registration rights with respect to the shares of Common Stock underlying the Medley Warrants and any other shares of Common Stock that may be acquired by such parties in the future.
	Pegasus Guaranty and Pegasus Warrants
	Pegasus Capital Partners IV, L.P. and Pegasus Capital Partners V, L.P. (collectively, the “Pegasus Guarantors”) have agreed to provide a guaranty of the Company’s obligations under the Medley Loan Agreement in favor of Medley (the “Pegasus Guaranty”). As consideration for the Pegasus Guaranty, on February 19, 2014, the Company issued a warrant to purchase 5,000,000 shares of Common Stock to each of the Pegasus Guarantors (the “Pegasus Guaranty Warrants”). The Pegasus Guaranty Warrants have an exercise price equal to $0.50 and, if unexercised, expire on February 19, 2024. The Pegasus Guaranty Warrants are not exercisable until the Company effects the Charter Amendment.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable, inventories, intangible assets and other long-lived assets, legal contingencies, and customer incentives, among others. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency and energy markets, and declines in consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
Foreign Currency Translation	'
	Foreign Currency Translation
	The functional currency for the foreign operations of the Company is the local currency of the respective foreign subsidiary. For the operations of Lighting Science Group B.V. (“LSGBV”), the Company’s Netherlands based subsidiary, the functional currency is the Euro, for the operations of Lighting Science Group Mexico SRL, (“LSG Mexico”), the Company’s Mexican subsidiary, the functional currency is the Mexican Peso and for the operations of Lighting Science India Private Limited (“LSIPL”), the Company’s Indian subsidiary, the functional currency is the Indian Rupee. The translation of foreign currencies into U.S. dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet dates and for revenue and expense accounts using the average exchange rate for each period during the year. Any gains or losses resulting from the translation are included in accumulated other comprehensive loss in the consolidated statements of stockholders’ (deficit) equity and are excluded from net loss.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. As of December 31, 2013 and 2012, the Company had $0 and $21,000, respectively, in cash equivalents. The Company regularly maintains cash balances in excess of federally insured limits. To date, the Company has not experienced any losses on its cash and cash equivalents. As of December 31, 2013, the Company had $16.0 million in cash and cash equivalents and restricted cash held in banks in the United States in excess of the federally insured limits.
Restricted Cash	'
	Restricted Cash
	As required by the Company’s asset-based revolving credit facility (as amended, the “Wells Fargo ABL”) with Wells Fargo Bank N.A. (“Wells Fargo”) the Company was required to maintain a minimum qualified cash balance of $5.0 million as a compensating balance against the Wells Fargo ABL. Changes in the restricted cash balance were reflected as a financing activity in the consolidated statement of cash flows.
Accounts Receivable	'
	Accounts Receivable
	The Company records accounts receivable at the invoiced amount when its products are shipped to customers or upon the completion of specific milestone billing requirements. The Company’s receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, aging of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based upon age or customer circumstances that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of December 31, 2013 and 2012, the Company’s accounts receivable are reflected net of an allowance for doubtful accounts of $475,000 and $1.2 million, respectively.
	As of December 31, 2013 and 2012, there were $6.8 million and $11.4 million, respectively of eligible accounts receivable pledged as collateral for the Company’s line of credit with Wells Fargo.
Inventories	'
	Inventories
	Inventories, which consist of raw materials and purchased components and subsystems, work-in-process and finished lighting products, are stated at the lower of cost or market. The Company uses a standard costing methodology to value its inventories. This costing methodology approximates actual cost on a weighted average basis. The Company reviews and sets its standard costs of raw materials, work-in-process and finished goods inventory on a periodic basis to ensure that its inventories approximate current actual costs. Any purchase price variances related to labor and overhead that would indicate a loss on disposition of inventory is recorded to cost of goods sold in the statement of operations at the end of each reporting period. Work in process and finished lighting products include raw materials, labor and allocated overhead. Slow product adoption, rapid technological changes and new product introductions and enhancements could result in excess or obsolete inventory. The Company evaluates inventory levels and expected usage on a periodic basis to specifically identify obsolete, slow-moving or non-salable inventory. The write-down of excess and obsolete inventory based on this evaluation creates a new cost basis and is included in cost of goods sold.
	On a quarterly basis, the Company considers the need to record a lower of cost or market adjustment once raw materials are used to produce specific finished goods. The market value of finished goods is determined based upon current sales transactions, less the cost of disposal of the respective finished goods. The write-down of inventory to the lower of cost or market creates a new cost basis that cannot be marked up even if there are subsequent changes in the underlying facts and circumstances.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Equipment under capital leases is stated at the present value of future minimum lease payments. Depreciation is provided using the straight-line method over the estimated economic lives of the assets, as follows:
			Estimated
			Useful Lives
	Leasehold improvements		1-5 years
	Office, furniture and equipment		2-5 years
	Tooling, production and test equipment		2-4 years
	Leasehold improvements and equipment under capital leases are amortized on a straight-line basis over the shorter of the minimum lease term or the estimated useful life of the assets. Expenditures for repairs and maintenance are charged to expense as incurred. The costs for major renewals and improvements are capitalized and depreciated over their estimated useful lives. All costs incurred for building of production tooling and molds are capitalized and amortized over the estimated useful life of the tooling set or mold.
Intangible Assets	'
	Intangible Assets
	Intangible assets include patents and patents pending. Intangible assets with estimable useful lives are amortized over their respective useful lives on a straight-line basis. Finite –lived intangible assets are reviewed for impairment or obsolescence annually, or more frequently if events or changes in circumstance indicate that the carrying amount of an intangible asset may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash flows.
Impairment of Long-lived Assets	'
	Impairment of Long-lived Assets
	Long lived assets, such as property, plant, and equipment, and purchased intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third party independent appraisals, as considered necessary.
Derivative Instruments	'
	Derivative Instruments
	The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. All derivatives are recorded at fair value on the consolidated balance sheets and changes in the fair value of such derivatives are measured in each period and are reported in other income (expense).
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
		•		Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
		•		Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
		•		Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.
Revenue Recognition	'
	Revenue Recognition
	The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once these terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.
Shipping and Handling Fees and Costs	'
	Shipping and Handling Fees and Costs
	Shipping and handling fees billed to customers are included in revenue. Shipping and handling costs associated with in-bound freight are included in cost of goods sold. Other shipping and handling costs are included in selling, distribution and administrative expenses and totaled $3.4 million, $5.1 million and $3.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Research and Development	'
	Research and Development
	The Company expenses all research and development costs, including amounts for design prototypes and modifications made to existing prototypes, as incurred, except for prototypes that have alternative future uses.
Product Warranties	'
	Product Warranties
	The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products and such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The following table summarizes changes in the warranty provision during the years ended December 31, 2013 and 2012:
	Warranty provision as of December 31, 2011		$	526,906
	Additions to provision			2,966,313
	Less warranty costs			(1,385,207	)
	Warranty provision as of December 31, 2012			2,108,012
	Additions to provision			4,927,844
	Less warranty costs			(3,803,865	)
	Warranty provision as of December 31, 2013		$	3,231,991
Share Based Compensation	'
	Share Based Compensation
	The Company recognizes all employee stock based compensation as a cost in the financial statements based on the fair value of the share based compensation award. Equity classified awards are measured at the grant date fair value of the award. The Company estimates grant date fair value using the Black Scholes Merton option pricing model.
	As of December 31, 2013 and 2012, the Company had two share based compensation plans. The fair value of share based compensation awards, which historically have included stock options and restricted stock awards, is recognized as compensation expense in the statement of operations. The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. Option valuation methods require the input of highly subjective assumptions, including the expected stock price volatility. Measured compensation expense related to such option grants is recognized ratably over the vesting period of the related grants. Restricted stock awards are valued on the date of grant.
Income Taxes	'
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in the income tax provision.
Advertising	'
	Advertising
	Advertising costs, included in sales and marketing expenses, are expensed when the advertising first takes place. The Company primarily promotes its product lines through print media and trade shows, including trade publications and promotional brochures. Advertising expenses were $1.43 million, $872,000 and $2.0 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Segment Reporting	'
	Segment Reporting
	The Company operates as a single segment under Accounting Standard Codification (“ASC”) 280-10-50, “Disclosures about Segments of an Enterprise and Related Information”. The Company’s chief operating decision maker reviews financial information at the enterprise level and makes decisions accordingly.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Estimated Economic Lives of the Assets	'
	Depreciation is provided using the straight-line method over the estimated economic lives of the assets, as follows:
		Estimated
		Useful Lives
	Leasehold improvements	1-5 years
	Office, furniture and equipment	2-5 years
	Tooling, production and test equipment	2-4 years
Summary of Warranty Provision	'
	The following table summarizes changes in the warranty provision during the years ended December 31, 2013 and 2012:
	Warranty provision as of December 31, 2011	$	526,906
	Additions to provision		2,966,313
	Less warranty costs		(1,385,207	)
	Warranty provision as of December 31, 2012		2,108,012
	Additions to provision		4,927,844
	Less warranty costs		(3,803,865	)
	Warranty provision as of December 31, 2013	$	3,231,991

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Company's Financial Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis	'
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013, according to the valuation techniques the Company used to determine their fair values:
		Fair Value Measurement as of December 31, 2013
		Quoted Price in			Significant Other		Significant
		Active Markets for			Observable Inputs		Unobservable Inputs
		Identical Assets
		Level 1			Level 2		Level 3
	Assets (Recurring):
	Pegasus Commitment	$	—		$	—	$	1,407,335
	Liabilities (Recurring):
	Riverwood Warrants	$	—		$	—	$	5,002,664
	September 2012 Warrants		—			—		1,407,335
	Pegasus Warrant		—			—		2,765,047
		$	—		$	—	$	9,175,046
Reconciliation of the Beginning and Ending Balances for Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis	'
	The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs as defined above for the year ended December 31, 2013:
		Total			Pegasus		Riverwood			September 2012			Pegasus
					Commitment		Warrants			Warrant			Warrant
	Beginning balance, December 31, 2012	$	(7,960,705	)	$	1,360,000	$	(7,960,705	)	$	(1,360,000	)	$	—
	Realized and unrealized gains (losses) included in net loss		3,892,994			47,335		2,958,041			(47,335	)		934,953
	Purchases, sales, issuances and settlements		(3,700,000	)		—		—			—			(3,700,000	)
	Transfers in or out of Level 3		—			—		—			—			—
	Ending balance, December 31, 2013	$	(7,767,711	)	$	1,407,335	$	(5,002,664	)	$	(1,407,335	)	$	(2,765,047	)

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventory	'
	Inventories are comprised of the following:
		December 31, 2013		December 31, 2012
	Raw materials and components	$	6,868,139	$	15,150,768
	Work-in-process		1,599,089		1,309,447
	Finished goods		10,593,891		12,521,229
	Total inventory, net	$	19,061,119	$	28,981,444

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property Plant And Equipment [Abstract]	'
Schedule of Property and Equipment, Net	'
	Property and equipment consists of the following:
		December 31, 2013			December 31, 2012
	Leasehold improvements	$	1,486,628		$	1,627,933
	Office furniture and equipment		1,141,314			1,255,244
	Computer hardware and software		8,802,484			8,924,424
	Tooling, production and test equipment		16,141,358			19,194,959
	Construction-in-process		325,252			134,240
	Total property and equipment		27,897,036			31,136,800
	Accumulated depreciation		(21,398,431	)		(14,593,687	)
	Total property and equipment, net	$	6,498,605		$	16,543,113
	Depreciation related to property and equipment was $8.7 million, $8.2 million and $4.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.

Intangible_Assets_and_Goodwill1

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'
Schedule of Intangible Assets	'
	Intangible assets that have finite lives are amortized over their useful lives. The intangible assets, their original fair values, adjusted for impairment charges in the third quarter of 2012, and their net book values are detailed below as of the dates presented:
		Cost, Less		Accumulated			Net Book		Estimated
		Impairment		Amortization			Value		Remaining
		Charges							Useful Life
	December 31, 2013:
	Technology and intellectual property	$	2,011,654	$	(161,243	)	$	1,850,411		10.6 to 20.0 years
	December 31, 2012:
	Technology and intellectual property	$	988,629	$	(124,219	)	$	864,410		11.6 to 20.0 years
Summary of Impairment Charges	'
	The following table summarizes the total impairment charges recorded by the Company in 2012:
	Patents acquired on the acquisition of LSGBV	$	15,984
	Trademarks acquired on the acquisition of LSGBV		19,541
	License agreements acquired on the acquisition of LSGBV		44,923
	Customer relationships acquired on the acquisition of LSGBV		299,089
	Total impairment charge	$	379,537
	Goodwill arising on the acquisition of LED Effects	$	1,626,482
	Technology and patents acquired on the acquisition of LED Effects		1,252,335
	Trademarks acquired on the acquisition of Lamina		590,782
	Customer relationships acquired on the acquisition of Lamina		651,750
	Total impairment charge	$	4,121,349
Schedule of Expected Amortization Expense	'
	The table below is the estimated amortization expense, adjusted for any impairment charges, for the Company’s intangible assets for each of the next five years and thereafter:
	2014	$	76,021
	2015		76,021
	2016		76,021
	2017		76,021
	2018		76,021
	Thereafter		1,470,306
		$	1,850,411

Series_F_and_Series_G_Preferre1

Series F and Series G Preferred Units and Repurchase Obligation (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Allocation of the Proceeds on the Series F and Series G Units between the Fair Market Value of the Common Stock and the Redeemable Preferred Shares	'
	The following table sets forth the allocation of the proceeds on the Series F and Series G Preferred Units between the fair market value of the common stock and the redeemable preferred shares:
		Total		Fair Market		Redeemable
		Proceeds		Value of		Preferred
				Common Stock		Stock
	2011:00:00
	Series F Preferred Units issued	$	11,500,000	$	2,204,895	$	9,295,105
	Series G Preferred Units issued		22,608,000		4,949,768		17,658,232
	Total Series F and G Preferred Units	$	34,108,000	$	7,154,663	$	26,953,337
	2012:00:00
	Series G Preferred Units issued	$	18,250,000	$	1,904,684	$	16,345,316

Stockholders_Equity_and_Recapi1

Stockholders' Equity and Recapitalization Agreement (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Schedule of Warrants for Purchase of Common Stock	'
	As of December 31, 2013, the Company had the following warrants outstanding for the purchase of common stock:
	Warrant Holder	Reason for Issuance	Number of		Exercise		Expiration Date
			Common		Price
			Shares
	Investors in rights offering	Series D Warrants		567,912	$	5.57 to	March 3, 2022 through April 19,
					$	5.59	2022
	The Home Depot	Purchasing agreement		5,123,715	$	1.95	2014 through 2018
	RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760		Variable	25-May-22
	Certain other investors	Riverwood Warrants		5,427,751		Variable	25-May-22
	Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$	0.72	25-Sep-22
	Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$	0.72	25-Sep-22
	Portman Limited	September 2012 Warrants		4,000,000	$	0.72	25-Sep-22
	Aquillian Investments LLC	Private Placement Series H		830,508	$	1.18	25-Sep-17
	Pegasus	Pegasus Warrant		10,000,000		Variable	25-May-22
				42,614,646

Earnings_Loss_Per_Share_Tables

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Computation of Basic and Diluted Net Loss Per Share of Common Stock	'
	The following table sets forth the computation of basic and diluted net loss per share of common stock:
		For the Years Ended December 31,
		2013						2012						2011
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss from operations	$	(74,506,560	)	$	(15,310,772	)	$	(93,066,715	)	$	(18,273,694	)	$	(90,434,568	)
	Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders		—			—			12,488,175			(12,488,175	)		—
	Deemed dividends due to issuance of Commitment Shares attributable to all shareholders		—			—			(1,337,401	)		(262,599	)		—
	Deemed dividends related to the Series H, I and J Preferred Stock attributable to all shareholders		(20,206,288	)		(4,152,304	)		(170,193,331	)		(33,417,541	)		—
	Undistributed net loss	$	(94,712,848	)	$	(19,463,076	)	$	(252,109,272	)	$	(64,442,009	)	$	(90,434,568	)
	Basic and diluted weighted average number of common shares outstanding		170,662,220			35,070,340			171,336,891			33,642,080			189,671,299
	Basic and diluted net loss per common share:	$	(0.55	)	$	(0.55	)	$	(1.47	)	$	(1.92	)	$	(0.48	)

Equity_Based_Compensation_Plan1

Equity Based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Stock Option Activity	'
	The following table summarizes stock option activity for all of the Company’s stock-based plans as of December 31, 2013 and changes during the year then ended:
		Number of			Weighted		Weighted		Aggregate
		Shares			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term
	Outstanding as of December 31, 2012		31,877,527		$	1.42
	Granted		11,336,229			0.57
	Exercised		—			—
	Forfeited or expired		(14,817,607	)		1.21
	Outstanding as of December 31, 2013		28,396,149		$	1.19		5.71	$	—
	Vested or expected to vest as of December 31, 2013		26,598,213		$	1.21		5.59	$	—
	Exercisable as of December 31, 2013		13,898,301		$	1.31		4.1	$	—
Stock Options Outstanding and Exercisable	'
	The following table summarizes information about stock options outstanding and exercisable as of December 31, 2013:
		Options Outstanding							Options Exercisable
	Range of Exercise Price	Number			Weighted		Weighted		Number		Weighted
					Average		Average				Average
					Remaining		Exercise				Exercise
					Contractual		Price				Price
					Term
	$0.44 - $ 0.44		36,750			9.29	$	0.44		1,750	$	0.44
	$0.50 - $ 0.50		5,352,000			7.67		0.5		18,000		0.5
	$0.60 - $ 0.92		2,018,000			3.89		0.7		1,331,500		0.67
	$1.00 - $ 1.00		5,382,375			5.49		1		5,271,375		1
	$1.01 - $ 1.09		160,750			7.44		1.07		56,125		1.07
	$1.34 - $ 1.34		13,597,989			5.12		1.34		6,153,516		1.34
	$1.35 - $ 10.80		1,848,285			6.7		3.25		1,066,035		3.54
	Total		28,396,149			5.71	$	1.19		13,898,301	$	1.31
Other Information Pertaining to Stock Options	'
	Other information pertaining to stock options is as follows:
		For the Years Ended December 31,
		2013			2012		2011
	Weighted average grant date fair value per share of options	$	0.39		$	1.02	$	3.66
	Total intrinsic value of options exercised	$	—		$	339,649	$	3,044,903
Nonvested Shares of Restricted Stock Awards Outstanding	'
	A summary of nonvested shares of restricted stock awards (“RSAs”) outstanding under all of the Company’s stock-based plans as of December 31, 2013 and changes during the year then ended is as follows:
		Number of			Weighted
		Shares			Average
					Grant Date
					Fair Value
	Nonvested as of December 31, 2012		—		$	—
	Granted		2,546,815			0.47
	Vested		(384,699	)		0.54
	Forfeited		(385,417	)		0.64
	Nonvested as of December 31, 2013		1,776,699		$	0.42
Weighted Average Assumptions Used to Value Stock Option Grants	'
	The Company recorded stock option expense of $6.9 million, $7.3 million and $3.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	The weighted average assumptions used to value stock option grants were as follows:
		For the Years Ended December 31,
	Variable Ranges	2013		2012	2011
	Exercise price	$0.44 - $0.70		$0.74 - $1.59	$2.50 - $5.05
	Fair market value of the underlying stock on date of grant	$0.38 - $0.64		$0.74 - $1.59	$2.50 - $5.05
	Stock Option Grants:
	Risk-free interest rate	1.03% - 2.00%		0.60% - 1.24%	0.92% - 2.37%
	Expected life, in years	6.00 - 6.25		2.00 - 6.25	4.00 - 6.25
	Expected volatility	99.51% - 101.82%		97.25% - 103.17%	71.10% - 100.05%
	Expected dividend yield	0.00%		0.00%	0.00%
	Expected forfeiture rate	7.49%		8.78%	8.78%
	Fair value per share	$0.08 - $0.52		$0.59 - $1.24	$1.91 - $3.29

Restructuring_Expenses_Tables

Restructuring Expenses (Tables)	12 Months Ended
	Dec. 31, 2013
Accrued Liability Associated with Restructuring Charges	'
	The following table summarizes our restructuring expenses and related charges for the following years ended December 31:
			For the Years Ended December 31,
			2013			2012			2011
	Broad based reduction of facilities and personnel (1)		$	4,479,076		$	—		$	—
	Mexico Closing (2)			102,688			3,908,562			—
	Organization Optimization Initiative (3)			77,061			2,304,374			598,037
	Total		$	4,658,825		$	6,212,936		$	598,037
	-1	These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company’s manufacturing to its contract manufacturers in Asia, related workforce reduction in Satellite Beach, Florida of approximately 43 positions, including the termination of several members of the Company’s senior management and a $2.4 million write-down of property and equipment, cost reductions in our foreign subsidiaries and refocusing the Company’s efforts within North America, which resulted in the elimination of all but one employee at LSGBV and a commitment to close LSIPL. In addition to the charges noted above, the Company expects to incur approximately $100,000 additional expense throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred in the first half of 2014.
	-2	On September 24, 2012, the Company’s Board of Directors committed to the closing of our manufacturing facility in Mexico, which was substantially complete as of December 31, 2013. The Mexico Closing resulted in the termination of approximately 520 employees and $1.7 million in a non-cash asset impairment.
	-3	In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. This restructuring plan included a reduction in full time headcount in the United States, which was completed in October 2011. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount in Mexico resulting from the Company’s continued shift of its manufacturing and production processes to the Company’s contract manufacturer in Mexico, the replacement of ten members of management in the United States, following the completion of the Series H and I Preferred Offering in May 2012 and the closing of the Companies offices in the United Kingdom and Australia. As of December 31, 2013, this plan was substantially complete.
Accrued Liabilities [Member]	'
Accrued Liability Associated with Restructuring Charges	'
	As of December 31, 2013 and 2012, the accrued liability associated with the restructuring and other related charges consisted of the following:
			Workforce			Excess			Other			Total
			Reduction			Facilities			Exit Costs
	Accrued liability as of December 31, 2011		$	368,168		$	174,839		$	—		$	543,007
	Charges			4,158,032			—			—			4,158,032
	Payments			(2,905,244	)		(174,839	)		—			(3,080,083	)
	Accrued liability as of December 31, 2012		$	1,620,956		$	—		$	—		$	1,620,956
	Charges			1,449,584			134,373			509,541		$	2,093,498
	Payments			(2,370,708	)		(134,373	)		(232,585	)		(2,737,666	)
	Accrued liability as of December 31, 2013		$	699,832		$	—		$	276,956		$	976,788

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Consolidated Income Tax Provision (Benefit) from Continuing Operations	'
	The components of the consolidated income tax provision (benefit) from continuing operations are as follows:
		For the Years Ended December 31,
		2013			2012			2011
	Loss before taxes
	Domestic	$	(86,599,121	)	$	(108,719,057	)	$	(88,529,365	)
	Foreign		(3,218,211	)		(2,621,352	)		(1,905,203	)
	Total	$	(89,817,332	)	$	(111,340,409	)	$	(90,434,568	)
Reconciliation of the Provision for Income Taxes from Continuing Operations	'
	The reconciliation of the provision for income taxes from continuing operations at the United States Federal statutory tax rate of 34% is as follows:
		For the Years Ended December 31,
		2013			2012			2011
	Loss before taxes	$	(89,817,332	)	$	(111,340,409	)	$	(90,434,568	)
	Income tax benefit applying United States federal statutory rate of 34%	$	(30,537,893	)	$	(37,855,739	)	$	(30,747,753	)
	State taxes, net of federal benefit		(1,674,412	)		(2,472,538	)		(2,101,978	)
	Permanent differences
	Accretion of preferred stock		—			2,869,489			81,399
	Preferred stock dividends		—			128,850			80,860
	Derivative fair value adjustment		(1,323,618	)		(2,891,183	)		—
	Goodwill impairment		—			—			978,797
	Life insurance proceeds		—			—			(2,380,000	)
	Other		40,669			87,336			110,030
	Increase in valuation allowance		31,336,114			37,172,107			31,771,303
	Change in effective tax rate—United States		1,597,640			—			2,333,139
	Change in effective tax rate—foreign					—			266,728
	Expiration/true up of NOL’s		110,950			2,594,689			—
	Rate difference between United States federal statutory rate and Netherlands statutory rate		450,550			366,989			—
	Other		—			—			(392,525	)
	Income tax expense (benefit)	$	—		$	—		$	—
Deferred Income Taxes Reflect the Net Tax Effects of Temporary Differences between the Carrying Amounts of Assets and Liabilities for Financial Reporting Purposes	'
	Significant components of the Company’s deferred income taxes are as follows:
		As of December 31,
		2013			2012
	Deferred income tax assets
	Net operating loss carryforwards	$	147,867,489		$	118,000,686
	Charitable contribution carryforward		41,080			35,681
	Stock based compensation		7,699,202			5,032,075
	Inventories		8,536,445			9,017,002
	Reserve for losses on non-cancelable purchase commitments		439,438			2,439,522
	Accounts receivable		150,639			366,973
	Warranty liability		1,158,759			725,723
	Accrued vacation					—
	Goodwill impairment on asset acquisition		857,283			943,552
	Accrued compensation		425,923			321,906
	Accrued legal fees		186,934			107,277
	Fixed Asset Impairment		919,185			—
	India Start up Costs		32,122			—
	Depreciation		28,236			18,303
	Accrued Florida use tax		286			223
	Total deferred income tax assets		168,343,021			137,008,923
	Less: valuation allowance		(168,176,326	)		(136,840,211	)
	Net deferred tax assets	$	166,695		$	168,712
	Deferred income tax liabilities
	Stock losses	$	(166,695	)	$	(168,712	)
	Total deferred income tax liabilities		(166,695	)		(168,712	)
	Net deferred tax liabilities	$	—		$	—
Tax Loss Carryforwards Available to Offset Future Income Taxes	'
	As of December 31, 2013, the Company had tax loss carryforwards available to offset future income taxes, subject to expiration as follows:
	Year of Expiration	United States			The Netherlands
		Net Operating			Net Operating
		Tax Loss			Tax Loss
		Carryforwards			Carryforwards
	2016	$	—		$	3,869,995
	2017		—			4,265,206
	2018		13,760,592			4,692,440
	2019		2,293,432			908,706
	2020		1,473,066			1,200,654
	2021		2,769,043			1,967,494
	2022		1,840,300			—
	2023		2,031,270			—
	2024		3,353,481			—
	2025		2,293,432			—
	2026		2,293,432			—
	2027		9,937,230			—
	2028		33,456,349			—
	2029		33,916,312			—
	2030		50,887,617
	2031		67,057,312
	2032		90,683,320
	2033		85,216,468
	Total	$	403,262,656		$	16,904,495

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Summary of Commitments Under Operating Leases for Property and Equipment	'
	As of December 31, 2013, the Company had the following commitments under operating leases for property and equipment for each of the next five years:
	Year	Amount
	2014	$	955,436
	2015		891,829
	2016		842,856
	2017		724,476
	2018		120,746
	Thereafter		—
		$	3,535,343

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Company's Consolidated Quarterly Results of Operations	'
	The following is a summary of the Company’s consolidated quarterly results of operations for each of the years ended December 31, 2013 and 2012:
		2013
		1st Quarter			2nd Quarter			3rd Quarter			4th Quarter
	Revenue	$	19,981,607		$	19,992,942		$	21,951,094		$	21,295,914
	Gross deficit		1,868,492			393,545			(5,309,971	)		(11,773,789	)
	Net loss		(16,478,204	)		(15,737,704	)		(25,503,127	)		(32,098,297	)
	Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.01	)	$	(0.98	)	$	(0.37	)	$	(0.16	)
	Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.51	)	$	(0.94	)	$	(0.37	)	$	(0.16	)
		2012
		1st Quarter			2nd Quarter			3rd Quarter			4th Quarter
	Revenue	$	38,938,981		$	30,073,451		$	32,056,779		$	26,042,140
	Gross deficit		3,920,992			(20,266,275	)		(475,431	)		(2,970,742	)
	Net loss		(18,524,116	)		(50,429,655	)		(23,995,506	)		(18,391,132	)
	Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.01	)	$	(0.98	)	$	(0.37	)	$	(0.09	)
	Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.51	)	$	(0.94	)	$	(0.37	)	$	(0.09	)

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2013
Valuation And Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	Valuation and qualifying accounts deducted	Balance as of		Currency			Additions		Additions			Deductions from			Balance as of
	from the assets to which they apply	Beginning of		Translation			Charged to Costs		Charged			Allowances			End of Period
		Period		Adjustments			and Expenses		(Credited) to
									Other Accounts
	Allowance for doubtful accounts
	2013	$	1,188,366		7,381			245,151		—			(965,943	)	$	474,955
	2012	$	1,513,611		2,720			577,090		—			(905,055	)	$	1,188,366
	2011	$	851,191		(9,133	)		2,001,614		—			(1,330,061	)	$	1,513,611
	Provision for purchase commitments
	2013	$	5,678,992		—			844,233		(4,562,550	)		(770,080	)	$	1,190,595
	2012	$	5,806,032		—			5,580,993		(5,708,033	)		—		$	5,678,992
	2011	$	—		—			8,549,202		(2,743,170	)		—		$	5,806,032

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Plan	Plan
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Cash equivalents	$0	$21,000	'
Cash and cash equivalents and restricted cash held in banks	16,000,000	'	'
Highly liquid investments original maturities	'three months or less	'	'
Highly liquid investment period Maximum	'3 months	'	'
Minimum qualified cash balance	5,000,000	5,000,000	'
Allowance for doubtful accounts receivable	475,000	1,200,000	'
Accounts receivable, net	7,771,623	13,130,387	'
Period of warranty on products	'5 years	'	'
Number of share based compensation plan	2	2	'
Advertising expenses	1,300,000	872,000	2,000,000
Selling, Distribution and Administrative Expenses [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Other shipping and handling costs	3,400,000	5,100,000	3,800,000
Receivables Pledged as Collateral [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Accounts receivable, net	$6,800,000	$11,400,000	'
Minimum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Recognized income tax positions	50.00%	'	'

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Estimated Economic Lives of the Assets (Detail)	12 Months Ended
	Dec. 31, 2013
Leasehold Improvements [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'1 year
Leasehold Improvements [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'5 years
Office Furniture and Equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'2 years
Office Furniture and Equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'5 years
Tooling, Production and Test Equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'2 years
Tooling, Production and Test Equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'4 years

Summary_of_Significant_Account5

Summary of Significant Accounting Policies - Summary of Warranty Provision (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Regulatory Assets [Abstract]	'	'
Warranty provision, Beginning Balance	$2,108,012	$526,906
Additions to provision	4,927,844	2,966,313
Less warranty costs	-3,803,865	-1,385,207
Warranty provision, Ending Balance	$3,231,991	$2,108,012

Liquidity_and_Capital_Resource1

Liquidity and Capital Resources - Additional Information (Detail) (USD $)

1 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

2 Months Ended

2 Months Ended

12 Months Ended

Sep. 25, 2012

25-May-12

Dec. 31, 2013

Sep. 11, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Nov. 18, 2013

Oct. 16, 2013

Sep. 11, 2013

Dec. 31, 2013

Dec. 31, 2012

Feb. 19, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Holdings II [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Zouk [Member]

Other Accredited Investors [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Warrants [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Liquidity And Capital Resources [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated deficit

'

'

($734,733,900)

'

($644,916,568)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' deficit

'

'

-410,849,963

'

-304,497,378

12,584,499

24,681,511

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Negative working capital

'

'

19,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and cash equivalents

'

'

11,195,412

'

15,834,077

3,071,673

14,489,700

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted cash under asset-based revolving credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

'

Maximum borrowing capacity under credit facility

'

'

'

'

'

'

'

'

'

'

'

'

22,500,000

'

'

'

'

'

'

'

'

'

'

50,000,000

'

Maximum borrowing percentage of accounts receivable invoices

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

85.00%

'

Credit facility restricted cash and cash equivalents computation eligible inventory maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,500,000

'

Description of Line of Credit with Wells Fargo ABL

'

'

'The Wells Fargo ABL provides the Company with a borrowing capacity of up to $50.0 million, which capacity is equal to the sum of (i) 85% of its eligible accounts receivable plus up to $7.5 million of eligible inventory, less certain reserves established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) unrestricted cash held in a Wells Fargo deposit account (bQualified Cashb), plus (iii) the amount of the Second Lien Letter of Credit Facility with Ares Capital Corporation (bAres Capitalb), pledged in favor of Wells Fargo (the bAres Letter of Credit Facilityb) for the benefit of the Company (collectively, the bBorrowing Baseb). The Company is at all times required to maintain (i) a Borrowing Base that exceeds the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million in Qualified Cash. The Company would be required to comply with certain specified EBITDA requirements in the event that it has less than $2.0 million available for borrowing under the Wells Fargo ABL.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan period

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

Amount of term loan

'

'

'

'

'

'

'

'

'

'

'

'

30,500,000

'

'

'

'

'

'

'

'

'

'

'

'

Delayed draw term loan period

'

'

'

'

'

'

'

'

'

'

'

'

'2 years

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of eligible inventory

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

Required to maintain minimum excess of borrowing availability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

'

Available borrowing with certain specified EBITDA Requirements less than

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

Amount outstanding under credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40,200,000

1,500,000

Remaining borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,800,000

48,500,000

Issuance of preferred stock

'

'

113,609

'

113,643

'

'

20,000

'

'

20,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, par value

'

$1,000

$0.00

$1,000

$0.00

'

'

$0.00

'

'

$0.00

$0.00

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

Fair value per share

'

'

'

'

'

'

'

$1,000

'

'

'

'

'

$1,000

'

'

'

'

'

'

$0.08

$0.59

$1.91

'

'

Gross Proceeds

49,000,000

67,100,000

'

'

'

'

'

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sufficient capital to fund operations in term of months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'12 months

'

'

'

'

Units issued during period

'

'

'

'

'

'

'

'

'

'

'

'

'

17,475

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Units issue

'

'

'

'

'

'

'

'

'

'

'

'

'

$17,500,000

'

'

'

'

'

'

'

'

'

'

'

Common stock in One Series J Unit

'

'

42,614,646

'

'

'

'

'

'

'

'

'

'

'

2,650

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock, exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.001

'

'

'

'

'

'

'

'

'

'

Issuance of preferred stock

'

'

'

'

'

'

'

'

1,449

17,394

'

'

'

'

'

19,657

8,500

5,254

2,570

1,494

'

'

'

'

'

Fair_Value_Measurements_Compan

Fair Value Measurements - Company's Financial Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) (Fair Value Measurements [Member], USD $)	Dec. 31, 2013
Quoted Price in Active Markets for Identical Assets Level 1 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] | Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] | Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] | September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] | Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Significant Other Observable Inputs Level 2 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Significant Other Observable Inputs Level 2 [Member] | Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	'
Significant Other Observable Inputs Level 2 [Member] | Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Significant Other Observable Inputs Level 2 [Member] | September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Significant Other Observable Inputs Level 2 [Member] | Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	'
Significant Unobservable Inputs Level 3 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	9,175,046
Significant Unobservable Inputs Level 3 [Member] | Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	1,407,335
Significant Unobservable Inputs Level 3 [Member] | Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	5,002,664
Significant Unobservable Inputs Level 3 [Member] | September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	1,407,335
Significant Unobservable Inputs Level 3 [Member] | Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Liabilities (Recurring)	$2,765,047

Fair_Value_Measurements_Reconc

Fair Value Measurements - Reconciliation of the Beginning and Ending Balances for Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
		Significant Unobservable Inputs Level 3 [Member]	Significant Unobservable Inputs Level 3 [Member]	Significant Unobservable Inputs Level 3 [Member]	Significant Unobservable Inputs Level 3 [Member]	Significant Unobservable Inputs Level 3 [Member]
			Pegasus Commitment [Member]	Riverwood Warrants [Member]	September 2012 Warrants [Member]	Pegasus Warrant [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'	'	'
Beginning balance	'	($7,960,705)	'	($7,960,705)	($1,360,000)	'
Realized and unrealized gains (losses) included in net loss	'	3,892,994	'	2,958,041	-47,335	934,953
Purchases, sales, issuances and settlements	'	-3,700,000	'	'	'	-3,700,000
Transfers in or out of Level 3	0	'	'	'	'	'
Ending balance	'	-7,767,711	'	-5,002,664	-1,407,335	-2,765,047
Beginning balance	'	'	1,360,000	'	'	'
Realized and unrealized gains (losses) included in net loss	'	'	47,335	'	'	'
Purchases, sales, issuances and settlements	'	'	'	'	'	'
Transfers in or out of Level 3	'	'	'	'	'	'
Ending balance	'	'	$1,407,335	'	'	'

Fair_Value_Measurements_Additi

Fair Value Measurements - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
		Riverwood Warrants [Member]	Significant Unobservable Inputs Level 3 [Member]	Significant Unobservable Inputs Level 3 [Member]	Fair Value Measurements [Member]
				Riverwood Warrants [Member]	Significant Unobservable Inputs Level 3 [Member]
					LSGBV [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'	'
Intangible assets fair value	'	'	'	'	$0
Assets measured on a non-recurring basis	0	'	'	'	'
Liabilities measured on a non-recurring basis	0	'	'	'	'
Securities transfer in or out of Level 3	0	'	'	'	'
Unrealized loss	'	$8,500,000	'	'	'

Inventories_Schedule_of_Invent

Inventories - Schedule of Inventory (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]	'	'
Raw materials and components	$6,868,139	$15,150,768
Work-in-process	1,599,089	1,309,447
Finished goods	10,593,891	12,521,229
Total inventory, net	$19,061,119	$28,981,444

Inventories_Additional_Informa

Inventories - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Inventory Disclosure [Abstract]	'	'	'
Consigned inventory	$693,000	'	$2,000,000
Inventory valuation allowance	11,350,469	15,829,639	20,537,341
Inventory allowances	24,100,000	25,600,000	'
Provisions for losses on noncancelable purchase commitments	2,347,905	5,580,993	8,549,202
Provision for losses on purchase commitments, accrued	$1,600,000	$5,700,000	'

Property_and_Equipment_Schedul

Property and Equipment - Schedule of Property and Equipment, Net (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	$27,897,036	$31,136,800
Accumulated depreciation	-21,398,431	-14,593,687
Total property and equipment, net	6,498,605	16,543,113
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	1,486,628	1,627,933
Office Furniture and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	1,141,314	1,255,244
Computer Hardware and Software [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	8,802,484	8,924,424
Tooling, Production and Test Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	16,141,358	19,194,959
Construction-in-process [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	$325,252	$134,240

Property_and_Equipment_Additio

Property and Equipment - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Property Plant And Equipment Useful Life And Values [Abstract]	'	'	'
Depreciation related to property and equipment	$8,700,000	$8,200,000	$4,200,000
Impairment charge	$2,420,132	$1,698,356	'

Intangible_Assets_and_Goodwill2

Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Indefinite-lived Intangible Assets [Line Items]	'	'
Net Book Value	1,850,411	864,410
Technology and Intellectual Property [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Cost, Less Impairment Charges	2,011,654	988,629
Accumulated Amortization	-161,243	-124,219
Net Book Value	1,850,411	864,410
Minimum [Member] | Technology and Intellectual Property [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Estimated Remaining Useful Life	'10 years 7 months 6 days	'11 years 7 months 6 days
Maximum [Member] | Technology and Intellectual Property [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Estimated Remaining Useful Life	'20 years	'20 years

Intangible_Assets_and_Goodwill3

Intangible Assets and Goodwill - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Amortization expense of intangible assets	$40,000	$203,000	$713,000
Total impairment charge	'	379,537	4,121,349
LED [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	1,600,000
Goodwill	'	'	0
LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	380,000	'
Lamina [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	$4,100,000

Intangible_Assets_and_Goodwill4

Intangible Assets and Goodwill - Summary of Impairment Charges (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	$379,537	$4,121,349
LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	380,000	'
LED [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	1,600,000
Lamina [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	4,100,000
Patents [Member] | LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	15,984	'
Trademarks [Member] | LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	19,541	'
Trademarks [Member] | Lamina [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	590,782
License Agreements [Member] | LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	44,923	'
Customer Relationships [Member] | LSGBV [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	299,089	'
Customer Relationships [Member] | Lamina [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	651,750
Goodwill [Member] | LED [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	1,626,482
Technology and Patents [Member] | LED [Member]	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'
Total impairment charge	'	'	$1,252,335

Intangible_Assets_and_Goodwill5

Intangible Assets and Goodwill - Schedule of Expected Amortization Expense (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
2014	$76,021	'
2015	76,021	'
2016	76,021	'
2017	76,021	'
2018	76,021	'
Thereafter	1,470,306	'
Net Book Value	$1,850,411	$864,410

Lines_of_Credit_Additional_Inf

Lines of Credit - Additional Information (Detail) (USD $)

3 Months Ended

6 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2012

Mar. 31, 2012

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2013

Jun. 04, 2013

Mar. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Mar. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Sep. 21, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Minimum [Member]

Maximum [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL Amendment No. 6 [Member]

Wells Fargo ABL Amendment No. 6 [Member]

Wells Fargo ABL Amendment No. 6 [Member]

Ares Capital [Member]

Ares Capital [Member]

Ares Capital [Member]

Ares Capital [Member]

Ares Capital [Member]

LIBOR [Member]

Minimum [Member]

Maximum [Member]

Federal Fund Rate [Member]

Interest Rate Option One [Member]

Interest Rate Option One [Member]

Interest Rate Option Two [Member]

Interest Rate Option Two [Member]

Interest Rate Option Three [Member]

Interest Rate Option Three [Member]

Maximum [Member]

Interest Rate Option One [Member]

Interest Rate Option Two [Member]

Interest Rate Option Three [Member]

LIBOR [Member]

LIBOR [Member]

LIBOR [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity under credit facility

'

'

'

'

'

'

$50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$47,500,000

$10,000,000

'

'

'

'

'

Maximum borrowing percentage of accounts receivable invoices

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit facility, maximum borrowing of accounts receivable plus of eligible inventory less certain reserves

'

'

'

'

'

'

7,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount outstanding under credit facility

'

'

'

'

'

'

40,200,000

'

'

1,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining borrowing capacity

'

'

'

'

'

'

4,800,000

'

'

48,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accounts receivable, net

13,130,387

'

'

7,771,623

'

'

6,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inventories, net

28,981,444

'

'

19,061,119

'

'

16,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash

'

'

'

'

'

'

11,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage added to base rate

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

0.50%

'

3.00%

'

3.50%

'

4.00%

'

'

'

0.50%

'

1.00%

1.50%

10.00%

Interest rate added to base rate depending on credit availability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.75%

'

1.25%

'

1.75%

'

'

'

'

9.00%

'

'

'

'

Interest rate on the Wells Fargo ABL

'

'

'

'

'

'

3.30%

'

'

3.10%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unused line fee percentage

'

'

'

'

'

'

'

'

'

'

'

0.38%

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Termination fee

'

'

'

'

'

'

'

'

'

'

'

250,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility maturity date

'

'

'

'

'

'

22-Nov-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum excess borrowing availability

'

'

'

'

'

'

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted cash

5,000,000

'

'

5,000,000

'

'

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Borrowing availability bench mark to comply with EDITDA requirements

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increased amount of authorized advances or payments

1,800,000

1,400,000

1,500,000

'

750,000

860,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fee paid for amendment

'

'

'

'

'

'

'

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduced credit available under the Wells Fargo ABL

'

'

'

'

'

'

'

'

2,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Company's consolidated earnings (loss) before interest, tax, depreciation, and amortization

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-20,200,000

'

'

'

'

'

'

'

Securities pledged as collateral

'

'

'

'

'

'

65.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advances to certain affiliates

'

'

'

'

'

'

'

'

'

'

'

'

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advances to certain affiliates, Thereafter

'

'

'

'

'

'

'

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increased the Letter of Credit

'

'

'

'

'

'

'

7,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letter of Credit Limit

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Standby letter of credit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000,000

'

'

'

Annual administrative fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$50,000

'

'

'

'

Quarterly fronting fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.75%

'

'

'

'

Quarterly letter of credit fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

Issued and outstanding capital stock pledged

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

65.00%

'

'

'

'

Series_J_Redeemable_Convertibl1

Series J Redeemable Convertible Preferred Stock - Additional Information (Detail) (USD $)

1 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

Sep. 25, 2012

25-May-12

Dec. 31, 2013

Sep. 11, 2013

Dec. 31, 2013

Sep. 11, 2013

Dec. 31, 2013

Dec. 31, 2013

Nov. 18, 2013

Oct. 16, 2013

Sep. 11, 2013

Dec. 31, 2013

Sep. 11, 2013

Sep. 11, 2013

Sep. 11, 2013

Dec. 31, 2013

Nov. 21, 2013

Pegasus Warrant [Member]

Pegasus Warrant [Member]

May 26, 2014 Prior [Member]

May 26, 2014 After [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Holdings II [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Pegasus [Member]

Pegasus [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Pegasus Warrant [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Temporary Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of preferred stock

'

'

'

'

'

'

'

'

'

1,449

17,394

'

12,500

2,500

2,394

'

'

Shares purchased, per share value

'

'

'

'

'

'

'

'

$1,000

'

'

'

$1,000

'

'

'

'

Gross Proceeds

$49,000,000

$67,100,000

'

'

'

'

'

'

$20,000,000

'

'

'

$17,400,000

'

'

'

'

Shares issued to Holdings II, in consideration for advisory services

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

'

'

'

Description of Series J subscription agreement

'

'

'Pursuant to the Series J Subscription Agreement, Pegasus committed to purchase the number of shares of Series J Preferred Stock equal to 20,000 minus the aggregate number of shares of Series J Preferred Stock issued in the Series J Preferred Offering and the Preemptive Rights Offering at a price per share equal to the Stated Value (the "Pegasus Series J Commitment").

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Shares sold

'

'

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate gross proceeds

'

'

'

'

'

'

'

'

'

1,400,000

'

'

'

'

'

'

'

Purchase of Preferred Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,157

Aggregate gross proceeds

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,200,000

Conversion price per share

'

'

'

$0.95

'

'

'

'

'

'

'

$0.95

'

'

'

'

'

Number of times liquidation amount multiplied

'

'

'

'

'

'

1.75

2

'

'

'

'

'

'

'

'

'

Redemption value of preferred stock deemed dividend

'

'

'

'

'

'

'

'

'

'

'

24,300,000

'

'

'

'

'

Number of shares of common stock

'

'

42,614,646

'

'

10,000,000

'

'

'

'

'

'

'

'

'

10,000,000

'

Percentage of total equity

'

'

'

'

'

2.76%

'

'

'

'

'

'

'

'

'

'

'

Total equity value

'

'

'

'

'

523,900,000

'

'

'

'

'

'

'

'

'

'

'

Pegasus Warrant expiration date

'

'

'

'

'

25-May-22

'

'

'

'

'

'

'

'

'

'

'

Change in fair value of warrants

'

'

'

'

$935,000

'

'

'

'

'

'

'

'

'

'

'

'

Series_H_and_Series_I_Redeemab1

Series H and Series I Redeemable Convertible Preferred Stock - Additional Information (Detail) (USD $)

0 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Sep. 11, 2013

Sep. 25, 2012

25-May-12

Dec. 31, 2013

Dec. 31, 2012

25-May-12

25-May-12

25-May-12

25-May-12

25-May-12

25-May-12

Dec. 31, 2012

25-May-12

25-May-12

Dec. 31, 2013

Dec. 31, 2012

Sep. 25, 2012

Sep. 25, 2012

Sep. 25, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Sep. 25, 2012

25-May-12

25-May-12

25-May-12

Sep. 25, 2012

Sep. 25, 2012

Dec. 31, 2013

Dec. 31, 2012

25-May-12

25-May-12

25-May-12

25-May-12

25-May-12

Dec. 31, 2013

Dec. 31, 2012

Sep. 25, 2012

25-May-12

Dec. 31, 2013

25-May-12

Dec. 31, 2012

Sep. 25, 2012

Dec. 31, 2012

Sep. 25, 2012

Jan. 13, 2011

One Year Anniversary [Member]

Two Year Anniversary [Member]

Three Year Anniversary [Member]

Wagner [Member]

Continental Company [Member]

Remaining holders [Member]

Settlement of Repurchase Obligation [Member]

Settlement of Repurchase Obligation [Member]

Riverwood Warrant [Member]

Riverwood Warrant [Member]

Riverwood Warrant [Member]

Portman [Member]

Cleantech A [Member]

Cleantech B [Member]

September 2012 Warrants [Member]

September 2012 Warrants [Member]

Pegasus Commitment [Member]

Pegasus Commitment [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Holdings II [Member]

Holdings II [Member]

Holdings II [Member]

Holdings II [Member]

PCA Holdings [Member]

PCA Holdings [Member]

September 2012 Warrant [Member]

September 2012 Warrant [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Remaining holders [Member]

Rollover Offering [Member]

Cleantech A [Member]

Cleantech B [Member]

Wagner [Member]

Continental Company [Member]

Remaining holders [Member]

Rollover Offering [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of preferred stock

'

'

'

113,609

113,643

'

'

'

'

'

'

'

'

'

'

'

24,500

'

'

'

'

'

'

113,609

113,609

49,000

60,705

'

4,346

20,862

3,638

62,365

62,365

6,364

'

'

'

50,001

'

'

'

'

'

'

'

51,000

'

'

'

Shares purchased, per share value

$1,000

'

$1,000

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross Proceeds

'

$49,000,000

$67,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion price per share

'

$1.18

$1.18

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair market value of common stock

'

$0.86

$1.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deemed dividend

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17,700,000

'

'

'

'

'

'

16,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional paid-in capital

'

'

34,600,000

331,199,891

347,686,258

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

53,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deemed dividend per share

'

'

$0.32

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from selling stockholders in the offering minimum

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Market capitalization of business

'

'

500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of times the liquidation amount multiplied

'

'

'

'

'

1.5

1.75

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion price per share

$0.95

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial conversion price per share

$1.18

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Consolidated earnings before interest, taxes, depreciation and amortization

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in consolidated earnings before interest, taxes, depreciation and amortization

50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deemed dividend

14,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redemption value of preferred stock deemed dividend

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

66,200,000

'

'

'

'

'

'

47,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redemption value of preferred stock in additional paid-in capital

'

'

113,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in redemption value

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage to purchase pro rata shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

95.00%

'

'

Warrant convertible conversion ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

163.2653

'

Holders owning the right to purchase offered shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49,102

'

'

'

'

'

'

'

'

'

Number of warrants assigned rights to participate in preferred offering

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,016,653

'

'

'

'

'

'

'

'

Number of common shares

'

'

'

'

'

'

'

'

'

'

'

'

2,505,000

'

'

'

4,000,000

3,406,041

593,959

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

Number of days available for redemption of shares

'

'

'

'

'10 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 days

'

'

'

'

Rollover offering conversion right, shares converted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

14,958

'

'

'

17,650

'

'

'

'

'

'

Converted preferred shares series

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,575

'

18,314

'

'

'

'

'

Elected Convertible Stock of Series G

'

'

'

'

'

'

'

'

6,500

5,000

8,250

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Converted Preferred Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,346

'

'

'

'

'

'

6,649

5,176

4,281

'

'

'

'

'

'

'

'

'

'

'

'

Preferred equity issued

'

'

'

'

'

'

'

'

'

'

'

'

80,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Surrendering common stock

'

'

'

'

'

'

'

'

'

'

'

'

3,750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redeemable preferred stock

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Indemnification payment to continental

'

'

'

'

'

'

'

'

'

'

'

'

16,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash paid for indemnification payment

'

'

'

'

'

'

'

'

'

'

'

10,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional cash paid for indemnification payment

'

'

'

'

'

'

'

'

'

'

'

6,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued under indemnification payment

'

'

'

'

'

'

'

'

'

'

'

6,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of common stock surrendered

'

'

'

'

'

'

'

'

'

'

'

'

3,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrant was issued to Riverwood Management

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25-May-12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Right to purchase common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

18,092,511

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise percent of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity value of company exceeds

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expiration date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25-May-22

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in fair value of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

8,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise price of common stock per share

'

'

'

'

$0.72

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in fair value of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

240,000

47,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

change in fair value of commitment shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$240,000

$47,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series_F_and_Series_G_Preferre2

Series F and Series G Preferred Units and Repurchase Obligation - Additional Information (Detail) (USD $)

1 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

Sep. 25, 2012

25-May-12

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 11, 2013

Jan. 17, 2012

Jan. 17, 2012

Dec. 31, 2012

Jan. 17, 2012

31-May-11

26-May-11

Jan. 17, 2012

31-May-11

Jan. 17, 2012

Dec. 31, 2011

Dec. 31, 2011

Nov. 17, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

18-May-12

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

31-May-12

18-May-12

Mar. 28, 2012

Mar. 20, 2012

2-May-12

Apr. 12, 2012

Feb. 24, 2012

Dec. 31, 2011

Apr. 13, 2012

Dec. 31, 2011

Dec. 31, 2011

Pegasus IV [Member]

Continental Company [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

LSGC Holdings [Member]

Series F Preferred Units [Member]

Series F Preferred Units [Member]

Series F Preferred Units [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Wells Fargo ABL [Member]

Continental Company [Member]

Continental Company [Member]

PCA Holdings [Member]

Leon Wagner [Member]

Wagner [Member]

November 17, 2012 [Member]

February 21, 2014 [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Holdings II [Member]

Holdings II [Member]

Accredited Investors [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Units issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40,000

10,000

1,500

'

'

'

18,250

1,500

'

'

10,000

17,650

2,000

2,000

2,000

2,000

1,000

2,000

6,500

2,000

14,958

13,250

Shares purchased, per share value

'

$1,000

$0.00

$0.00

'

$1,000

'

'

'

'

'

'

'

'

'

$1,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, shares outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

83

'

'

'

'

83

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value

'

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross Proceeds

$49,000,000

$67,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

$50,000,000

'

'

'

'

$50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Date to be redeemed

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21-Feb-14

'

'

21-Feb-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redemption period, maximum days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'91 days

'

'

'91 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate purchase price of shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

1,500,000

'

'

34,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of aggregate Series G Preferred units issued and outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

52,358

34,108

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issue price per Series G Preferred unit

'

'

'

'

'

'

'

'

'

'

$4

'

'

'

'

'

'

'

'

'

$1,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Consideration from Preferred units issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

52,400,000

18,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series G Preferred Stock in One Series G Unit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accretion of preferred stock

'

'

'

7,523,459

239,408

'

'

'

'

'

'

'

'

'

'

'

'

'

0

7,500,000

239,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss of Conversion of Series G Preferred Stock

'

'

'

6,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial annual cumulative dividend

'

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

15.00%

18.00%

'

'

'

'

'

'

'

'

'

'

'

'

Dividend preferred stock

'

'

-24,358,592

-202,105,466

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,800,000

238,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued

'

'

210,349,168

208,063,486

'

'

'

'

'

'

3,750,000

'

'

562,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net proceeds after agent commission

'

'

'

'

'

'

'

'

'

'

'

14,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issued senior preferred membership interests

'

'

'

'

'

'

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issue proceeds

'

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of Series G Preferred Units

'

'

'

'

'

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price of Series G preferred units

'

'

'

'

'

'

'

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional distribution of shares of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

682,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum working capital facility in total credit

'

'

'

'

'

'

'

'

'

'

'

'

75,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Working capital facility exceed certain percentage on earning before interest, taxes, depreciation and amortization

'

'

'

'

'

'

'

'

'

300.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Original principal amount of outstanding preferred equity securities issue

'

'

'

'

'

'

'

'

'

80,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock returned

'

'

'

'

'

'

'

'

3,750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of common stock shares distributed available for surrender

'

'

'

'

'

'

'

'

'

2,505,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Transaction fees reimbursement

'

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party interest expense

'

'

'

250,000

43,200

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of the repurchase obligation

'

$12,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series_F_and_Series_G_Preferre3

Series F and Series G Preferred Units and Repurchase Obligation - Allocation of the Proceeds on the Series F and Series G Units between the Fair Market Value of the Common Stock and the Redeemable Preferred Shares (Detail) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Preferred Units [Line Items]	'	'
Total Proceeds	'	$34,108,000
Common Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	'	7,154,663
Redeemable Preferred Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	'	26,953,337
Series F Preferred Units [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	'	11,500,000
Series F Preferred Units [Member] | Common Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	'	2,204,895
Series F Preferred Units [Member] | Redeemable Preferred Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	'	9,295,105
Redeemable Series G Preferred Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	18,250,000	22,608,000
Redeemable Series G Preferred Stock [Member] | Common Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	1,904,684	4,949,768
Redeemable Series G Preferred Stock [Member] | Redeemable Preferred Stock [Member]	'	'
Preferred Units [Line Items]	'	'
Total Proceeds	$16,345,316	$17,658,232

Stockholders_Equity_and_Recapi2

Stockholders' Equity and Recapitalization Agreement - Additional Information (Detail) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

Dec. 04, 2013

Nov. 11, 2013

Aug. 14, 2013

Aug. 12, 2013

Mar. 22, 2013

Jan. 02, 2013

Mar. 14, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Nov. 08, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

25-May-12

25-May-12

Dec. 31, 2013

25-May-12

25-May-12

25-May-12

Dec. 31, 2013

25-May-12

25-May-12

25-May-12

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Sep. 25, 2012

Mar. 14, 2012

Dec. 31, 2012

Mar. 28, 2012

Mar. 14, 2012

25-May-12

18-May-12

Dec. 31, 2012

Dec. 31, 2011

Apr. 28, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

25-May-12

Jan. 13, 2011

25-May-12

25-May-12

Chief Executive Officer [Member]

Board of Directors Serving on One or More Committee [Member]

September 2012 Warrants [Member]

Restricted Stock Awards [Member]

Restricted Stock Awards [Member]

Restricted Stock Awards [Member]

Restricted Stock Awards [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

2007 Private Placement Warrants [Member]

Series D Warrants [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Series H And I Preferred Offering [Member]

Series H And I Preferred Offering [Member]

September 2012 Preferred Offering [Member]

September 2012 Preferred Offering [Member]

Non-Employee Directors [Member]

Non-Employee Directors [Member]

Non-Employee Directors [Member]

Audit Committee and Committee of Independent Directors [Member]

Resignation of the Board Members [Member]

Termination of James Haworth [Member]

Termination of James Haworth [Member]

Termination of James Haworth [Member]

Termination of James Haworth [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Fair Market Value of Warrants [Member]

Chief Executive Officer [Member]

2007 Private Placement Warrants [Member]

Series H Preferred Warrants [Member]

Series I Preferred Warrants [Member]

2007 Private Placement Warrants [Member]

Series H Preferred Warrants [Member]

Series I Preferred Warrants [Member]

Restricted Stock Awards [Member]

Restricted Stock Awards [Member]

Minimum [Member]

Maximum [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued for compensation package

'

'

'

'

192,308

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expenses related to stock options issued

'

'

'

'

'

'

'

$6,900,000

$7,300,000

$3,200,000

'

'

'

$746,000

$846,000

$945,000

$173,000

$20,000

$718,000

$178,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unvested restricted shares

'

'

'

'

'

'

'

'

'

'

385,417

'

'

385,417

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

220,594

736,111

'

'

'

'

'

'

'

'

'

'

Restricted stock issued as part of settlement of director fees

14,795

26,301

1,813,411

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted stock issued for each member of the Board of Directors

'

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional restricted stock issued

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional restricted stock issued

'

'

'

'

'

'

'

'

'

'

'

15,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Settlement of director fees

'

'

'

'

'

'

875,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

347,000

'

27,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payable to each director

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock options to issue to purchase shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Shares of Common stock to issue Directors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, Purchase price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.19

'

$1.19

'

'

'

'

'

'

'

'

'

$2

'

'

Stock options and restricted shares of common stock vesting period

'

'

'

'

'

'

'On the first day of each calendar quarter, commencing January 1, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vesting rate per quarter

'

'

'

'

'

'

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock option expiration date

'

'

'

'

'

'

13-Mar-22

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted common stock issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

630,254

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

Common stock option to purchase

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

125,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued

'

'

'

'

'

'

'

210,349,168

208,063,486

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

218,096

'

30,901

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options to Purchase

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,068

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expenses incurred in issue of restricted stock awards

'

'

'

'

'

'

'

891,000

1,200,000

484,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

332,000

592,000

'

'

'

'

'

'

'

'

Common stock, shares outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

'

'

Strategic Purchasing Agreement date with the home depot to supply LED retrofit lamps and fixtures

'

'

'

'

'

'

'

23-Jul-10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Base date to exercise price of warrant

'

'

'

'

'

'

'

23-Jul-10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock vested shares

'

'

'

'

'

'

'

'

'

'

'

'

'

384,699

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

Percentage of gross product order

'

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vesting date of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Dec-14

'

'

'

31-Dec-15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long- term purchase commitment additional extension time period, years

'

'

'

'3 years

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long- term purchase commitment, time period, years

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Per share of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.18

$5.90

$5.57

'

$1.60

$5.92

$5.59

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.95

$2

Common stock exercisable warrants

'

'

'

'

'

'

'

42,614,646

'

'

'

'

'

'

'

'

'

'

'

'

1,273,112

1,171,044

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

'

'

'

Number of exercisable shares of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,726,249

1,240,798

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,123,715

'

'

'

Warrants expiration date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30-Nov-12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrant exercisable date

'

'

'

'

'

'

'

'

'

'

'

'

9-Oct-15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issuable pursuant to warrant vested

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,024,743

1,024,743

1,024,743

'

'

'

'

Shares issuable pursuant to warrant vested

'

'

'

'

'

'

'

2,049,486

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total equity value of company

'

'

'

'

'

'

'

523,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue (increase) reduction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

$458,000

$2,500,000

'

'

'

'

Stockholders_Equity_and_Recapi3

Stockholders' Equity and Recapitalization Agreement - Schedule of Warrants for Purchase of Common Stock (Detail)

Dec. 31, 2013

Sep. 11, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Pegasus Warrant [Member]

RW LSG Management Holdings LLC [Member]

Certain Other Investors [Member]

Cleantech Europe II (A) LP [Member]

Cleantech Europe II (B) LP [Member]

Portman Limited [Member]

Aquillian Investments LLC [Member]

Pegasus [Member]

Investors in Rights Offering [Member]

Investors in Rights Offering [Member]

Investors in Rights Offering [Member]

The Home Depot [Member]

Riverwood Warrants [Member]

Riverwood Warrants [Member]

September 2012 Warrants [Member]

September 2012 Warrants [Member]

September 2012 Warrants [Member]

Private Placement Series H [Member]

Pegasus Warrant [Member]

Series D Warrants [Member]

Series D Warrants [Member]

Series D Warrants [Member]

Purchasing Agreement [Member]

Minimum [Member]

Maximum [Member]

Class of Warrant or Right [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of common shares

42,614,646

10,000,000

12,664,760

5,427,751

3,406,041

593,959

4,000,000

830,508

10,000,000

567,912

'

'

5,123,715

Exercise Price

'

'

'

'

0.72

0.72

0.72

1.18

'

'

5.57

5.59

1.95

Exercise Price, Description

'

'

'Variable

'Variable

'

'

'

'

'Variable

'

'

'

'

Expiration Date, period start

'

'

'

'

'

'

'

'

'

'March 3, 2022

'

'

'2014

Expiration Date, period end

'

'

'May 25, 2022

'May 25, 2022

'September 25, 2022

'September 25, 2022

'September 25, 2022

'September 25, 2017

'May 25, 2022

'April 19, 2022

'

'

'2018

Earnings_Loss_Per_Share_Additi

Earnings (Loss) Per Share - Additional Information (Detail)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]	'	'	'
Method used to compute net loss per share of noncontrolling shareholders and controlling shareholders common stock	'two-class method	'two-class method	'
Common stock equivalents outstanding	88.1	77.7	9.2

Earnings_Loss_Per_Share_Comput

Earnings (Loss) Per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Basic and diluted net income per share:	'	'	'	'	'	'	'	'	'	'	'
Net loss from operations	'	'	'	'	'	'	'	'	($89,817,332)	($111,340,409)	($90,434,568)
Deemed dividends related to Preferred Stock attributable to all shareholders	'	'	'	'	'	'	'	'	-24,358,592	-202,105,466	'
Undistributed net loss	'	'	'	'	'	'	'	'	'	'	-90,434,568
Basic and diluted weighted average number of common shares outstanding	'	'	'	'	'	'	'	'	'	'	189,671,299
Basic and diluted net loss per common share:	'	'	'	'	'	'	'	'	'	'	($0.48)
Controlling Shareholders [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net income per share:	'	'	'	'	'	'	'	'	'	'	'
Net loss from operations	'	'	'	'	'	'	'	'	-74,506,560	-93,066,715	'
Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders	'	'	'	'	'	'	'	'	'	12,488,175	'
Deemed dividends due to issuance of Commitment Shares attributable to all shareholders	'	'	'	'	'	'	'	'	'	-1,337,401	'
Undistributed net loss	'	'	'	'	'	'	'	'	-94,712,848	-252,109,272	'
Basic and diluted weighted average number of common shares outstanding	'	'	'	'	'	'	'	'	170,662,220	171,336,891	'
Basic and diluted net loss per common share:	($0.16)	($0.37)	($0.98)	($0.01)	($0.09)	($0.37)	($0.98)	($0.01)	($0.55)	($1.47)	'
Controlling Shareholders [Member] | Series H and I and J Preferred Stock [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net income per share:	'	'	'	'	'	'	'	'	'	'	'
Deemed dividends related to Preferred Stock attributable to all shareholders	'	'	'	'	'	'	'	'	-20,206,288	-170,193,331	'
Noncontrolling Shareholders [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net income per share:	'	'	'	'	'	'	'	'	'	'	'
Net loss from operations	'	'	'	'	'	'	'	'	-15,310,772	-18,273,694	'
Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders	'	'	'	'	'	'	'	'	'	-12,488,175	'
Deemed dividends due to issuance of Commitment Shares attributable to all shareholders	'	'	'	'	'	'	'	'	'	-262,599	'
Undistributed net loss	'	'	'	'	'	'	'	'	-19,463,076	-64,442,009	'
Basic and diluted weighted average number of common shares outstanding	'	'	'	'	'	'	'	'	35,070,340	33,642,080	'
Basic and diluted net loss per common share:	($0.16)	($0.37)	($0.94)	($0.51)	($0.09)	($0.37)	($0.94)	($0.51)	($0.55)	($1.92)	'
Noncontrolling Shareholders [Member] | Series H and I and J Preferred Stock [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net income per share:	'	'	'	'	'	'	'	'	'	'	'
Deemed dividends related to Preferred Stock attributable to all shareholders	'	'	'	'	'	'	'	'	($4,152,304)	($33,417,541)	'

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2011

18-May-12

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

25-May-12

Dec. 31, 2013

Sep. 30, 2012

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

2-May-12

Apr. 12, 2012

Feb. 24, 2012

Dec. 31, 2011

18-May-12

Mar. 28, 2012

Mar. 20, 2012

Dec. 31, 2012

31-May-12

Apr. 13, 2012

Dec. 31, 2011

Series H Redeemable Convertible Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

2012 Support Services Agreement [Member]

Riverwood Support Services Agreement [Member]

Riverwood Support Services Agreement [Member]

Riverwood Support Services Agreement [Member]

Riverwood Support Services Agreement [Member]

Zouk Support Services Agreement [Member]

Zouk Support Services Agreement [Member]

Pegasus Capital [Member]

LSGC Holdings [Member]

Riverwood [Member]

GYRO LLC [Member]

GYRO LLC [Member]

GYRO LLC [Member]

T&M Protection Resources [Member]

T&M Protection Resources [Member]

T&M Protection Resources [Member]

MWW Group [Member]

MWW Group [Member]

MWW Group [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Leon Wagner [Member]

Leon Wagner [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

PCA Holdings [Member]

Holdings II [Member]

Holdings II [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Riverwood Support Services Agreement [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Redeemable Series G Preferred Stock [Member]

Maximum [Member]

Maximum [Member]

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due to related parties

'

'

'

'

'

'

'

$125,000

'

'

$20,000

'

$100,000

'

$187,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ownership percentage of subsidiary held in parent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

83.10%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Services agreement, expiration terms

'

'

'

'

'

'

'

'The 2012 Support Services Agreement expires upon the earlier of (i) June 30, 2017; (ii) a Change of Control or (iii) a QPO. During the first 30 days of any calendar quarter, the Company has the right to terminate the 2012 Support Services Agreement, effective immediately upon written notice to Pegasus Capital.

'

'

'the Riverwood Support Services Agreement with Riverwood Holdings, pursuant to which the Company agreed to pay Riverwood Holdings $20,000 for the period from May 25, 2012 through June 30, 2012 and thereafter $50,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The Riverwood Support Services Agreement expires upon the earlier of: (i) May 25, 2022, (ii) such date that Riverwood Management and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the Preferred Offering, on an as-converted basis (together with any shares of common stock issued upon conversion thereof); (iii) such date that the Company and Riverwood may mutually agree in writing (iv) a Change of Control or (v) a QPO. In addition, the Company has brought in several employees of Riverwood to provide consulting services, including Brad Knight, who served as the Companybs Chief Executive Officer from October 19, 2012 through January 1, 2013 and is currently the Companybs Chief Operations Officer. During the year ended December 31, 2012, the Company recorded $70,000 of management fees pursuant to the Riverwood Support Services Agreement, included in general and administrative expenses. During the year ended December 31, 2012, the Company incurred $1.0 million of consulting fees for services provided by Riverwood, of which $28,000 were included in sales and marketing expenses, $357,000 were included in operations expenses and $647,000 were included in general and administrative expenses.

'

'The Zouk Support Services Agreement expires upon the earlier of (i) September 25, 2022; (ii) such date that Zouk and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the September 2012 Preferred Offering, on an as-converted basis; (iii) such date that the Company and Zouk may mutually agree in writing; (iv) a Change of Control and (v) a QPO.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letter agreement entering date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17-Jan-12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party interest expense

'

250,000

43,200

'

'

'

'

'

'

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party expense

0

313,000

625,000

'

'

'

'

'

'

70,000

'

'

'

'

'

'

'

0

118,000

369,000

14,000

40,000

122,000

0

174,000

549,000

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of shares owned in preferred stock

'

'

'

'

'

'

'

'

'

'

'

37.50%

'

37.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Future Payment to Riverwood Holdings

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party service consulting fees

'

'

'

'

'

'

'

'

2,200,000

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Legal fees and out of pocket expenses

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

48,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Units issued

'

'

'

'

'

'

18,250

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000

1,000

2,000

6,500

2,000

2,000

2,000

10,000

17,650

2,000

14,958

Proceeds from sale of series G preferred units

'

'

$34,108,000

$108,199,594

$18,250,000

$22,608,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5,000,000

'

'

'

'

$6,000,000

$6,000,000

$6,000,000

'

'

$2,000,000

'

Equity_Based_Compensation_Plan2

Equity Based Compensation Plans - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Shares authorized for issuance	55,000,000	'	'
Common stock available for issuance	22,100,000	'	'
Unrecognized compensation cost	$14,500,000	'	'
Weighted average period	'2 years 7 months 28 days	'	'
Compensation expense related to restricted stock awards	891,000	1,200,000	484,000
Stock option expense	6,900,000	7,300,000	3,200,000
Directors Plan [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Common stock available for issuance	1,000,000	'	'
Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Term of stock options granted	'10 years	'	'
Stock option expense	20,000	718,000	178,000
Restricted Stock Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Weighted average period	'7 months 13 days	'	'
Unrecognized compensation cost related to restricted stock granted	47,000	'	'
Stock option expense	$746,000	$846,000	$945,000
2011 Employee Stock Purchase Plan [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Shares authorized for issuance	2,000,000	'	'
Common stock available for issuance	1,800,000	'	'
Percentage to elect	30.00%	'	'
Maximum number of shares to be purchased	2,000	'	'
Percentage of fair market value of a share of common stock	85.00%	'	'
Common stock issued	88,284	89,707	13,705
2011 Employee Stock Purchase Plan [Member] | Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Common stock issued per share	$0.29	'	'
2011 Employee Stock Purchase Plan [Member] | Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Common stock issued per share	$2.32	'	'

Equity_Based_Compensation_Plan3

Equity Based Compensation Plans - Stock Option Activity (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Number of shares, Outstanding, Beginning balance	31,877,527
Number of shares, Granted	11,336,229
Number of shares, Exercised	'
Number of shares, Forfeited or expired	-14,817,607
Number of shares, Outstanding, Ending balance	28,396,149
Number of shares, Vested or expected to vest, Ending balance	26,598,213
Number of shares, Exercisable, Ending balance	13,898,301
Weighted average exercise price, Outstanding, Beginning balance	$1.42
Weighted average exercise price, Granted	$0.57
Weighted average exercise price, Exercised	'
Weighted average exercise price, Forfeited or expired	$1.21
Weighted average exercise price, Outstanding, Ending balance	$1.19
Weighted average exercise price, Vested or expected to vest, Ending balance	$1.21
Weighted average exercise price, Exercisable, Ending balance	$1.31
Weighted average remaining contractual term, Outstanding, Ending balance	'5 years 8 months 16 days
Weighted average remaining contractual term, Vested or expected to vest, Ending balance	'5 years 7 months 2 days
Weighted average remaining contractual term, Exercisable, Ending balance	'4 years 1 month 6 days
Aggregate intrinsic value, Outstanding, Ending balance	'
Aggregate intrinsic value, Vested or expected to vest, Ending balance	'
Aggregate intrinsic value, Exercisable, Ending balance	'

Equity_Based_Compensation_Plan4

Equity Based Compensation Plans - Stock Options Outstanding and Exercisable (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number	28,396,149
Options Outstanding, Weighted Average Remaining Contractual Term	'5 years 8 months 16 days
Options Outstanding, Weighted Average Exercise Price	$1.19
Options Exercisable, Number	13,898,301
Options Exercisable, Weighted Average Exercise Price	$1.31
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$0.44
Range of Exercise Price, Upper range limit	$0.44
Options Outstanding, Number	36,750
Options Outstanding, Weighted Average Remaining Contractual Term	'9 years 3 months 15 days
Options Outstanding, Weighted Average Exercise Price	$0.44
Options Exercisable, Number	1,750
Options Exercisable, Weighted Average Exercise Price	$0.44
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$0.50
Range of Exercise Price, Upper range limit	$0.50
Options Outstanding, Number	5,352,000
Options Outstanding, Weighted Average Remaining Contractual Term	'7 years 8 months 1 day
Options Outstanding, Weighted Average Exercise Price	$0.50
Options Exercisable, Number	18,000
Options Exercisable, Weighted Average Exercise Price	$0.50
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$0.60
Range of Exercise Price, Upper range limit	$0.92
Options Outstanding, Number	2,018,000
Options Outstanding, Weighted Average Remaining Contractual Term	'3 years 10 months 21 days
Options Outstanding, Weighted Average Exercise Price	$0.70
Options Exercisable, Number	1,331,500
Options Exercisable, Weighted Average Exercise Price	$0.67
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$1
Range of Exercise Price, Upper range limit	$1
Options Outstanding, Number	5,382,375
Options Outstanding, Weighted Average Remaining Contractual Term	'5 years 5 months 27 days
Options Outstanding, Weighted Average Exercise Price	$1
Options Exercisable, Number	5,271,375
Options Exercisable, Weighted Average Exercise Price	$1
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$1.01
Range of Exercise Price, Upper range limit	$1.09
Options Outstanding, Number	160,750
Options Outstanding, Weighted Average Remaining Contractual Term	'7 years 5 months 9 days
Options Outstanding, Weighted Average Exercise Price	$1.07
Options Exercisable, Number	56,125
Options Exercisable, Weighted Average Exercise Price	$1.07
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$1.34
Range of Exercise Price, Upper range limit	$1.34
Options Outstanding, Number	13,597,989
Options Outstanding, Weighted Average Remaining Contractual Term	'5 years 1 month 13 days
Options Outstanding, Weighted Average Exercise Price	$1.34
Options Exercisable, Number	6,153,516
Options Exercisable, Weighted Average Exercise Price	$1.34
Range Seven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Price, Lower range limit	$1.35
Range of Exercise Price, Upper range limit	$10.80
Options Outstanding, Number	1,848,285
Options Outstanding, Weighted Average Remaining Contractual Term	'6 years 8 months 12 days
Options Outstanding, Weighted Average Exercise Price	$3.25
Options Exercisable, Number	1,066,035
Options Exercisable, Weighted Average Exercise Price	$3.54

Equity_Based_Compensation_Plan5

Equity Based Compensation Plans - Other Information Pertaining to Stock Options (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'	'	'
Weighted average grant date fair value per share of options	$0.39	$1.02	$3.66
Total intrinsic value of options exercised	'	$339,649	$3,044,903

Equity_Based_Compensation_Plan6

Equity Based Compensation Plans - Nonvested Shares of Restricted Stock Awards Outstanding (Detail) (Restricted Stock Awards [Member], USD $)	12 Months Ended
	Dec. 31, 2013
Restricted Stock Awards [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Shares, Nonvested, Beginning balance	'
Number of Shares, Granted	2,546,815
Number of Shares, Vested	-384,699
Number of Shares, Forfeited	-385,417
Number of Shares, Nonvested, Ending balance	1,776,699
Weighted Average Grant Date Fair Value, Nonvested, Beginning balance	'
Weighted Average Grant Date Fair Value, Granted	$0.47
Weighted Average Grant Date Fair Value, Vested	$0.54
Weighted Average Grant Date Fair Value, Forfeited	$0.64
Weighted Average Grant Date Fair Value, Nonvested, Ending balance	$0.42

Equity_Based_Compensation_Plan7

Equity Based Compensation Plans - Weighted Average Assumptions Used to Value Stock Option Grants (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Option Grants:	'	'	'
Expected dividend yield	0.00%	0.00%	0.00%
Expected forfeiture rate	7.49%	8.78%	8.78%
Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Exercise price	0.44	0.74	2.5
Fair market value of the underlying stock on date of grant	0.38	0.74	2.5
Stock Option Grants:	'	'	'
Risk-free interest rate	1.03%	0.60%	0.92%
Expected life, in years	'6 years	'2 years	'4 years
Expected volatility	99.51%	97.25%	71.10%
Fair value per share	0.08	0.59	1.91
Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Exercise price	0.7	1.59	5.05
Fair market value of the underlying stock on date of grant	0.64	1.59	5.05
Stock Option Grants:	'	'	'
Risk-free interest rate	2.00%	1.24%	2.37%
Expected life, in years	'6 years 3 months	'6 years 3 months	'6 years 3 months
Expected volatility	101.82%	103.17%	100.05%
Fair value per share	0.52	1.24	3.29

Restructuring_Expenses_Summary

Restructuring Expenses - Summary of Restructuring Expenses and Related Charges (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]	'	'	'
Multi-year initiatives and related charges	$4,657,497	$6,212,936	$598,037
Multi Year Initiatives [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Multi-year initiatives and related charges	4,658,825	6,212,936	598,037
Multi Year Initiatives [Member] | Facility Closing [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Multi-year initiatives and related charges	4,479,076	'	'
Multi Year Initiatives [Member] | Organization Optimization Initiative [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Multi-year initiatives and related charges	77,061	2,304,374	598,037
Mexico [Member] | Multi Year Initiatives [Member] | Facility Closing [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Multi-year initiatives and related charges	$102,688	$3,908,562	'

Restructuring_Expenses_Summary1

Restructuring Expenses - Summary of Restructuring Expenses and Related Charges (Parenthetical) (Detail) (Multi Year Initiatives [Member], USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	31-May-12
	Position	Mexico [Member]	Mexico [Member]	United States [Member]
		Employee	Non-cash Impairment [Member]	Employee
Restructuring Cost and Reserve [Line Items]	'	'	'	'
No of employees terminated	43	520	'	'
Write-down of property and equipment	$2,400,000	'	'	'
Expected additional cost	100,000	'	'	'
Restructuring accrued expenses and charges	'	'	$1,700,000	'
Number of employees replaced	'	'	'	10

Restructuring_Expense_Accrued_

Restructuring Expense - Accrued Liability Associated with the Restructuring Charges (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve [Line Items]	'	'
Accrued liability, Beginning Balance	$1,620,956	$543,007
Charges	2,093,498	4,158,032
Payments	-2,737,666	-3,080,083
Accrued liability, Ending Balance	976,788	1,620,956
Organization Optimization Initiative [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Accrued liability, Beginning Balance	1,620,956	368,168
Charges	1,449,584	4,158,032
Payments	-2,370,708	-2,905,244
Accrued liability, Ending Balance	699,832	1,620,956
Excess Facilities [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Accrued liability, Beginning Balance	'	174,839
Charges	134,373	'
Payments	-134,373	-174,839
Accrued liability, Ending Balance	'	'
Other Exit Costs [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Accrued liability, Beginning Balance	'	'
Charges	509,541	'
Payments	-232,585	'
Accrued liability, Ending Balance	$276,956	'

Restructuring_Expense_Addition

Restructuring Expense - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Restructuring Costs [Abstract]	'
Remaining accrual	$977,000

Income_Taxes_Consolidated_Inco

Income Taxes - Consolidated Income Tax Provision (Benefit) from Continuing Operations (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Loss before taxes	'	'	'
Domestic	($86,599,121)	($108,719,057)	($88,529,365)
Foreign	-3,218,211	-2,621,352	-1,905,203
Loss before income tax expense	($89,817,332)	($111,340,409)	($90,434,568)

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating Loss Carryforwards [Line Items]	'	'	'
Percentage of federal statutory rate income tax benefit applied	'	34.00%	'
Valuation allowance	$168,176,326	$136,840,211	'
Change in the valuation allowance	31,300,000	'	'
Expiration date of loss carryforwards	'From 2016 through 2033	'	'
Percentage of tax benefits recognized upon ultimate settlement	50.00%	'	'
Unrecognized tax benefits	0	0	'
Accrued or paid interest or penalties	0	0	0
2012 through 2030 [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Accumulated operating loss carryforwards	$75,000,000	'	'

Income_Taxes_Reconciliation_of

Income Taxes - Reconciliation of the Provision for Income Taxes from Continuing Operations (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Loss before taxes	($89,817,332)	($111,340,409)	($90,434,568)
Income tax benefit applying United States federal statutory rate of 34%	-30,537,893	-37,855,739	-30,747,753
State taxes, net of federal benefit	-1,674,412	-2,472,538	-2,101,978
Permanent differences	'	'	'
Accretion of preferred stock	'	2,869,489	81,399
Preferred stock dividends	'	128,850	80,860
Derivative fair value adjustment	-1,323,618	-2,891,183	'
Goodwill impairment	'	'	978,797
Life insurance proceeds	'	'	-2,380,000
Other	40,669	87,336	110,030
Increase in valuation allowance	31,336,114	37,172,107	31,771,303
Change in effective tax rate - United States	1,597,640	'	2,333,139
Change in effective tax rate - foreign	'	'	266,728
Expiration/true up of NOL's	110,950	2,594,689	'
Rate difference between United States federal statutory rate and Netherlands statutory rate	450,550	366,989	'
Other	'	'	-392,525
Income tax expense (benefit)	'	'	'

Income_Taxes_Deferred_Income_T

Income Taxes - Deferred Income Taxes Reflect the Net Tax Effects of Temporary Differences between the Carrying Amounts of Assets and Liabilities for Financial Reporting Purposes (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred income tax assets	'	'
Net operating loss carryforwards	$147,867,489	$118,000,686
Charitable contribution carryforward	41,080	35,681
Stock based compensation	7,699,202	5,032,075
Inventories	8,536,445	9,017,002
Reserve for losses on non-cancelable purchase commitments	439,438	2,439,522
Accounts receivable	150,639	366,973
Warranty liability	1,158,759	725,723
Accrued vacation	'	'
Goodwill impairment on asset acquisition	857,283	943,552
Accrued compensation	425,923	321,906
Accrued legal fees	186,934	107,277
Fixed Asset Impairment	919,185	'
Depreciation	28,236	18,303
Accrued Florida use tax	286	223
Total deferred income tax assets	168,343,021	137,008,923
Less: valuation allowance	-168,176,326	-136,840,211
Net deferred tax assets	166,695	168,712
Deferred income tax liabilities	'	'
Stock losses	-166,695	-168,712
Total deferred income tax liabilities	-166,695	-168,712
Net deferred tax liabilities	'	'
India [Member]	'	'
Deferred income tax assets	'	'
India Start up Costs	$32,122	'

Income_Taxes_Tax_Loss_Carryfor

Income Taxes - Tax Loss Carryforwards Available to Offset Future Income Taxes (Detail) (USD $)	Dec. 31, 2013
United States [Member]	'
Operating Loss Carryforwards [Line Items]	'
2018	$13,760,592
2019	2,293,432
2020	1,473,066
2021	2,769,043
2022	1,840,300
2023	2,031,270
2024	3,353,481
2025	2,293,432
2026	2,293,432
2027	9,937,230
2028	33,456,349
2029	33,916,312
2030	50,887,617
2031	67,057,312
2032	90,683,320
2033	85,216,468
Total	403,262,656
The Netherlands [Member]	'
Operating Loss Carryforwards [Line Items]	'
2016	3,869,995
2017	4,265,206
2018	4,692,440
2019	908,706
2020	1,200,654
2021	1,967,494
Total	$16,904,495

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Customer	Customer	Customer
Concentration Risk [Line Items]	'	'	'
Number of customers	1	2	2
Percentage of revenue represented by major customers	55.00%	70.00%	73.00%
Accounts Receivable [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Number of customers	1	2	'
Concentration risk, percentage	55.00%	77.00%	'

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
	USD ($)	USD ($)	USD ($)	Geveran Investments Ltd. [Member]	LSGBV [Member]	LSGBV [Member]
	Employees			USD ($)	USD ($)	EUR (€)
Contingencies And Commitments [Line Items]	'	'	'	'	'	'
Purchase commitments, which are generally non-cancellable	$19,000,000	'	'	'	'	'
Rent expense incurred	2,100,000	2,300,000	2,600,000	'	'	'
Number of employee defendants in lawsuit	2	'	'	'	'	'
Investment in the company, as well as recovery of costs and attorney's fees	'	'	'	25,000,000	1,200,000	'
Accrued expenses	$7,180,108	$6,754,946	'	'	$460,000	€ 310,000

Commitments_and_Contingencies_2

Commitments and Contingencies - Summary of Commitments Under Operating Leases for Property and Equipment (Detail) (USD $)	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
2014	$955,436
2015	891,829
2016	842,856
2017	724,476
2018	120,746
Thereafter	'
Total	$3,535,343

Defined_Contribution_Plan_Addi

Defined Contribution Plan - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Total employee contributions	'	'	50.00%
Employee contributions during the year	'	'	6.00%
401(k) Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Company's contributed to the 401(k) Plan	$303,000	$332,000	$194,000

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) - Company's Consolidated Quarterly Results of Operations (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue	$21,295,914	$21,951,094	$19,992,942	$19,981,607	$26,042,140	$32,056,779	$30,073,451	$38,938,981	'	'	'
Gross deficit	-11,773,789	-5,309,971	393,545	1,868,492	-2,970,742	-475,431	-20,266,275	3,920,992	-14,821,723	-19,791,456	-20,205,557
Net loss	($32,098,297)	($25,503,127)	($15,737,704)	($16,478,204)	($18,391,132)	($23,995,506)	($50,429,655)	($18,524,116)	($89,817,332)	($111,340,409)	($90,434,568)
Basic and diluted net loss per weighted average common share attributable to controlling shareholders	'	'	'	'	'	'	'	'	'	'	($0.48)
Controlling Shareholders [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net loss per weighted average common share attributable to controlling shareholders	($0.16)	($0.37)	($0.98)	($0.01)	($0.09)	($0.37)	($0.98)	($0.01)	($0.55)	($1.47)	'
Noncontrolling Shareholders [Member]	'	'	'	'	'	'	'	'	'	'	'
Basic and diluted net loss per weighted average common share attributable to controlling shareholders	($0.16)	($0.37)	($0.94)	($0.51)	($0.09)	($0.37)	($0.94)	($0.51)	($0.55)	($1.92)	'

Valuation_and_Qualifying_Accou2

Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Allowance for Doubtful Accounts [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance as of Beginning of Period	$1,188,366	$1,513,611	$851,191
Currency Translation Adjustments	7,381	2,720	-9,133
Additions Charged to Costs and Expenses	245,151	577,090	2,001,614
Additions Charged (Credited) to Other Accounts	'	'	'
Deductions from Allowances	-965,943	-905,055	-1,330,061
Balance as of End of Period	474,955	1,188,366	1,513,611
Provision for Purchase Commitments [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance as of Beginning of Period	5,678,992	5,806,032	'
Currency Translation Adjustments	'	'	'
Additions Charged to Costs and Expenses	844,233	5,580,993	8,549,202
Additions Charged (Credited) to Other Accounts	-4,562,550	-5,708,033	-2,743,170
Deductions from Allowances	-770,080	'	'
Balance as of End of Period	$1,190,595	$5,678,992	$5,806,032

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Oct. 16, 2013

Sep. 11, 2013

Dec. 31, 2013

Nov. 18, 2013

Dec. 31, 2012

Sep. 11, 2013

Sep. 11, 2013

Sep. 11, 2013

Feb. 19, 2014

Feb. 19, 2014

Feb. 19, 2014

Feb. 19, 2014

Mar. 07, 2014

Mar. 07, 2014

Feb. 19, 2014

Feb. 19, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Jan. 03, 2014

Mar. 07, 2014

Jan. 03, 2014

Mar. 07, 2014

Mar. 07, 2014

Mar. 07, 2014

Jan. 03, 2014

In Millions, except Share data, unless otherwise specified

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Holdings II [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Closing Date Term Loan [Member]

Closing Date Term Loan [Member]

Delayed Draw Term Loan [Member]

Delayed Draw Term Loan [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Warrants [Member]

Medley Warrants [Member]

Pegasus Guaranty Warrants [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Holdings II [Member]

PCA Holdings [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Riverwood Holdings [Member]

Zouk [Member]

Other Accredited Investors [Member]

LSGC Holdings [Member]

Maximum [Member]

Maximum [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Warrants [Member]

Common Stock [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Issuance [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Units issued during period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17,475

'

'

'

17,475

'

'

'

'

'

'

'

'

'

'

Issuance of preferred stock

'

'

1,449

17,394

'

'

'

12,500

2,500

2,394

'

'

'

'

'

'

'

'

'

'

'

6,000

'

6,000

'

2,860

2,570

45

'

Number of common shares

42,614,646

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,650

5,000,000

5,000,000

'

'

99,308,750

'

6,625,000

'

6,344,100

'

'

'

36,191,050

Issuance of preferred stock

113,609

113,643

'

'

20,000

20,000

0

'

'

'

'

'

'

'

'

'

'

'

'

37,475

'

'

'

'

'

'

'

'

'

Term loan bears interest at a floating rate description

'

'

'

'

'

'

'

'

'

'

'The Closing Date Term Loan bears interest at a floating rate equal to three-month LIBOR plus 12% per annum

'

'The Delayed Draw Term Loan bears interest equal to three month LIBOR plus 12% per annum, as follows (i) up to 2% (at the Company's election) of interest may be paid as "payment in kind" by adding such accrued interest to the unpaid principal balance of the Closing Date Term Loan and (ii) the remainder is payable in cash monthly in arrears. The outstanding principal balance and all accrued and unpaid interest on the Delayed Draw Term Loan is due and payable on February 19, 2016.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate on term loan

'

'

'

'

'

'

'

'

'

'

12.00%

'

10.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued interest to the unpaid principal balance

'

'

'

'

'

'

'

'

'

'

'

2.00%

'

2.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing date secure term loan

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due and payable date of term loan

'

'

'

'

'

'

'

'

'

'

19-Feb-19

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan re-borrowing, closing date

'

'

'

'

'

'

'

'

'

'

'

'

'2014-06

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Borrowing limit of eligible accounts

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Borrowing limit of inventory

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Liquidity requirement

'

'

'

'

'

'

'

'

'

'

'

'

$2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan bears interest rate

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding principal balance and all accrued and unpaid interest are due and payable date

'

'

'

'

'

'

'

'

'

'

'

'

19-Feb-16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

Warrants exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.001

0.95

0.5

'

'

'

'

'

'

'

'

'

'

'

Warrants expire date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

19-Feb-24

19-Feb-24

'

'

'

'

'

'

'

'

'

'

'